<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Pharmacol</journal-id><journal-id journal-id-type="iso-abbrev">Front Pharmacol</journal-id><journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id><journal-title-group><journal-title>Frontiers in Pharmacology</journal-title></journal-title-group><issn pub-type="epub">1663-9812</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32063855</article-id><article-id pub-id-type="pmc">6997777</article-id><article-id pub-id-type="doi">10.3389/fphar.2019.01649</article-id><article-categories><subj-group subj-group-type="heading"><subject>Pharmacology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Small Leucine-Rich Proteoglycans in Skin Wound Healing</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pang</surname><given-names>Xiaoxiao</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/593530"/></contrib><contrib contrib-type="author"><name><surname>Dong</surname><given-names>Nuo</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/819517"/></contrib><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Zhong</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref><uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/592893"/></contrib></contrib-group><aff id="aff1">
<sup>1</sup>
<institution>Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Stomatological Hospital of Chongqing Medical University</institution>, <addr-line>Chongqing</addr-line>, <country>China</country>
</aff><aff id="aff2">
<sup>2</sup>
<institution>Division of Growth and Development, School of Dentistry, University of California, Los Angeles</institution>, <addr-line>Los Angeles, CA</addr-line>, <country>United States</country>
</aff><author-notes><fn fn-type="edited-by"><p>Edited by: Ali H. Eid, American University of Beirut, Lebanon</p></fn><fn fn-type="edited-by"><p>Reviewed by: Dragana Nikitovic, University of Crete, Greece; Edward Tredget, University of Alberta Hospital, Canada; George N. Tzanakakis, University of Crete, Greece</p></fn><corresp id="fn001">*Correspondence: Zhong Zheng, <email xlink:href="mailto:zzheng@dentistry.ucla.edu" xlink:type="simple">zzheng@dentistry.ucla.edu</email>
</corresp><fn fn-type="other" id="fn002"><p>This article was submitted to Translational Pharmacology, a section of the journal Frontiers in Pharmacology</p></fn></author-notes><pub-date pub-type="epub"><day>28</day><month>1</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>10</volume><elocation-id>1649</elocation-id><history><date date-type="received"><day>30</day><month>9</month><year>2019</year></date><date date-type="accepted"><day>16</day><month>12</month><year>2019</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Pang, Dong and Zheng</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Pang, Dong and Zheng</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Healing of cutaneous wounds is a complex and well-coordinated process requiring cooperation among multiple cells from different lineages and delicately orchestrated signaling transduction of a diversity of growth factors, cytokines, and extracellular matrix (ECM) at the wound site. Most skin wound healing in adults is imperfect, characterized by scar formation which results in significant functional and psychological sequelae. Thus, the reconstruction of the damaged skin to its original state is of concern to doctors and scientists. Beyond the traditional treatments such as corticosteroid injection and radiation therapy, several growth factors or cytokines-based anti-scarring products are being or have been tested in clinical trials to optimize skin wound healing. Unfortunately, all have been unsatisfactory to date. Currently, accumulating evidence suggests that the ECM not only functions as the structural component of the tissue but also actively modulates signal transduction and regulates cellular behaviors, and thus, ECM should be considered as an alternative target for wound management pharmacotherapy. Of particular interest are small leucine-rich proteoglycans (SLRPs), a group of the ECM, which exist in a wide range of connecting tissues, including the skin. This manuscript summarizes the most current knowledge of SLRPs regarding their spatial-temporal expression in the skin, as well as lessons learned from the genetically modified animal models simulating human skin pathologies. In this review, particular focus is given on the diverse roles of SLRP in skin wound healing, such as anti-inflammation, pro-angiogenesis, pro-migration, pro-contraction, and orchestrate transforming growth factor (TGF)&#x003b2; signal transduction, since cumulative investigations have indicated their therapeutic potential on reducing scar formation in cutaneous wounds. By conducting this review, we intend to gain insight into the potential application of SLRPs in cutaneous wound healing management which may pave the way for the development of a new generation of pharmaceuticals to benefit the patients suffering from skin wounds and their sequelae.</p></abstract><kwd-group><kwd>skin</kwd><kwd>skin wound healing</kwd><kwd>small leucine rich proteoglycans</kwd><kwd>extracelluar matrix</kwd><kwd>fibromodulin</kwd><kwd>decorin</kwd><kwd>biglycan</kwd><kwd>lumican</kwd></kwd-group><counts><fig-count count="5"/><table-count count="1"/><equation-count count="0"/><ref-count count="243"/><page-count count="18"/><word-count count="8332"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>The skin, comprised of the epidermis, dermis, and deeper subcutaneous tissue, is the largest organ of the body, and functions as the first line of defense from external assaults (<xref rid="B167" ref-type="bibr">Proksch et&#x000a0;al., 2008</xref>). Surgery and trauma in adults often result in wounds, which can cause the formation of refractory scars [i.e., hypertrophic scars and keloids, which are specific to humans (<xref rid="B9" ref-type="bibr">Baker et&#x000a0;al., 2009</xref>)] with significant functional and psychological consequences (<xref rid="B12" ref-type="bibr">Bayat et&#x000a0;al., 2003</xref>) that reduce the quality of life of individuals (<xref rid="B23" ref-type="bibr">Brown et&#x000a0;al., 2008</xref>). Compared to the normal scars that can be much smaller than the original wound, keloids are defined as pathologic scars that extend beyond the area of the original wound, while hypertrophic scars are restricted to the wound borders (<xref ref-type="fig" rid="f1">
<bold>Figure 1</bold>
</xref>) (<xref rid="B7" ref-type="bibr">Atiyeh et&#x000a0;al., 2005</xref>; <xref rid="B9" ref-type="bibr">Baker et&#x000a0;al., 2009</xref>; <xref rid="B152" ref-type="bibr">Naylor and Brissett, 2012</xref>). Consequently, annual spending on managing unwanted scarring exceeds $20 billion in the United States (<xref rid="B20" ref-type="bibr">Block et&#x000a0;al., 2015</xref>). Local corticosteroid injection and radiation therapy are the current standards of care for patients who suffer from scar formation (<xref rid="B211" ref-type="bibr">Tziotzios et&#x000a0;al., 2012</xref>); however, neither method shows consistent efficacy and often results in undesirable, sometimes severe, side effects (<xref rid="B65" ref-type="bibr">Gauglitz et&#x000a0;al., 2011</xref>). For instance, local corticosteroids injection is known to cause reduced wound strength with increased risks of dehiscence, pigmentation changes, granulomas, and skin atrophy (<xref rid="B34" ref-type="bibr">Chang and Ries, 2001</xref>; <xref rid="B12" ref-type="bibr">Bayat et&#x000a0;al., 2003</xref>); while radiation therapy is associated with growth inhibition, decreased wound strength, and increased long-term cancer risks (<xref rid="B78" ref-type="bibr">Haubner et&#x000a0;al., 2012</xref>).</p><fig id="f1" position="float"><label>Figure 1</label><caption><p>A diagram of typical appearances of normal scar, hypertrophic scar, and keloid. Unlike that the normal scar is often smaller than the original wound, keloids extend beyond the edge of the original wound, while hypertrophic scars are restricted to the wound borders. The black dotted line demarcates the area of the original wound.</p></caption><graphic xlink:href="fphar-10-01649-g001"/></fig><p>To date, several anti-scarring products targeting growth factors involved in the cutaneous wound healing process are being, or have been, tested in clinical trials for wound healing management. These include Juvista&#x02122; [recombinant transforming growth factor (TGF)&#x003b2;3, traditionally considered as an &#x0201c;antifibrotic TGF&#x003b2; isoform&#x0201d;; <uri xlink:type="simple" xlink:href="http://clinicaltrials.gov">clinicaltrials.gov</uri>: NCT00742443], interleukin (IL)10 (<uri xlink:type="simple" xlink:href="http://clinicaltrials.gov">clinicaltrials.gov</uri>: NCT00984646) (<xref rid="B108" ref-type="bibr">Kieran et&#x000a0;al., 2013</xref>; <xref rid="B109" ref-type="bibr">Kieran et&#x000a0;al., 2014</xref>), DSC127 (NorLeu3-angiotensin; <uri xlink:type="simple" xlink:href="http://clinicaltrials.gov">clinicaltrials.gov</uri>: NCT01830348), siRNA (RXI-109; <uri xlink:type="simple" xlink:href="http://clinicaltrials.gov">clinicaltrials.gov</uri>: NCT02030275) and antisense oligonucleotides (EXC 001; <uri xlink:type="simple" xlink:href="http://clinicaltrials.gov">clinicaltrials.gov</uri>: NCT01038297) that downregulate the expression of connective tissue growth factor (CTGF). However, most of these products failed to demonstrate efficacy in human trials. For instance, Juvista&#x02122; failed in phase III clinical trial in 2011 (<xref rid="B137" ref-type="bibr">McKee, 2011</xref>); Derma Sciences reported to stop all development work with DSC127 in scar reduction in 2015 (<xref rid="B119" ref-type="bibr">Levin, 2015</xref>); IL10 showed no efficacy of scar reduction in humans of African continental ancestral origin (<xref rid="B109" ref-type="bibr">Kieran et&#x000a0;al., 2014</xref>); and clinical trials appear to have been halted for EXC001 (<xref rid="B165" ref-type="bibr">Pfizer, 2011</xref>) as there have been no public updates since 2012; Relatively, RXI-109 seems to have some benefits on the visual appearance of scar tissue in phase II clinical trials, but it requires multiple post-surgery injections, which bring higher therapeutic costs and increase the patient&#x02019;s suffering (<xref rid="B62" ref-type="bibr">Galiano, 2015</xref>). As a consequence, no drugs have been officially approved for the prevention and reduction of cutaneous scarring.</p><p>The extracellular matrix (ECM), composed of numerous macromolecules, not only functions as the critical structural components but also plays essential roles in modulating vital cellular processes, such as adhesion (<xref rid="B98" ref-type="bibr">Jian et&#x000a0;al., 2013</xref>; <xref rid="B50" ref-type="bibr">Desseaux and Klok, 2015</xref>; <xref rid="B192" ref-type="bibr">Shih et&#x000a0;al., 2016</xref>), migration (<xref rid="B55" ref-type="bibr">Estrach et&#x000a0;al., 2011</xref>; <xref rid="B44" ref-type="bibr">Daley and Yamada, 2013</xref>; <xref rid="B98" ref-type="bibr">Jian et&#x000a0;al., 2013</xref>; <xref rid="B179" ref-type="bibr">Scarpa and Mayor, 2016</xref>; <xref rid="B241" ref-type="bibr">Zheng et&#x000a0;al., 2017</xref>), proliferation (<xref rid="B222" ref-type="bibr">Wight et&#x000a0;al., 1992</xref>; <xref rid="B118" ref-type="bibr">Leiton et&#x000a0;al., 2015</xref>; <xref rid="B38" ref-type="bibr">Cheng et&#x000a0;al., 2016</xref>), differentiation (<xref rid="B98" ref-type="bibr">Jian et&#x000a0;al., 2013</xref>; <xref rid="B86" ref-type="bibr">Hoshiba et&#x000a0;al., 2016</xref>; <xref rid="B241" ref-type="bibr">Zheng et&#x000a0;al., 2017</xref>), apoptosis (<xref rid="B89" ref-type="bibr">Ii et&#x000a0;al., 2006</xref>; <xref rid="B160" ref-type="bibr">Oskarsson et&#x000a0;al., 2015</xref>; <xref rid="B234" ref-type="bibr">Zhang et&#x000a0;al., 2015</xref>), and cell fate determination (<xref rid="B18" ref-type="bibr">Bi et&#x000a0;al., 2007</xref>; <xref rid="B237" ref-type="bibr">Zheng et&#x000a0;al., 2012</xref>; <xref rid="B121" ref-type="bibr">Li et&#x000a0;al., 2016</xref>; <xref rid="B242" ref-type="bibr">Zheng et&#x000a0;al., 2019</xref>). Consequently, the ECM-based pharmacotherapeutics have been considered for treating fibrotic diseases (<xref rid="B229" ref-type="bibr">Ye et&#x000a0;al., 2007</xref>), osteoarthritis (<xref rid="B40" ref-type="bibr">Clegg et&#x000a0;al., 2006</xref>), osteoporosis (<xref rid="B199" ref-type="bibr">Stoch and Wagner, 2008</xref>), and malignancies (<xref rid="B138" ref-type="bibr">McKenzie, 2007</xref>). The most abundant ECM protein in connective tissues, collagen, forms the highly organized, three-dimensional macrostructure of the healthy skin (<xref rid="B173" ref-type="bibr">Ruszczak, 2003</xref>; <xref rid="B47" ref-type="bibr">Davison-Kotler et&#x000a0;al., 2019</xref>). The initial formation and maintenance of normal, healthy collagenous matrix alignment require proteoglycans (PGs) (<xref rid="B36" ref-type="bibr">Chen and Birk, 2013</xref>), which are another broadly distributed component of the ECM in connective tissues to provide resilience, viscoelasticity, and a suitable environment for cellular function and development (<xref rid="B90" ref-type="bibr">Iozzo and Schaefer, 2015</xref>). Consisting of a core protein covalently attached with one or more glycosaminoglycan (GAG) chains, PGs play a pivotal role in the proper alignment of fibrous and elastic components in the skin and control the bioavailability of several growth factors in the ECM surrounding cells to stimulate the skin turnover and repair (<xref rid="B135" ref-type="bibr">Mary and James, 2015</xref>). Based on their structure, location, and properties, PGs can be divided into 4 classes: intracellular PGs, basement membrane PGs, cell-surface PGs, and extracellular PGs (<xref rid="B218" ref-type="bibr">Vynios, 2014</xref>; <xref rid="B90" ref-type="bibr">Iozzo and Schaefer, 2015</xref>). In this review we are primarily concerned with the extracellular PGs, which are known to play a role in skin wound healing. For instance, a large, aggregating and water-retaining extracellular PG, versican, is widely detected in the skin (<xref rid="B30" ref-type="bibr">Carrino et&#x000a0;al., 2011</xref>). Versican accumulation in the pericellular matrix leads to the fibroblast-myofibroblast transition in the dermis by knocking out a versican-degrading protease [ADAM metallopeptidase with thrombospondin type 1 motif (ADAMTS)5] (<xref rid="B77" ref-type="bibr">Hattori et&#x000a0;al., 2011</xref>). This indicates that versican accumulation may be beneficial for skin wound healing since the fibroblast-myofibroblast transition is pivotal for wound contraction. Aggrecan is another extracellular PG that was initially found in the cartilage and is absent in normal skin but accumulates in scar tissue (<xref rid="B212" ref-type="bibr">Velasco et&#x000a0;al., 2011</xref>; <xref rid="B218" ref-type="bibr">Vynios, 2014</xref>; <xref rid="B135" ref-type="bibr">Mary and James, 2015</xref>). Aggrecan accumulation may hinder cell migration to the wound and prevent the transition of fibroblast progenitor cells to mature fibroblasts (<xref rid="B212" ref-type="bibr">Velasco et&#x000a0;al., 2011</xref>). These studies suggest that aggrecan may be a potential target for reducing scar formation.</p><p>Besides versican and aggrecan, small leucine-rich proteoglycans (SLRPs), constitute another large family of extracellular PGs (<xref rid="B166" ref-type="bibr">Pietraszek-Gremplewicz et&#x000a0;al., 2019</xref>) that play a pivotal role in collagen fibril growth, fibril organization, and ECM assembly in healthy skin (<xref rid="B141" ref-type="bibr">Merline et&#x000a0;al., 2009</xref>; <xref rid="B36" ref-type="bibr">Chen and Birk, 2013</xref>). A typical SLRP has a core protein of 40&#x02013;60 kDa with 10&#x02013;12 leucine-rich repeat (LRR) motifs (<xref rid="B92" ref-type="bibr">Iozzo, 1999</xref>). Each LRR motif contains 20&#x02013;29 amino acids, in which an 11-amino acid hallmark, LXXLXLXXNXL (X being any amino acid) can be identified (<xref rid="B91" ref-type="bibr">Iozzo, 1998</xref>; <xref rid="B136" ref-type="bibr">McEwan et&#x000a0;al., 2006</xref>; <xref rid="B14" ref-type="bibr">Bella et&#x000a0;al., 2008</xref>). Each LRR motif generally forms a curved conchoid structure in which LXXLXLXXNXL builds a &#x003b2;-strand, while &#x003b2;-strands from the LRRs assemble into a &#x003b2;-sheet that constitutes the concave surface of the entire SLRP core protein (<xref ref-type="fig" rid="f2">
<bold>Figure 2</bold>
</xref>) (<xref rid="B185" ref-type="bibr">Scott et&#x000a0;al., 2004</xref>). The core proteins of SLRPs are thought to carry a two-fold biological function in the skin: (1) Regulating collagen fibrillogenesis, fibril organization, and ECM assembly to control tissue strength and biomechanics (<xref rid="B168" ref-type="bibr">Rada et&#x000a0;al., 1993</xref>), which is prerequisite for skin development (<xref rid="B196" ref-type="bibr">Smith and Melrose, 2015</xref>); (2) modulating the bioactivities of a myriad of cytokines, chemokines, ligands, and receptors (<xref rid="B208" ref-type="bibr">Tillgren et&#x000a0;al., 2009</xref>; <xref rid="B36" ref-type="bibr">Chen and Birk, 2013</xref>; <xref rid="B87" ref-type="bibr">Hultgardh-Nilsson et&#x000a0;al., 2015</xref>) that orchestrate the wound healing process (<xref rid="B11" ref-type="bibr">Barrientos et&#x000a0;al., 2008</xref>). Besides, members of the SLRP family generally obtain GAG modifications post-translationally. The multitude of substitution sites on the SLRP core protein, along with variable glycosylation states, result in a variety of SLRPs which can further facilitate their interactions with various cell surface receptors, chemokines, cytokines, and growth factors (<xref rid="B112" ref-type="bibr">Kram et&#x000a0;al., 2017</xref>). Abnormalities in SLPR expression or structure often alter matrix integrity and lead to dysfunctional matrix assembly in the skin, like those found in human pathological situations and SLRP-deficient animal models (<xref rid="B36" ref-type="bibr">Chen and Birk, 2013</xref>). For example, expression and structural changes of some SLRPs were noticed during skin development (<xref rid="B30" ref-type="bibr">Carrino et&#x000a0;al., 2011</xref>), which was summarized below. Taken together, SLRPs are not only important for structural establishment of the ECM but also crucial in a variety of biological and pathological processes, such as the remodeling of the ECM during cutaneous injury and repair (<xref rid="B102" ref-type="bibr">Kalamajski and Oldberg, 2010</xref>; <xref rid="B106" ref-type="bibr">Karsdal et&#x000a0;al., 2013</xref>; <xref rid="B209" ref-type="bibr">Tracy et&#x000a0;al., 2016</xref>; <xref rid="B105" ref-type="bibr">Karamanou et&#x000a0;al., 2018</xref>).</p><fig id="f2" position="float"><label>Figure 2</label><caption><p>The crystal structure of the DCN. DCN is the archetypal SLRP [the structure was retrieved from Protein Data Bank (PDB), ID: 1XKU] (<xref rid="B185" ref-type="bibr">Scott et&#x000a0;al., 2004</xref>). DCN is a single-domain structure with a righthanded, curved solenoid fold characteristic of LRR proteins. The long &#x003b2;-sheet that forms the inner, concave face is comprised of 14 &#x003b2;-strands. The penultimate LRR that extends laterally from the main body of the molecule is referred to as the &#x02018;ear&#x02019; (yellow) repeat, which is thought to be a distinctive feature of the SLRP family.</p></caption><graphic xlink:href="fphar-10-01649-g002"/></fig><p>This review aims at summarizing all relevant available information about the spatial-temporal expression pattern of SLRPs in the skin, their relationship with human skin pathologies, and current understandings of their roles in skin wound healing to gain insights into their potentials as wound healing management pharmaceuticals.</p></sec><sec id="s2"><title>The SLRPs in Normal and Diseased Skin</title><p>Since decorin (DCN) was identified as the first SLRP (<xref rid="B113" ref-type="bibr">Krusius and Ruoslahti, 1986</xref>), many SLRP family members have been recognized in the last 30 years. Currently, 18 SLRPs have been divided into 5 classes based on the homologies at the genomic and protein level, the feature of the N-terminal cysteine residues with defined spacing, and chromosomal organization (<xref rid="B58" ref-type="bibr">Fisher et&#x000a0;al., 1989</xref>; <xref rid="B80" ref-type="bibr">Henry et&#x000a0;al., 2001</xref>; <xref rid="B136" ref-type="bibr">McEwan et&#x000a0;al., 2006</xref>; <xref rid="B180" ref-type="bibr">Schaefer and Iozzo, 2008</xref>). For instance, SLRPs detected in the skin are predominantly Class I-III, which share a distinctive characteristic at the C-terminal, called an &#x0201c;ear&#x0201d; repeat (<xref ref-type="fig" rid="f2">
<bold>Figure 2</bold>
</xref>). The &#x0201c;ear&#x0201d; repeat is the penultimate LRR that forms the most extended loop laterally from the convex face of the entire molecule (<xref rid="B136" ref-type="bibr">McEwan et&#x000a0;al., 2006</xref>; <xref rid="B35" ref-type="bibr">Chen and Birk, 2011</xref>). The &#x0201c;ear&#x0201d; spreads from the first conserved C-terminal cysteine residue to the cysteine residue of the last LRR. Importantly, residues in the &#x0201c;ear&#x0201d; are not highly conserved among different SLRPs, which indicates a possible relationship to their specific functions. Consequently, the &#x0201c;ear&#x0201d; repeat is thought to maintain the configuration of the core protein and affect its ligand-binding ability (<xref rid="B35" ref-type="bibr">Chen and Birk, 2011</xref>; <xref rid="B36" ref-type="bibr">Chen and Birk, 2013</xref>). In comparison, Class IV and V SLRPs lack the &#x0201c;ear&#x0201d; repeat and are categorized as non-canonical classes of SLRPs (<xref rid="B180" ref-type="bibr">Schaefer and Iozzo, 2008</xref>).</p><sec id="s2_1"><title>Class I SLRPs</title><p>Five SLRP members are identified in this class, including DCN (<xref rid="B46" ref-type="bibr">Danielson et&#x000a0;al., 1997</xref>), biglycan (BGN) (<xref rid="B43" ref-type="bibr">Corsi et&#x000a0;al., 2002</xref>), asporin (ASPN) (<xref rid="B80" ref-type="bibr">Henry et&#x000a0;al., 2001</xref>), extracellular matrix protein 2 (ECM2) (<xref rid="B155" ref-type="bibr">Nishiu et&#x000a0;al., 1998</xref>), and extracellular matrix protein X (ECMX) (<xref rid="B90" ref-type="bibr">Iozzo and Schaefer, 2015</xref>). DCN, BGN, and ASPN all present in the skin with different transcriptional patterns, and ECM2 mRNA expression can also be detected in the skin (<xref rid="B132" ref-type="bibr">Maquart et&#x000a0;al., 2010</xref>).</p><sec id="s2_1_1"><title>Decorin (DCN)</title><p>Containing a 36 kDa core protein with single chondroitin sulfate (CS) or dermatan sulfate (DS) chain (<xref rid="B172" ref-type="bibr">Roughley, 2006</xref>), DCN has been considered as the predominant interstitial PG in human skin (<xref rid="B30" ref-type="bibr">Carrino et&#x000a0;al., 2011</xref>; <xref rid="B120" ref-type="bibr">Li et&#x000a0;al., 2013</xref>). In the skin, DCN has been detected mostly in the reticular dermis, but absent from the papillary dermis. Minor DCN expression was also found in the epidermis (<xref rid="B59" ref-type="bibr">Fleischmajer et&#x000a0;al., 1991</xref>; <xref rid="B126" ref-type="bibr">Lochner et&#x000a0;al., 2007</xref>). Since DCN comprises most of the type I collagen-binding PGs in human skin (<xref rid="B120" ref-type="bibr">Li et&#x000a0;al., 2013</xref>), it is thought to play a critical role in the regulation of fibril structure in the skin.</p><p>In fetal rat skin, transcription of DCN increases between embryonic days 16.5 (E16.5) and E18.5 (term, 21.5 days) which is correlated to the transition from fetal-type scarless healing to adult-type scarring period in the skin (<xref rid="B197" ref-type="bibr">Soo et&#x000a0;al., 2000</xref>; <xref rid="B240" ref-type="bibr">Zheng et&#x000a0;al., 2016</xref>). In human skin, the level of DCN accelerates with aging (<xref rid="B28" ref-type="bibr">Carrino et&#x000a0;al., 2000</xref>; <xref rid="B29" ref-type="bibr">Carrino et&#x000a0;al., 2003</xref>). For example, a clinical study showed that the transcriptional level of DCN in skin biopsies from older adult donors (61&#x02013;68 years) was twofold greater than that of their younger counterparts (25&#x02013;35 years) (<xref rid="B126" ref-type="bibr">Lochner et&#x000a0;al., 2007</xref>). In addition to its elevated expression, the molecular weight of DCN in older human skin was found to be significantly smaller due to the shortened GAG chains (<xref rid="B120" ref-type="bibr">Li et&#x000a0;al., 2013</xref>). Similar results have been replicated in rats (<xref rid="B93" ref-type="bibr">Ito et&#x000a0;al., 2001</xref>; <xref rid="B156" ref-type="bibr">Nomura et&#x000a0;al., 2003</xref>). Importantly, the cutaneous wound healing process of the elderly is much slower, while all healing phases differ from their younger counterparts, including delayed inflammatory response, delayed proliferative response, and much weaker remodeling phase (<xref rid="B66" ref-type="bibr">Gerstein et&#x000a0;al., 1993</xref>; <xref rid="B70" ref-type="bibr">Gould et&#x000a0;al., 2015</xref>). Therefore, the elevated expression and reduced weight of DCN in the skin of the aged population may be associated with their functional alterations, although the underlying mechanism is not fully elucidated and warrants further investigations. Moreover, altered expression of DCN has been detected in a number of human diseases with skin phenotypes, including decreased DCN in fibroblasts in patients with neonatal Marfan syndrome (<xref rid="B169" ref-type="bibr">Raghunath et&#x000a0;al., 1993</xref>), increased DCN in fibroblasts from patients with localized scleroderma (<xref rid="B94" ref-type="bibr">Izumi et&#x000a0;al., 1995</xref>), and increased DCN in fibroblasts from patients with systemic sclerosis (<xref rid="B221" ref-type="bibr">Westergren-Thorsson et&#x000a0;al., 1996</xref>). Targeted disruption of DCN in mice results in abnormal collagen fibril morphology and skin fragility with markedly reduced tensile strength (<xref rid="B46" ref-type="bibr">Danielson et&#x000a0;al., 1997</xref>). Another study showed that DCN and BGN double-knockout (KO) mice directly resemble the rare progeroid variant of human Ehlers-Danlos syndrome (EDS), in which skin fragility and progeroid changes in the skin (reduced hypodermis) are dramatically displayed (<xref rid="B43" ref-type="bibr">Corsi et&#x000a0;al., 2002</xref>). Furthermore, in a progeroid patient carrying two point mutations in beta-1,4-galactosyltransferase 7 (B4GALT7), only 50% of the DCN exhibit GAG side-chain substitution on their core protein, which is thought to be a major mechanistic cause for the skin and wound healing defects observed in this patient with the progeroid form of EDS (<xref rid="B69" ref-type="bibr">Gotte and Kresse, 2005</xref>). These investigations indicate that DCN is crucial to the normal function of the skin and maybe a potential candidate for pharmacological development in the treatment of some skin diseases.</p></sec><sec id="s2_1_2"><title>Biglycan (BGN)</title><p>Another well-studied Class I SLRP is BGN. BGN usually contains a 38 kDa core protein attached with two CS/DS chains; however, nonglycanated forms of BGN have also been detected in human intervertebral discs (<xref rid="B101" ref-type="bibr">Johnstone et&#x000a0;al., 1993</xref>). While both BGN and DCN belong to Class I SLRPs and are able to bind with type I collagen fibrils directly, their spatial expression in skin is very different. For instance, DCN is mainly synthesized by interstitial fibroblasts, whereas BGN is secreted by both dermal and epidermal cells (<xref rid="B120" ref-type="bibr">Li et&#x000a0;al., 2013</xref>). Besides, BGN is present in the connective tissue sheath of the hair follicle (<xref rid="B131" ref-type="bibr">Malgouries et&#x000a0;al., 2008</xref>).</p><p>Similar to DCN, decreased BGN expression was also found in fibroblasts isolated from the skin of systemic sclerosis patients (<xref rid="B221" ref-type="bibr">Westergren-Thorsson et&#x000a0;al., 1996</xref>). Although BGN deficiency in mice also induces changes in collagen fibril morphology in the skin and leads to the mild cutaneous abnormalities with thinning of the dermis, skin fragility of BGN-deficient mice is not noticeably altered (<xref rid="B43" ref-type="bibr">Corsi et&#x000a0;al., 2002</xref>). Corsi et al. claimed that the skin abnormalities in BGN-deficient mice were more subtle in comparison with DCN-deficient mice (<xref rid="B43" ref-type="bibr">Corsi et&#x000a0;al., 2002</xref>), which in turn resulted in that research was not focused on BGN and its role in skin and wound healing.</p></sec><sec id="s2_1_3"><title>Asporin (ASPN)</title><p>Unlike general SLPRs, ASPN contains a 43 kDa core protein, but lacks a GAG side chain (<xref rid="B128" ref-type="bibr">Lorenzo et&#x000a0;al., 2001</xref>) and carries a polymorphic calcium-binding polyaspartate sequence (<xref rid="B103" ref-type="bibr">Kalamajski et&#x000a0;al., 2009</xref>). ASPN has been found in dermis, perichondrium and periosteum, tendon, and eye sclera (<xref rid="B111" ref-type="bibr">Kou et&#x000a0;al., 2007</xref>). ASPN-null mice exhibit an increased skin mechanical toughness due to the altered GAG composition and structure in the ECM (<xref rid="B130" ref-type="bibr">Maccarana et&#x000a0;al., 2017</xref>). However, ASPN has not been studied in depth for its involvement in skin development and cutaneous wound healing.</p></sec></sec><sec id="s2_2"><title>Class II SLRPs</title><p>To date, this class contains 5 members that can be divided into 3 subgroups based on their protein homology. Subgroup A consists of fibromodulin (FMOD) (<xref rid="B213" ref-type="bibr">Velez-Delvalle et&#x000a0;al., 2008</xref>) and lumican (LUM) (<xref rid="B230" ref-type="bibr">Yeh et&#x000a0;al., 2010</xref>), subgroup B includes keratocan (KERA) (<xref rid="B42" ref-type="bibr">Corpuz et&#x000a0;al., 1996</xref>) and proline and arginine rich end leucine rich repeat protein (PRELP) (<xref rid="B72" ref-type="bibr">Grover and Roughley, 2001</xref>), and subgroup C is comprised of osteomodulin (OMD) (<xref rid="B207" ref-type="bibr">Tasheva et&#x000a0;al., 2002</xref>).</p><sec id="s2_2_1"><title>Fibromodulin (FMOD)</title><p>FMOD has a 42 kDa core protein with up to 4 N-linked keratan sulfate (KS) attached, which shares significant sequence homology with DCN and BGN (<xref rid="B3" ref-type="bibr">Antonsson et&#x000a0;al., 1993</xref>). In the skin, FMOD is predominately secreted by dermal fibroblast and is also expressed by human epidermal keratinocytes <italic>in vitro</italic> and detected in the human epidermis <italic>in vivo</italic> (<xref rid="B213" ref-type="bibr">Velez-Delvalle et&#x000a0;al., 2008</xref>).</p><p>Unlike other SLRPs, expression of FMOD significantly decreases during the transition from fetal-type scarless repair to adult-type repair with scaring in a fetal rat skin model (<xref rid="B197" ref-type="bibr">Soo et&#x000a0;al., 2000</xref>; <xref rid="B240" ref-type="bibr">Zheng et&#x000a0;al., 2016</xref>). Moreover, our recent study demonstrated that FMOD is essential for fetal-type scarless cutaneous wound healing by loss- and gain-of-function studies in mouse and rat models (<xref rid="B197" ref-type="bibr">Soo et&#x000a0;al., 2000</xref>; <xref rid="B240" ref-type="bibr">Zheng et&#x000a0;al., 2016</xref>).</p><p>Although FMOD-null mice showed no apparent defects in the unwounded skin (<xref rid="B33" ref-type="bibr">Chakravarti, 2002</xref>), a wider distribution of collagen fibril diameters accompanied with enlarged interfibrillar spaces between collagen fibrils was observed (<xref rid="B107" ref-type="bibr">Khorasani et&#x000a0;al., 2011</xref>). Meanwhile, thinner collagen fibrils and abnormal fibers with increased deposition of LUM were also found in the tendons of FMOD-null mice (<xref rid="B203" ref-type="bibr">Svensson et&#x000a0;al., 1999</xref>). As expected, FMOD and LUM double-deficient mice showed more obvious abnormalities, such as reduced body size, increased skin hyperextensibility, escalated gait abnormality, intensified joint laxity, and accelerated age-dependent osteoarthritis resembling EDS (<xref rid="B97" ref-type="bibr">Jepsen et&#x000a0;al., 2002</xref>). These abnormal phenotypes may indicate a functional overlap between FMOD and LUM in modulating the ECM and cellular behavior in a broad range of tissues (<xref rid="B33" ref-type="bibr">Chakravarti, 2002</xref>; <xref rid="B97" ref-type="bibr">Jepsen et&#x000a0;al., 2002</xref>). It is known that the re-organization of ECM is necessary during the healing process since pathological scarring occurs when the ECM is not appropriately reformed. Thus, the fact that FMOD is essential for regular collagen fibril organization in connective tissues suggests that FMOD may play a pivotal role in skin wound healing.</p></sec><sec id="s2_2_2"><title>Lumican (LUM)</title><p>LUM was first isolated from the chicken cornea (<xref rid="B19" ref-type="bibr">Blochberger et&#x000a0;al., 1992</xref>). LUM has a 38 kDa core protein with 4 N-linked sites within the LRR domain of the core protein that can be substituted by KS (<xref rid="B186" ref-type="bibr">Scott, 1996</xref>). It is expressed in the subepithelial dermis by dermal fibroblasts (<xref rid="B231" ref-type="bibr">Ying et&#x000a0;al., 1997</xref>; <xref rid="B32" ref-type="bibr">Chakravarti et&#x000a0;al., 1998</xref>). Interestingly, LUM is also secreted by melanoma cells but not normal melanocytes (<xref rid="B194" ref-type="bibr">Sifaki et&#x000a0;al., 2006</xref>).</p><p>Unlike FMOD whose expression is reduced from early/mid-gestation when skin wounds heal scarlessly to late-gestation when skin wounds end up with adult-type scarring, LUM expression in fetal skin is upregulated during the same transition period, much like DCN (<xref rid="B240" ref-type="bibr">Zheng et&#x000a0;al., 2016</xref>). On the contrary, a significant negative correlation between LUM transcriptional levels in human skin fibroblasts and donors&#x02019; age was observed in a study involving 1-month- to 83-year-old participants (<xref rid="B217" ref-type="bibr">Vuillermoz et&#x000a0;al., 2005</xref>). The steady decline in LUM expression accompanied by the upregulation of DCN expression with aging indicates that these changes may be contributing to the functional impairment of fibroblasts during aging, such as decreased fibroblast growth and survival (<xref rid="B25" ref-type="bibr">Campisi, 1998</xref>; <xref rid="B24" ref-type="bibr">Brown, 2004</xref>; <xref rid="B217" ref-type="bibr">Vuillermoz et&#x000a0;al., 2005</xref>). Interestingly, similar to DCN-deficient mice, LUM-null mice display skin laxity and fragility resembling EDS (<xref rid="B32" ref-type="bibr">Chakravarti et&#x000a0;al., 1998</xref>). It is worth noting that wounds in FMOD-null mice have delayed dermal fibroblast migration but accelerated epidermal migration accompanied by elevated LUM expression (<xref rid="B239" ref-type="bibr">Zheng et&#x000a0;al., 2014b</xref>), indicating FMOD and LUM may predominately function on fibroblast and keratinocytes, respectively. Thus, in comparison with FMOD whose biopotency is mainly assessed on dermal functions (<xref rid="B238" ref-type="bibr">Zheng et&#x000a0;al., 2014a</xref>; <xref rid="B239" ref-type="bibr">Zheng et&#x000a0;al., 2014b</xref>; <xref rid="B240" ref-type="bibr">Zheng et&#x000a0;al., 2016</xref>), the investigation of LUM is more focused on the cornea in which epidermal migration plays more essential roles during wound healing (<xref rid="B174" ref-type="bibr">Saika et&#x000a0;al., 2000</xref>; <xref rid="B188" ref-type="bibr">Seomun and Joo, 2008</xref>; <xref rid="B60" ref-type="bibr">Frikeche et&#x000a0;al., 2016</xref>).</p></sec><sec id="s2_2_3"><title>Keratocan (KERA)</title><p>KERA is a 60&#x02013;70 kDa KS substituted member of the SLRP family (<xref rid="B135" ref-type="bibr">Mary and James, 2015</xref>). It is mainly abundant in the cornea and detected in much lesser amount in the skin as a non-sulfated glycoprotein (<xref rid="B42" ref-type="bibr">Corpuz et&#x000a0;al., 1996</xref>). The variety of the abundance and GAG structure of KERA found in different tissues suggests that its function be tissue-dependent. For example, in the cornea, KERA with long, highly sulfated KS chains has been thought to be essential for corneal transparency (<xref rid="B104" ref-type="bibr">Kao and Liu, 2002</xref>). Thus, similar to LUM (<xref rid="B228" ref-type="bibr">Yamanaka et&#x000a0;al., 2013</xref>), KERA is also a potential target for cornea healing therapies (<xref rid="B104" ref-type="bibr">Kao and Liu, 2002</xref>; <xref rid="B26" ref-type="bibr">Carlson et&#x000a0;al., 2003</xref>; <xref rid="B123" ref-type="bibr">Liu et&#x000a0;al., 2003</xref>; <xref rid="B37" ref-type="bibr">Chen et&#x000a0;al., 2011</xref>). However, its role in the skin is still ambiguous for delineating.</p></sec><sec id="s2_2_4"><title>Proline and Arginine Rich End Leucine Rich Repeat Protein (PRELP)</title><p>PRELP contains a 55-kDa core protein with no GAG and an N-terminal region which is highly unique, conserved, and rich in arginine and proline (<xref rid="B15" ref-type="bibr">Bengtsson et&#x000a0;al., 2000</xref>). It functions as a molecule by anchoring basal membranes to the underlying connective tissue (<xref rid="B71" ref-type="bibr">Grover and Roughley, 1998</xref>; <xref rid="B72" ref-type="bibr">Grover and Roughley, 2001</xref>). For example, PRELP is expressed in the basement membrane between the epidermis and the dermis in the skin (<xref rid="B16" ref-type="bibr">Bengtsson et&#x000a0;al., 2002</xref>). Overexpression of PRELP in mice leads to reduced collagen fiber bundle content and size in the dermis and decreases the thickness of the hypodermal fat layer in the skin (<xref rid="B73" ref-type="bibr">Grover et&#x000a0;al., 2007</xref>), which somewhat resembles the symptoms of Hutchinson&#x02013;Gilford progeria (<xref rid="B147" ref-type="bibr">Mounkes et&#x000a0;al., 2003</xref>). In addition, PRELP can bind to perlecan (<xref rid="B16" ref-type="bibr">Bengtsson et&#x000a0;al., 2002</xref>), which is thought to be essential for epidermal formation by regulating the survival of keratinocytes (<xref rid="B190" ref-type="bibr">Sher et&#x000a0;al., 2006</xref>). This indicates that PRELP may participate in regulating the function of keratinocytes, but further studies are needed to elucidate it. However, a clear application of PRELP for wound healing is still lacking.</p><p>Interestingly, in comparison with Class I SLRPs, most Class II SLRPs seem to have a more executive function on epidermal keratinocytes. The one exception is FMOD, which has proven to be critical for maintaining the normal function of dermal fibroblasts (<xref rid="B240" ref-type="bibr">Zheng et&#x000a0;al., 2016</xref>), as well as endothelial cells (<xref rid="B1" ref-type="bibr">Adini et&#x000a0;al., 2014</xref>; <xref rid="B238" ref-type="bibr">Zheng et&#x000a0;al., 2014a</xref>), like DCN and BGN. The response to different cell types may pave the fundamental for developing combination therapies of SLRPs to target both dermal and epidermal cells simultaneously to maximize their complementary biopotency and thus to optimize the skin wound healing outcome.</p></sec></sec><sec id="s2_3"><title>Class III SLRPs</title><p>To date, osteoglycin (OGN, also known as mimecan) (<xref rid="B207" ref-type="bibr">Tasheva et&#x000a0;al., 2002</xref>), epiphycan (EPYC) (<xref rid="B100" ref-type="bibr">Johnson et&#x000a0;al., 1997</xref>) and opticin (OPTC) (<xref rid="B170" ref-type="bibr">Reardon et&#x000a0;al., 2000</xref>) constitute this class, which is characterized by a relatively low number of LRRs (7 LRRs) compared to the classic 10-12 LRRs of other classes.</p><p>OGN was first identified as a 25 kDa KS SLRP in the cornea, and a 36 kDa OGN protein without KS chains was also detected in other connective tissues including aorta, sclera, skin, cartilage, the vagus nerve, and in lesser amounts in the cerebellum, kidney, intestines, myocardium, and skeletal muscle (<xref rid="B61" ref-type="bibr">Funderburgh et&#x000a0;al., 1997</xref>). As for its role in the skin, OGN-deficient mice display skin with moderately reduced tensile strength, which is correlated to the presence of thicker collagen fibrils that possess marked increases in collagen fibril diameter. OGN also plays a pivotal role in collagen fibrillogenesis in the skin (<xref rid="B207" ref-type="bibr">Tasheva et&#x000a0;al., 2002</xref>). Although transcription of EPYC and OPTC have been detected in the skin (<xref rid="B170" ref-type="bibr">Reardon et&#x000a0;al., 2000</xref>; <xref rid="B204" ref-type="bibr">Takanosu et&#x000a0;al., 2001</xref>; <xref rid="B132" ref-type="bibr">Maquart et&#x000a0;al., 2010</xref>), their biological function in the skin is unclear.</p></sec><sec id="s2_4"><title>Class IV and Class V SLRPs</title><p>Class IV and V SLRPs are considered to be non-canonical classes of SLRPs. These include chondroadherin (CHAD) (<xref rid="B74" ref-type="bibr">Haglund et&#x000a0;al., 2011</xref>), nyctalopin (NYX) (<xref rid="B13" ref-type="bibr">Bech-Hansen et&#x000a0;al., 2000</xref>), tsukushi (TSKU) (<xref rid="B157" ref-type="bibr">Ohta et&#x000a0;al., 2004</xref>), podocan (PODN) (<xref rid="B171" ref-type="bibr">Ross et&#x000a0;al., 2003</xref>), and recently identified podocan like 1 (PODNL1) (<xref rid="B144" ref-type="bibr">Mochida et&#x000a0;al., 2011</xref>). The function and spatial-temporal expression patterns of these SLRPs in the skin are rarely studied. A previous study detected CHAD mRNA in keratinocytes, and NYX mRNA in keratinocytes and skin fibroblasts (<xref rid="B132" ref-type="bibr">Maquart et&#x000a0;al., 2010</xref>). Future studies, not necessarily limited to the skin, are required to reveal their biological functions.</p><p>The expression and distribution of known SLRPs in the skin, as well as the abnormalities observed in SLRP-deficient mice, are summarized in <xref rid="T1" ref-type="table">
<bold>Table 1</bold>
</xref>.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>The expression and distribution of SLRPs and abnormalities of knock out and overexpression mice in the skin.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" rowspan="1" colspan="1">SLRP</th><th valign="top" align="center" rowspan="1" colspan="1">Expression and distribution in the skin</th><th valign="top" align="center" rowspan="1" colspan="1">Mice model</th><th valign="top" align="center" rowspan="1" colspan="1">Abnormalities in the skin</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Decorin</td><td valign="top" align="left" rowspan="1" colspan="1">Most expression in the dermis and minor expression in the epidermis</td><td valign="top" align="left" rowspan="1" colspan="1">Targeted disruption of decorin in exon2</td><td valign="top" align="left" rowspan="1" colspan="1">Skin fragility with markedly reduced tensile strength</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Biglycan</td><td valign="top" align="left" rowspan="1" colspan="1">Expression in the dermis, the epidermis and the sheath of hair follicle</td><td valign="top" align="left" rowspan="1" colspan="1">Targeted disruption of biglycan in exon2</td><td valign="top" align="left" rowspan="1" colspan="1">Mild skin abnormalities with thinning of the dermis but without distinct skin fragility</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Decorin and Biglycan</td><td valign="top" align="left" rowspan="1" colspan="1">Not applicable</td><td valign="top" align="left" rowspan="1" colspan="1">Decorin and biglycan double-knockout mice</td><td valign="top" align="left" rowspan="1" colspan="1">Skin fragility and progeroid changes in the skin (reduced hypodermis)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Asporin</td><td valign="top" align="left" rowspan="1" colspan="1">Expression in the dermis</td><td valign="top" align="left" rowspan="1" colspan="1">Targeted disruption of asporin in exons 2&#x02013;3</td><td valign="top" align="left" rowspan="1" colspan="1">Increased skin mechanical toughness</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Fibromodulin</td><td valign="top" align="left" rowspan="1" colspan="1">Expression in the dermal fibroblast and human epidermal keratinocytes <italic>in vitro</italic> and the epidermis <italic>in vivo</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Targeted disruption of fibromodulin in exon2</td><td valign="top" align="left" rowspan="1" colspan="1">No overt defects in skin, but larger collagen fibrils and less orderly packed collagen fibrils with increased interfibrillar space</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Lumican</td><td valign="top" align="left" rowspan="1" colspan="1">Expression in the dermis</td><td valign="top" align="left" rowspan="1" colspan="1">Targeted disruption of lumican in exon2</td><td valign="top" align="left" rowspan="1" colspan="1">Skin laxity and fragility</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Fibromodulin and Lumican</td><td valign="top" align="left" rowspan="1" colspan="1">Not applicable</td><td valign="top" align="left" rowspan="1" colspan="1">Fibromodulin and lumican double-knockout mice</td><td valign="top" align="left" rowspan="1" colspan="1">Additional gross skin phenotypes including skin hyperextensibility</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PRELP</td><td valign="top" align="left" rowspan="1" colspan="1">Expression in the basement membrane between the epidermis and the dermis</td><td valign="top" align="left" rowspan="1" colspan="1">Overexpression of PRELP transgenic mice</td><td valign="top" align="left" rowspan="1" colspan="1">Decreased collagen fiber bundle content and size in the dermis, and the thinner hypodermal fat layer</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Osteoglycin</td><td valign="top" align="left" rowspan="1" colspan="1">Expression in the skin</td><td valign="top" align="left" rowspan="1" colspan="1">Targeted disruption of osteoglycin in exon2</td><td valign="top" align="left" rowspan="1" colspan="1">Reduction in the tensile strength of the skin, thicker collagen fibrils and a significant increase in collagen fibril diameter in the skin</td></tr></tbody></table></table-wrap></sec></sec><sec id="s3"><title>The SLRPs in Skin Wounds and Wound Healing</title><p>As a protective barrier shielding the human body from the environment, the skin plays a pivotal role in maintaining physiological homeostasis of the human body. Any lesion breaking the skin barrier will make the organism vulnerable to infections, thermal disorders, and fluid loss (<xref rid="B198" ref-type="bibr">Sorg et&#x000a0;al., 2017</xref>). Skin wound healing is a dynamic, complex and tightly regulated process comprised of hemostasis, inflammation, proliferation, remodeling, and maturation phases, in which various cell types and mediators are recruited at the wound site, and complex interactions exist between different cells and the ECM (<xref rid="B134" ref-type="bibr">Martin, 1997</xref>; <xref rid="B51" ref-type="bibr">Diegelmann and Evans, 2004</xref>; <xref rid="B68" ref-type="bibr">Gibran et&#x000a0;al., 2007</xref>; <xref rid="B6" ref-type="bibr">Artlett, 2013</xref>). During the process of wound healing, the ECM not only provides structural support for the tissues, but also serves as a platform for cells and mediators that regulates inter/intracellular signaling (<xref rid="B67" ref-type="bibr">Ghatak et&#x000a0;al., 2015</xref>). As essential components of the ECMs, many SLRPs participate in a diversity of signaling pathways to regulate cellular activities during the wound healing process.</p><sec id="s3_1"><title>Inflammation</title><p>Following an injury, skin cells are exposed to acute inflammatory signals such as pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) (<xref rid="B205" ref-type="bibr">Takeuchi and Akira, 2010</xref>; <xref rid="B201" ref-type="bibr">Strbo et&#x000a0;al., 2014</xref>). These patterns can be recognized by toll-like receptors (TLRs) to initiate inflammation. Leukocytes are attracted to the site of injury, accompanied by elevated levels of pro-inflammatory cytokines, and thus amplify the inflammatory response (<xref rid="B54" ref-type="bibr">Eming et&#x000a0;al., 2014</xref>; <xref rid="B214" ref-type="bibr">Vestweber, 2015</xref>). Gradually, macrophages will display a transition from the M1 subset (phagocytic activity and production of pro-inflammatory cytokines) (<xref rid="B64" ref-type="bibr">Galli et&#x000a0;al., 2011</xref>; <xref rid="B195" ref-type="bibr">Sindrilaru and Scharffetter-Kochanek, 2013</xref>) to the M2 subset (reparative activity with the synthesis of anti-inflammatory mediators and the production of the ECM) (<xref rid="B21" ref-type="bibr">Brancato and Albina, 2011</xref>; <xref rid="B195" ref-type="bibr">Sindrilaru and Scharffetter-Kochanek, 2013</xref>). This switch corresponds to the transition from the inflammation stage to the proliferation stage in the wound healing process.</p><p>Although there have been studies investigating the effects of SLRPs on the inflammatory response, most do not specifically focus on skin wound healing. Several studies have shown that DCN, BGN, and LUM can interact with TLR2 and/or TLR4 signaling pathways in innate immune responses to combat microbial pathogens. For instance, in mouse peritoneal macrophages, DCN induces tissue necrosis factor (TNF) and programmed cell death 4 (PDCD4) production through TLR2 and TLR4, which enhances the proinflammatory effects of lipopolysaccharides (LPS), a vital constituent of Gram-negative bacteria, which can trigger a robust immune response (<xref rid="B142" ref-type="bibr">Merline et&#x000a0;al., 2011</xref>). BGN has also been proven to be a proinflammatory factor in mouse peritoneal macrophages by regulating the same signal pathways as DCN (<xref rid="B181" ref-type="bibr">Schaefer et&#x000a0;al., 2005</xref>). Like DCN and BGN, LUM enhances host immune responses to LPS <italic>via</italic> TLR4 in mouse peritoneal macrophages (<xref rid="B224" ref-type="bibr">Wu et&#x000a0;al., 2007</xref>). Unsurprisingly, LUM-null mice are hypo-responsive to LPS-induced septic shock with reduced pro-inflammatory cytokines production (<xref rid="B224" ref-type="bibr">Wu et&#x000a0;al., 2007</xref>). Also, LUM has been shown to regulate inflammation in the development of colitis in mice (<xref rid="B127" ref-type="bibr">Lohr et&#x000a0;al., 2012</xref>), and accelerate LPS-induced renal injury in mice <italic>via</italic> TLR4-nuclear factor &#x003ba;B (NF&#x003ba;B) pathway (<xref rid="B129" ref-type="bibr">Lu et&#x000a0;al., 2015</xref>). Moreover, in LPS-induced wounds of the cornea, no induction of TNF or IL1&#x003b2;, and reduced infiltration of neutrophils and macrophages were found in LUM-null mice (<xref rid="B216" ref-type="bibr">Vij et&#x000a0;al., 2005</xref>).</p><p>In contrast to their pro-inflammatory functions in the aforementioned infection scenario, SLRPs may act as anti-inflammatory factors to inhibit excessive inflammation during wound healing in the skin. For example, FMOD-null mice exhibit elevated and prolonged inflammatory infiltration in the skin wound area, accompanied by delayed reepithelialization (<xref rid="B239" ref-type="bibr">Zheng et&#x000a0;al., 2014b</xref>). Similarly, LUM-deficient mice display an increased inflammatory macrophage density with delayed cutaneous wound healing (<xref rid="B230" ref-type="bibr">Yeh et&#x000a0;al., 2010</xref>). Furthermore, TSKU has been detected in fibroblasts, myofibroblasts, and macrophages during skin wound healing in mice. Likewise, loss of TSKU causes increased TGF&#x003b2;1 expression and excess inflammation (<xref rid="B154" ref-type="bibr">Niimori et&#x000a0;al., 2014</xref>). Collectively, these studies suggest that SLRPs may play a diverse role in inflammatory response regulation, which may highly depend on the microenvironment.</p></sec><sec id="s3_2"><title>Angiogenesis</title><p>The process of angiogenesis occurs accompanied by fibroblast proliferation when endothelial cells migrate to the wound site and provide the nutritive perfusion for fibroblasts and epithelial cells during the healing process (<xref rid="B134" ref-type="bibr">Martin, 1997</xref>; <xref rid="B49" ref-type="bibr">Demidova-Rice et&#x000a0;al., 2012</xref>; <xref rid="B198" ref-type="bibr">Sorg et&#x000a0;al., 2017</xref>). The involvement of SLRPs has been identified in the angiogenesis of wound healing, tumorigenesis, and other inflammatory processes. For instance, DCN exhibits antiangiogenic activities during cutaneous wound healing, while higher DCN expression was detected in human benign tumors <italic>vs.</italic> malignant vascular tumors (<xref rid="B96" ref-type="bibr">Jarvelainen et&#x000a0;al., 2006</xref>; <xref rid="B175" ref-type="bibr">Salomaki et&#x000a0;al., 2008</xref>). Meanwhile, impaired angiogenesis was found in the injured cornea of DCN-null mice (<xref rid="B183" ref-type="bibr">Schonherr et&#x000a0;al., 2004</xref>), and repressed angiogenesis was also present in some tumors associated with reduced DCN expression (<xref rid="B151" ref-type="bibr">Nayak et&#x000a0;al., 2013</xref>; <xref rid="B39" ref-type="bibr">Chui et&#x000a0;al., 2014</xref>). These studies suggest that DCN can be either stimulatory or suppressive for angiogenesis, which may be related to the physiologic and pathologic conditions of tissues (<xref rid="B95" ref-type="bibr">J&#x000e4;rvel&#x000e4;inen et&#x000a0;al., 2015</xref>).</p><p>BGN has been shown to have a proangiogenic effect in fracture healing (<xref rid="B17" ref-type="bibr">Berendsen et&#x000a0;al., 2014</xref>; <xref rid="B149" ref-type="bibr">Myren et&#x000a0;al., 2016</xref>), colon cancer (<xref rid="B226" ref-type="bibr">Xing et&#x000a0;al., 2015</xref>), and tumor endothelial cells (<xref rid="B227" ref-type="bibr">Yamamoto et&#x000a0;al., 2012</xref>), though its role in angiogenesis during skin wound healing is not clear.</p><p>FMOD was found to promote angiogenesis during cutaneous wound healing (<xref rid="B236" ref-type="bibr">Zheng et&#x000a0;al., 2011</xref>; <xref rid="B238" ref-type="bibr">Zheng et&#x000a0;al., 2014a</xref>). Particularly, FMOD was found to accelerate human umbilical vein endothelial cell adhesion and spreading, actin stress fiber formation, and eventually tube-like structure network establishment <italic>in vitro</italic> (<xref rid="B98" ref-type="bibr">Jian et&#x000a0;al., 2013</xref>). Furthermore, it has been confirmed that FMOD stimulates angiogenesis in various <italic>in vivo</italic> systems, such as neovascularization, wound healing and Matrigel&#x02122; plug assays. FMOD was also found to enhance vascular sprouting during normal retinal development (<xref rid="B1" ref-type="bibr">Adini et&#x000a0;al., 2014</xref>). FMOD also promotes tumor angiogenesis of small cell lung cancer by upregulating angiogenic factor expression (<xref rid="B4" ref-type="bibr">Ao et&#x000a0;al., 2017</xref>). Overall, these studies constitute evidence that FMOD displays angiogenic biopotency in numerous biological processes.</p><p>On the other hand, LUM was found to inhibit angiogenesis by interfering with integrin &#x003b1;2&#x003b2;1 activity and repressing matrix metalloproteinase (MMP)14 expression <italic>in vivo</italic> (<xref rid="B153" ref-type="bibr">Niewiarowska et&#x000a0;al., 2011</xref>). LUM has also been identified as an inhibitor for tumor angiogenesis (<xref rid="B2" ref-type="bibr">Albig et&#x000a0;al., 2007</xref>; <xref rid="B22" ref-type="bibr">Brezillon et&#x000a0;al., 2009</xref>; <xref rid="B223" ref-type="bibr">Williams et&#x000a0;al., 2011</xref>). Interestingly, angiogenesis was not altered in LUM-deficient mice in aortic ring assays, Matrigel&#x02122; plugs, or healing wound biopsies (<xref rid="B189" ref-type="bibr">Sharma et&#x000a0;al., 2013</xref>). Thus, LUM is thought to exhibit an antiangiogenic effect in restricted circumstances, possibly only in some specific tumor microenvironments.</p><p>In summary, these studies paint the picture of SLRPs playing a wide range of roles in the angiogenesis of various biological processes. Specifically, FMOD is the only SLRP confirmed to enhance angiogenesis during skin wound healing, suggesting that it may have therapeutic potential in cutaneous healing of poorly vascularized wounds, such as in the scenarios of diabetic wounds.</p></sec><sec id="s3_3"><title>Fibroblast Activities</title><p>Dermal fibroblasts are the predominant cellular component in the wound healing process. During the proliferation stage, fibroblasts migrate into the wound site, and gradually grow to produce a new provisional ECM through the production of collagen and fibronectin (<xref rid="B143" ref-type="bibr">Midwood et&#x000a0;al., 2004</xref>). Wound contraction will occur when fibroblasts differentiate into myofibroblasts after reepithelialization. This process decreases the size of the wound and is followed by the removal of unneeded cells through apoptosis (<xref rid="B82" ref-type="bibr">Hinz, 2006</xref>). SLRPs are known to impact several of the critical functions of fibroblasts during wound healing, including migration, proliferation, differentiation, and collagen synthesis. As a result, abnormal expression of SLRPs can disrupt the wound healing process and possibly result in pathological scarring, as seen in keloids and hypertrophic scars.</p><p>TGF&#x003b2; signaling has been thought to play a central role in both skin wound healing and scar formation (<xref rid="B57" ref-type="bibr">Faler et&#x000a0;al., 2006</xref>; <xref rid="B164" ref-type="bibr">Penn et&#x000a0;al., 2012</xref>; <xref rid="B161" ref-type="bibr">Pakyari et&#x000a0;al., 2013</xref>), and DCN is known to bind to all three mammal TGF&#x003b2; isoforms and represses their activity by sequestering the isoforms to the ECM and thus inhibiting their signal transduction (<xref ref-type="fig" rid="f3">
<bold>Figure 3A</bold>
</xref>) (<xref rid="B52" ref-type="bibr">Droguett et&#x000a0;al., 2006</xref>; <xref rid="B164" ref-type="bibr">Penn et&#x000a0;al., 2012</xref>). DCN was also found to interact with CTGF-a downstream mediator of TGF&#x003b2;1 signaling (<xref ref-type="fig" rid="f3">
<bold>Figure 3B</bold>
</xref>) (<xref rid="B45" ref-type="bibr">Daniels et&#x000a0;al., 2003</xref>; <xref rid="B193" ref-type="bibr">Shi-Wen et&#x000a0;al., 2008</xref>; <xref rid="B215" ref-type="bibr">Vial et&#x000a0;al., 2011</xref>). Moreover, DCN is able to activate epidermal growth factor receptor (EGFR)&#x02010;mediated receptor auto-phosphorylation and downstream signaling pathways, such as the mitogen-activated protein kinase (MARK)1/3 pathway, to mobilize intracellular calcium, and activate other EGFR&#x02010;dependent pathways in tumor cells to suppress cell growth (<xref rid="B146" ref-type="bibr">Moscatello et&#x000a0;al., 1998</xref>; <xref rid="B163" ref-type="bibr">Patel et&#x000a0;al., 1998</xref>). DCN displays similar cell growth suppression ability in dermal fibroblasts (<xref rid="B115" ref-type="bibr">Laine et&#x000a0;al., 2000</xref>; <xref rid="B210" ref-type="bibr">Tran et&#x000a0;al., 2004</xref>). Furthermore, a recent study revealed that DCN repressed corneal stromal fibroblasts migration <italic>via</italic> inducing EGFR degradation (<xref ref-type="fig" rid="f3">
<bold>Figure 3C</bold>
</xref>) (<xref rid="B145" ref-type="bibr">Mohan et&#x000a0;al., 2019</xref>), which has not been well investigated in the context of skin wounds, although low levels of DCN and increased activation of the MARK1/3 signaling have been observed in keloid tissues (<xref rid="B140" ref-type="bibr">Meenakshi et&#x000a0;al., 2009</xref>). In addition to regulating growth factor signaling transduction, DCN serves as a stabilizer of the ECM tissue structure through binding of type I collagen and thus downregulates cellular proliferation and migration, as well as protein synthesis in a number of biological and pathologic processes (<xref rid="B92" ref-type="bibr">Iozzo, 1999</xref>; <xref rid="B210" ref-type="bibr">Tran et&#x000a0;al., 2004</xref>). Keloid fibroblasts have less DCN expression than normal fibroblasts (<xref rid="B148" ref-type="bibr">Mukhopadhyay et&#x000a0;al., 2010</xref>) while forcing DCN expression by adenovirus in keloid fibroblasts remarkably reduced their collagen synthesis and upregulated the transcriptional level of MMP1 and MMP3 (<xref rid="B117" ref-type="bibr">Lee et&#x000a0;al., 2015</xref>). The expression of DCN in the fibroblasts isolated from the deep dermis was also lower than those derived from the superficial dermis (<xref rid="B85" ref-type="bibr">Honardoust et&#x000a0;al., 2012b</xref>). This phenomenon indicates a possible relationship between lower DCN expression and hypertrophic scarring as deep dermal injuries often lead to hypertrophic scarring while superficial cutaneous wounds usually heal with minimal scarring (<xref rid="B220" ref-type="bibr">Wang et&#x000a0;al., 2008</xref>; <xref rid="B133" ref-type="bibr">Marshall et&#x000a0;al., 2018</xref>). In comparison to unwounded skin, post-burn hypertrophic scar tissue also has a lower level of DCN (<xref rid="B184" ref-type="bibr">Scott et&#x000a0;al., 1995</xref>; <xref rid="B178" ref-type="bibr">Sayani et&#x000a0;al., 2000</xref>). While DCN-deficient mice exhibit significantly postponed cutaneous wound healing (<xref rid="B96" ref-type="bibr">Jarvelainen et&#x000a0;al., 2006</xref>). The lower DCN levels in keloids and hypertrophic scars may contribute to the unordered collagen arrangement and excess ECM production. Meanwhile, recombinant human DCN inhibits fibroblast proliferation and downregulates TGF&#x003b2;1 production, and collagen synthesis in hypertrophic scar fibroblasts (<xref rid="B232" ref-type="bibr">Zhang et&#x000a0;al., 2007</xref>). Moreover, DCN can inhibit the contraction of collagen gel encapsulation in normal or hypertrophic scar fibroblasts, which gives further indication that it may pose therapeutic potential in hypertrophic scarring (<xref rid="B233" ref-type="bibr">Zhang et&#x000a0;al., 2009</xref>). Recent studies show that activation of Tuberoinfundibular peptide of 39 residues (TIP39)&#x02014;Parathyroid Hormone 2 Receptor (PTH2R) signaling or blocking of microRNA 181b can induce DCN expression and promote wound repair (<xref ref-type="fig" rid="f3">
<bold>Figure 3D</bold>
</xref>) (<xref rid="B114" ref-type="bibr">Kwan et&#x000a0;al., 2015</xref>; <xref rid="B177" ref-type="bibr">Sato et&#x000a0;al., 2017</xref>). Additionally, a collagen-binding peptidoglycan derived from DCN has been shown to inhibit MMP-mediated collagen degradation <italic>in vitro</italic> and reduce scar formation in mice (<xref rid="B202" ref-type="bibr">Stuart et&#x000a0;al., 2011</xref>). Collectively, these results indicate that DCN may be a potential therapeutic agent for keloids and hypertrophic scars.</p><fig id="f3" position="float"><label>Figure 3</label><caption><p>A schematic diagram of the functions of DCN in skin wound healing. <bold>(A)</bold> DCN is known to bind to mammal TGF&#x003b2; isoforms to sequester their signal transduction. <bold>(B)</bold> DCN can also bind to CTGF, which is a downstream mediator of TGF&#x003b2;1 signaling, to reduce hypertrophic scarring. <bold>(C)</bold> In addition, DCN can repress fibroblasts migration by inducing EGFR degradation. <bold>(D)</bold> On the other hand, activation of TIP39-PTH2R signaling or blocking of microRNA 181b can induce DCN production, and thus benefit skin wound repair.</p></caption><graphic xlink:href="fphar-10-01649-g003"/></fig><p>As a structurally homologous protein of DCN, BGN can also bind to TGF&#x003b2; isoforms to attenuate its signal transduction (<xref rid="B81" ref-type="bibr">Hildebrand et&#x000a0;al., 1994</xref>; <xref rid="B52" ref-type="bibr">Droguett et&#x000a0;al., 2006</xref>; <xref rid="B164" ref-type="bibr">Penn et&#x000a0;al., 2012</xref>). Expression of BGN was not altered in excisional skin wounds and hypercontracted/hyperpigmented scarring pig models (<xref rid="B158" ref-type="bibr">Olson et&#x000a0;al., 2000</xref>; <xref rid="B63" ref-type="bibr">Gallant et&#x000a0;al., 2004</xref>). However, the upregulation of BGN was observed in adult rat wound healing models (<xref rid="B197" ref-type="bibr">Soo et&#x000a0;al., 2000</xref>). Elevated BGN expression was also observed in hypertrophic scars compared with that in normal scars (<xref rid="B5" ref-type="bibr">Armour et&#x000a0;al., 2007</xref>; <xref rid="B83" ref-type="bibr">Honardoust et&#x000a0;al., 2011</xref>). Deep dermal fibroblasts also have a higher BGN level than that of the superficial dermal fibroblasts (<xref rid="B83" ref-type="bibr">Honardoust et&#x000a0;al., 2011</xref>; <xref rid="B84" ref-type="bibr">Honardoust et&#x000a0;al., 2012a</xref>). Unfortunately, whether higher BGN expression in deep dermal fibroblasts is relevant to the profibrotic or inflammatory response in deep dermal cutaneous injuries remains elusive. Although BGN has been shown to regulate proinflammatory cytokine expression and inflammatory response by TLR2 and TLR4 in the kidney, lung, and circulation (<xref rid="B8" ref-type="bibr">Babelova et&#x000a0;al., 2009</xref>). Moreover, BGN transcription was up-regulated in keloid tissues (<xref rid="B88" ref-type="bibr">Hunzelmann et&#x000a0;al., 1996</xref>). Interestingly, basic fibroblast growth factor (bFGF) can up-regulate BGN while suppressing DCN expression in keloid fibroblasts (<xref rid="B206" ref-type="bibr">Tan et&#x000a0;al., 1993</xref>). Taken together, these results imply that BGN may be related to keloid and hypertrophic scarring. Further investigations are needed to confirm the involvement of BGN in cutaneous wound healing and elucidate the specific roles of BGN and DCN during the scar formation.</p><p>FMOD was down-regulated during adult rat wound healing with scar formation (<xref rid="B197" ref-type="bibr">Soo et&#x000a0;al., 2000</xref>). Importantly, loss of FMOD can eliminate the ability of early-gestation fetal rodents to heal without scarring. Meanwhile, the administration of FMOD alone was capable of restoring scarless healing in late-gestation rat fetal wounds, which would naturally heal with scar (<xref rid="B240" ref-type="bibr">Zheng et&#x000a0;al., 2016</xref>). In addition to restoring scarless wound healing in late-gestation fetal wounds, forcing FMOD elevation by adenovirus can also promote skin wound healing in adult rabbit full-thickness incisions (<xref rid="B200" ref-type="bibr">Stoff et&#x000a0;al., 2007</xref>). Additionally, FMOD-deficient mice exhibit delayed wound closure and increased scar formation (<xref rid="B236" ref-type="bibr">Zheng et&#x000a0;al., 2011</xref>; <xref rid="B239" ref-type="bibr">Zheng et&#x000a0;al., 2014b</xref>).</p><p>Many review articles have already focused on the essential role of TGF&#x003b2; signaling in wound healing (<xref rid="B57" ref-type="bibr">Faler et&#x000a0;al., 2006</xref>; <xref rid="B164" ref-type="bibr">Penn et&#x000a0;al., 2012</xref>; <xref rid="B161" ref-type="bibr">Pakyari et&#x000a0;al., 2013</xref>; <xref rid="B122" ref-type="bibr">Lichtman et&#x000a0;al., 2016</xref>). However, among SLRPs, only FMOD has been studied in detail about its interaction with TGF&#x003b2; signaling to orchestrate the function of fibroblasts to enhance skin wound healing (<xref rid="B241" ref-type="bibr">Zheng et&#x000a0;al., 2017</xref>). For example, the delayed cutaneous wound closure in FMOD-deficient mice may be attributed to the elevated local TGF&#x003b2;3 levels (<xref rid="B236" ref-type="bibr">Zheng et&#x000a0;al., 2011</xref>), since TGF&#x003b2;3 selectively postpones dermal fibroblast proliferation and migration into the wound area (<xref rid="B10" ref-type="bibr">Bandyopadhyay et&#x000a0;al., 2006</xref>; <xref rid="B75" ref-type="bibr">Han et&#x000a0;al., 2012</xref>). Moreover, adult FMOD-null mouse wounds have higher expression of TGF&#x003b2; receptors in comparison with their wild-type counterparts during the proliferative stage, but reduced expression of TGF&#x003b2; ligands and receptors during the remodeling stage (<xref rid="B239" ref-type="bibr">Zheng et&#x000a0;al., 2014b</xref>). Similar to DCN, FMOD is downregulated in postburn hypertrophic scars (<xref rid="B83" ref-type="bibr">Honardoust et&#x000a0;al., 2011</xref>). Reduced fibromodulin in the deep dermis of the skin is thought to contribute to the development of hypertrophic scars after injuries (<xref rid="B84" ref-type="bibr">Honardoust et&#x000a0;al., 2012a</xref>; <xref rid="B85" ref-type="bibr">Honardoust et&#x000a0;al., 2012b</xref>). Interestingly, FMOD transcription was not altered following wound creation in an adult Yorkshire pig model, but exhibited a biphasic pattern of mRNA expression (initial increased at day 14, followed by decreased levels at days 28&#x02013;42 and then a second peak by days 56&#x02013;70) in an adult red Duroc pig model (<xref rid="B158" ref-type="bibr">Olson et&#x000a0;al., 2000</xref>; <xref rid="B63" ref-type="bibr">Gallant et&#x000a0;al., 2004</xref>). These observations are aligned with the previous hypothesis that the healing profile of the red Duroc pig wound model (which simulates hypertrophic healing in humans) (<xref rid="B76" ref-type="bibr">Harunari et&#x000a0;al., 2006</xref>; <xref rid="B225" ref-type="bibr">Xie et&#x000a0;al., 2007</xref>; <xref rid="B243" ref-type="bibr">Zhu et&#x000a0;al., 2007</xref>) is inherently different from that of the Yorkshire pig wound model (which simulates normal scarring) (<xref rid="B48" ref-type="bibr">De Hemptinne et&#x000a0;al., 2008</xref>; <xref rid="B187" ref-type="bibr">Seaton et&#x000a0;al., 2015</xref>). Mechanically, like DCN and BGN, FMOD shows similar properties in its ability to bind to mammal TGF&#x003b2; isoforms; however, it is a more effective competitor for TGF&#x003b2; binding than DCN or BGN (<xref rid="B81" ref-type="bibr">Hildebrand et&#x000a0;al., 1994</xref>). Traditionally, FMOD was considered an extracellular TGF&#x003b2; reservoir (<xref ref-type="fig" rid="f4">
<bold>Figure 4A</bold>
</xref>). Our recent studies have deeply explored the mechanisms by which FMOD orchestrates TGF&#x003b2;1 signaling and subsequently reduces scar formation in adult skin wounds (<xref rid="B241" ref-type="bibr">Zheng et&#x000a0;al., 2017</xref>): &#x0201c;(1) like fetal wounds (<xref rid="B116" ref-type="bibr">Larson et&#x000a0;al., 2010</xref>), FMOD treatment to adult wounds causes reduced and more transient TGF&#x003b2;1 expression; (2) like fetal wounds (<xref rid="B219" ref-type="bibr">Walraven et&#x000a0;al., 2015</xref>), FMOD treatment induces high level of SMAD2 and SMAD3 phosphorylation, and low levels of several fibrosis-associated targets; (3) like fetal fibroblasts (<xref rid="B176" ref-type="bibr">Sandulache et&#x000a0;al., 2007</xref>), FMOD treatment results in a more migratory and contractile phenotype; (4) like fetal fibroblasts (<xref rid="B41" ref-type="bibr">Colwell et&#x000a0;al., 2006</xref>), FMOD treatment exhibits higher TGF&#x003b2;1-stimulated CTGF expression levels for increased myofibroblast differentiation and contraction; and (5) much like fetal wounds (<xref rid="B31" ref-type="bibr">Cass et&#x000a0;al., 1997</xref>), FMOD treatment results in more rapid myofibroblast clearance from the wound&#x0201d; (<xref ref-type="fig" rid="f4">
<bold>Figure 4B</bold>
</xref>). Taken together, FMOD administration in adult wound models elicits a similar phenotype to fetal wounds at the molecular, cellular, and gross morphological levels (<xref rid="B241" ref-type="bibr">Zheng et&#x000a0;al., 2017</xref>). Moreover, recent studies demonstrate that FMOD can directly reprogram human dermal fibroblasts into a multipotent stage, indicating its ability to regulate the intracellular signaling cascade and determine the cell fate (<xref rid="B237" ref-type="bibr">Zheng et&#x000a0;al., 2012</xref>; <xref rid="B121" ref-type="bibr">Li et&#x000a0;al., 2016</xref>; <xref rid="B242" ref-type="bibr">Zheng et&#x000a0;al., 2019</xref>). Furthermore, from a translational aspect, recent studies have confirmed the biopotency of FMOD in reducing scar formation, accelerating wound tensile strength reestablishment, and improving dermal collagen architecture organization as well as gross wound appearance in multiple small and large preclinical animal models, and even within an excessive-mechanical-loading model (<xref rid="B241" ref-type="bibr">Zheng et&#x000a0;al., 2017</xref>; <xref rid="B99" ref-type="bibr">Jiang et&#x000a0;al., 2018</xref>), highlighting the enormous potentials of FMOD as a regenerative medicine for wound and scar therapies. Encouragingly, we have developed an FMOD-derived peptide (SLI-F06) which is being tested in a clinical trial for optimizing cutaneous wound healing (<uri xlink:type="simple" xlink:href="http://clinicaltrials.gov">clinicaltrials.gov</uri>: NCT03880058).</p><fig id="f4" position="float"><label>Figure 4</label><caption><p>Schematic depiction of the functions of FMOD in skin wound healing. <bold>(A)</bold> FMOD is able to bind to all three mammal TGF&#x003b2; isoforms as an extracellular TGF&#x003b2; reservoir. <bold>(B)</bold> Importantly, FMOD can selectively enhance SMAD3-mediated TGF&#x003b2;1-responsive pro-migration and pro-contraction signaling, while reducing AP-1-mediated TGF&#x003b2;1 auto-induction and fibrotic ECM accumulation during adult cutaneous wound healing.</p></caption><graphic xlink:href="fphar-10-01649-g004"/></fig><p>LUM is the only known SLRP expressed by the epithelia during wound healing (<xref rid="B60" ref-type="bibr">Frikeche et&#x000a0;al., 2016</xref>; <xref rid="B105" ref-type="bibr">Karamanou et&#x000a0;al., 2018</xref>). During cornea wound healing, LUM is known to regulate collagen fibrillogenesis, keratinocyte phenotypes, corneal transparency modulation, angiogenesis, and extravasation of inflammatory cells (<xref rid="B162" ref-type="bibr">Park and Tseng, 2000</xref>; <xref rid="B216" ref-type="bibr">Vij et&#x000a0;al., 2005</xref>; <xref rid="B79" ref-type="bibr">Hayashi et&#x000a0;al., 2010</xref>; <xref rid="B37" ref-type="bibr">Chen et&#x000a0;al., 2011</xref>; <xref rid="B105" ref-type="bibr">Karamanou et&#x000a0;al., 2018</xref>). However, the role of LUM in skin wound healing has not been adequately assessed. Liu et al. reported that recombinant LUM protein promoted skin wound healing in adult mice by facilitating dermal fibroblast activation and contraction without promoting keratinocyte proliferation and migration (<xref rid="B124" ref-type="bibr">Liu et&#x000a0;al., 2013</xref>). The increased fibroblast contractibility induced by LUM is regulated by integrin subunit alpha (ITGA)-2 (<xref rid="B124" ref-type="bibr">Liu et&#x000a0;al., 2013</xref>). Meanwhile, Zhao et al. reported that adenovirus-mediated LUM-overexpression suppressed excessive fibroblast proliferation and ECM production <italic>in vitro via</italic> inhibiting collagen - ITGA2 - protein tyrosine kinase (PTK)2 signaling through binding to the collagen receptor ITGA2 (<xref ref-type="fig" rid="f5">
<bold>Figure 5</bold>
</xref>), which in turn to reduce scar formation by significantly inhibiting ECM deposition <italic>in vivo</italic> (<xref rid="B235" ref-type="bibr">Zhao et&#x000a0;al., 2016</xref>). More interestingly, in comparison with normal skin-derived fibroblasts, hypertrophic scar-derived fibroblasts displayed reduced LUM expression (<xref rid="B235" ref-type="bibr">Zhao et&#x000a0;al., 2016</xref>), while keloid-derived fibroblasts exhibited elevated LUM expression (<xref rid="B150" ref-type="bibr">Naitoh et&#x000a0;al., 2005</xref>). Although LUM may be a potential pharmaceutical candidate for skin wound healing, its mechanism of action is far from clear.</p><fig id="f5" position="float"><label>Figure 5</label><caption><p>A schematic description of the functions of LUM in skin wound healing. LUM can suppress excessive fibroblast proliferation and ECM production <italic>via</italic> inhibiting ITGA-PTK2 signaling through binding to ITGA2.</p></caption><graphic xlink:href="fphar-10-01649-g005"/></fig><p>ASPN is upregulated in keloid margin biopsy specimens compared with that from adjacent healthy skin, indicating it may serve as a potential biomarker for keloid disease (<xref rid="B191" ref-type="bibr">Shih et&#x000a0;al., 2010</xref>). Likewise, comparative mass spectrometry-based proteomic analysis of keloids and healthy skin has shown that ASPN expression was significantly increased in keloid scars. This suggests that ASPN may be potentially used as a specific target for therapeutic intervention (<xref rid="B159" ref-type="bibr">Ong et&#x000a0;al., 2010</xref>). In addition, upregulated OGN expression was also found in keloids by cDNA microarray analysis (<xref rid="B150" ref-type="bibr">Naitoh et&#x000a0;al., 2005</xref>). However, except for DCN, BGN, FMOD, and LUM, investigations into other SLRPs for their potential benefits in skin wound healing are still very much in their infancy.</p></sec></sec><sec id="s4"><title>Conclusion and Perspectives</title><p>SLRPs are important components of the ECM that play crucial roles in collagen fibril growth, fibril organization, and ECM assembly. They are also capable of modulating the function of a significant number of growth factors and cytokines and have even been thought to prevent fibrosis and organ dysfunction (<xref rid="B139" ref-type="bibr">Mecham, 2011</xref>; <xref rid="B182" ref-type="bibr">Schaefer, 2011</xref>; <xref rid="B110" ref-type="bibr">Klingberg et&#x000a0;al., 2013</xref>). Thanks to worldwide collaboration over the last 30 years, much has been discovered in regard to the pivotal roles that SLRPs play in the different phases of the skin wound healing process, as well as the therapeutic potentials of SLRPs for reducing scar formation. However, the precise details concerning how each individual SLRP functions in the different phases of the healing process are still unclear. It is crucial to gain a specific understanding of the nature of the SLRP functional components, particularly in regard to their interactions with cell surface receptors, growth factors, and the ligands associated with molecular patterns of the skin wound healing process.</p><p>In conclusion, although there are still many obstacles that need to be surmounted before SLRPs can be applied in clinics for cutaneous wound healing management, a variety of SLRPs, such as DCN, BGN, FMOD, and LUM, exhibit great potential for future use in skin wound healing. For example, given the pro-angiogenic, pro-migratory, and pro-contraction potential of FMOD (<xref rid="B238" ref-type="bibr">Zheng et&#x000a0;al., 2014a</xref>; <xref rid="B239" ref-type="bibr">Zheng et&#x000a0;al., 2014b</xref>; <xref rid="B241" ref-type="bibr">Zheng et&#x000a0;al., 2017</xref>), besides reducing scar formation, it may be used to accelerate the healing of wound with retarded closure such as seen in the diabetic patients (<xref rid="B56" ref-type="bibr">Falanga, 2005</xref>; <xref rid="B53" ref-type="bibr">Ekmektzoglou and Zografos, 2006</xref>). Considering LUM enhances the epithelial cell migration (<xref rid="B188" ref-type="bibr">Seomun and Joo, 2008</xref>), it could also be a candidate to address the major problem of delayed wound healing. In addition to the skin, LUM and KERA may also be beneficial for corneal wound healing (<xref rid="B174" ref-type="bibr">Saika et&#x000a0;al., 2000</xref>; <xref rid="B27" ref-type="bibr">Carlson et&#x000a0;al., 2005</xref>), such as in the scene of corneal wounds caused by refractive surgeries (<xref rid="B125" ref-type="bibr">Ljubimov and Saghizadeh, 2015</xref>). Nevertheless, the delivery system and administration regimen of these SLRPs are insurmountable issues to be optimized in the pursuit of the most promising outcomes.</p></sec><sec id="s6"><title>Author Contributions</title><p>ZZ conceived the presented idea. XP wrote the manuscript with support from ZZ. ND modified the grammar and improved the language. All authors contributed to the final manuscript.</p></sec><sec id="s7"><title>Conflict of Interest</title><p>ZZ is an inventor on fibromodulin-related patents assigned to UCLA, and he is also a founder and former officer of Scarless Laboratories, Inc., which sublicenses fibromodulin-related patents from the UC Regents, who also holds equity in the company.</p><p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><title>Acknowledgments</title><p>We thank Nathaniel Burdekin (Department of Chemistry and Biochemistry, UCLA) for proofreading the manuscript. We thank Dr. Chia Soo (Division of Plastic and Reconstructive Surgery and Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, UCLA) and Dr. Kang Ting (Division of Growth and Development, School of Dentistry, UCLA) for the financial support.</p></ack><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Adini</surname><given-names>I.</given-names></name><name><surname>Ghosh</surname><given-names>K.</given-names></name><name><surname>Adini</surname><given-names>A.</given-names></name><name><surname>Chi</surname><given-names>Z.-L.</given-names></name><name><surname>Yoshimura</surname><given-names>T.</given-names></name><name><surname>Benny</surname><given-names>O.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment</article-title>. <source>J. Clin. Invest.</source>
<volume>124</volume> (<issue>1</issue>), <fpage>425</fpage>&#x02013;<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1172/JCI69404</pub-id>
<pub-id pub-id-type="pmid">24355922</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Albig</surname><given-names>A. R.</given-names></name><name><surname>Roy</surname><given-names>T. G.</given-names></name><name><surname>Becenti</surname><given-names>D. J.</given-names></name><name><surname>Schiemann</surname><given-names>W. P.</given-names></name></person-group> (<year>2007</year>). <article-title>Transcriptome analysis of endothelial cell gene expression induced by growth on matrigel matrices: identification and characterization of MAGP-2 and lumican as novel regulators of angiogenesis</article-title>. <source>Angiogenesis</source>
<volume>10</volume> (<issue>3</issue>), <fpage>197</fpage>&#x02013;<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1007/s10456-007-9075-z</pub-id>
<pub-id pub-id-type="pmid">17632767</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Antonsson</surname><given-names>P.</given-names></name><name><surname>Heinegard</surname><given-names>D.</given-names></name><name><surname>Oldberg</surname><given-names>A.</given-names></name></person-group> (<year>1993</year>). <article-title>Structure and deduced amino acid sequence of the human fibromodulin gene</article-title>. <source>Biochim. Biophys. Acta</source>
<volume>1174</volume> (<issue>2</issue>), <fpage>204</fpage>&#x02013;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1016/0167-4781(93)90117-v</pub-id>
<pub-id pub-id-type="pmid">8357838</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ao</surname><given-names>Z.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Qian</surname><given-names>P.</given-names></name><name><surname>Gao</surname><given-names>W.</given-names></name><name><surname>Guo</surname><given-names>R.</given-names></name><name><surname>Dong</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Tumor angiogenesis of SCLC inhibited by decreased expression of FMOD <italic>via</italic> downregulating angiogenic factors of endothelial cells</article-title>. <source>Biomed. Pharmacother.</source>
<volume>87</volume>, <fpage>539</fpage>&#x02013;<lpage>547</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2016.12.110</pub-id>
<pub-id pub-id-type="pmid">28081464</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Armour</surname><given-names>A.</given-names></name><name><surname>Scott</surname><given-names>P. G.</given-names></name><name><surname>Tredget</surname><given-names>E. E.</given-names></name></person-group> (<year>2007</year>). <article-title>Cellular and molecular pathology of HTS: basis for treatment</article-title>. <source>Wound Repair Regener.</source>
<volume>15</volume> (<issue>Suppl 1</issue>), <fpage>S6</fpage>&#x02013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1111/j.1524-475X.2007.00219.x</pub-id>
</mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Artlett</surname><given-names>C. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Inflammasomes in wound healing and fibrosis</article-title>. <source>J. Pathol.</source>
<volume>229</volume> (<issue>2</issue>), <fpage>157</fpage>&#x02013;<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1002/path.4116</pub-id>
<pub-id pub-id-type="pmid">23023641</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Atiyeh</surname><given-names>B. S.</given-names></name><name><surname>Costagliola</surname><given-names>M.</given-names></name><name><surname>Hayek</surname><given-names>S. N.</given-names></name></person-group> (<year>2005</year>). <article-title>Keloid or hypertrophic scar: the controversy: review of the literature</article-title>. <source>Ann. Plast. Surg.</source>
<volume>54</volume> (<issue>6</issue>), <fpage>676</fpage>&#x02013;<lpage>680</lpage>. <pub-id pub-id-type="doi">10.1097/01.sap.0000164538.72375.93</pub-id>
<pub-id pub-id-type="pmid">15900161</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Babelova</surname><given-names>A.</given-names></name><name><surname>Moreth</surname><given-names>K.</given-names></name><name><surname>Tsalastra-Greul</surname><given-names>W.</given-names></name><name><surname>Zeng-Brouwers</surname><given-names>J.</given-names></name><name><surname>Eickelberg</surname><given-names>O.</given-names></name><name><surname>Young</surname><given-names>M. F.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Biglycan, a danger signal that activates the NLRP3 inflammasome <italic>via</italic> toll-like and P2X receptors</article-title>. <source>J. Biol. Chem.</source>
<volume>284</volume> (<issue>36</issue>), <fpage>24035</fpage>&#x02013;<lpage>24048</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.014266</pub-id>
<pub-id pub-id-type="pmid">19605353</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baker</surname><given-names>R.</given-names></name><name><surname>Urso-Baiarda</surname><given-names>F.</given-names></name><name><surname>Linge</surname><given-names>C.</given-names></name><name><surname>Grobbelaar</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>Cutaneous Scarring: A Clinical Review</article-title>. <source>Dermatol. Res. Pract.</source>
<volume>2009</volume>. <pub-id pub-id-type="doi">10.1155/2009/625376</pub-id>
</mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bandyopadhyay</surname><given-names>B.</given-names></name><name><surname>Fan</surname><given-names>J.</given-names></name><name><surname>Guan</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Woodley</surname><given-names>D. T.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>A &#x0201c;traffic control&#x0201d; role for TGF&#x003b2;3: orchestrating dermal and epidermal cell motility during wound healing</article-title>. <source>J. Cell Biol.</source>
<volume>172</volume> (<issue>7</issue>), <fpage>1093</fpage>&#x02013;<lpage>1105</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200507111</pub-id>
<pub-id pub-id-type="pmid">16549496</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barrientos</surname><given-names>S.</given-names></name><name><surname>Stojadinovic</surname><given-names>O.</given-names></name><name><surname>Golinko</surname><given-names>M. S.</given-names></name><name><surname>Brem</surname><given-names>H.</given-names></name><name><surname>Tomic-Canic</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Growth factors and cytokines in wound healing</article-title>. <source>Wound Repair Regen.</source>
<volume>16</volume> (<issue>5</issue>), <fpage>585</fpage>&#x02013;<lpage>601</lpage>. <pub-id pub-id-type="doi">10.1111/j.1524-475X.2008.00410.x</pub-id>
<pub-id pub-id-type="pmid">19128254</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bayat</surname><given-names>A.</given-names></name><name><surname>McGrouther</surname><given-names>D. A.</given-names></name><name><surname>Ferguson</surname><given-names>M. W. J.</given-names></name></person-group> (<year>2003</year>). <article-title>Skin scarring</article-title>. <source>BMJ (Clin. Res. Ed.)</source>
<volume>326</volume> (<issue>7380</issue>), <fpage>88</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1136/bmj.326.7380.88</pub-id>
</mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bech-Hansen</surname><given-names>N. T.</given-names></name><name><surname>Naylor</surname><given-names>M. J.</given-names></name><name><surname>Maybaum</surname><given-names>T. A.</given-names></name><name><surname>Sparkes</surname><given-names>R. L.</given-names></name><name><surname>Koop</surname><given-names>B.</given-names></name><name><surname>Birch</surname><given-names>D. G.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness</article-title>. <source>Nat. Genet.</source>
<volume>26</volume> (<issue>3</issue>), <fpage>319</fpage>&#x02013;<lpage>323</lpage>. <pub-id pub-id-type="doi">10.1038/81619</pub-id>
<pub-id pub-id-type="pmid">11062471</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bella</surname><given-names>J.</given-names></name><name><surname>Hindle</surname><given-names>K.</given-names></name><name><surname>McEwan</surname><given-names>P.</given-names></name><name><surname>Lovell</surname><given-names>S.</given-names></name></person-group> (<year>2008</year>). <article-title>The leucine-rich repeat structure</article-title>. <source>Cell. Mol. Life Sci.</source>
<volume>65</volume> (<issue>15</issue>), <fpage>2307</fpage>&#x02013;<lpage>2333</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-008-8019-0</pub-id>
<pub-id pub-id-type="pmid">18408889</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bengtsson</surname><given-names>E.</given-names></name><name><surname>Aspberg</surname><given-names>A.</given-names></name><name><surname>Heinegard</surname><given-names>D.</given-names></name><name><surname>Sommarin</surname><given-names>Y.</given-names></name><name><surname>Spillmann</surname><given-names>D.</given-names></name></person-group> (<year>2000</year>). <article-title>The amino-terminal part of PRELP binds to heparin and heparan sulfate</article-title>. <source>J. Biol. Chem.</source>
<volume>275</volume> (<issue>52</issue>), <fpage>40695</fpage>&#x02013;<lpage>40702</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M007917200</pub-id>
<pub-id pub-id-type="pmid">11007795</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bengtsson</surname><given-names>E.</given-names></name><name><surname>Morgelin</surname><given-names>M.</given-names></name><name><surname>Sasaki</surname><given-names>T.</given-names></name><name><surname>Timpl</surname><given-names>R.</given-names></name><name><surname>Heinegard</surname><given-names>D.</given-names></name><name><surname>Aspberg</surname><given-names>A.</given-names></name></person-group> (<year>2002</year>). <article-title>The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor</article-title>. <source>J. Biol. Chem.</source>
<volume>277</volume> (<issue>17</issue>), <fpage>15061</fpage>&#x02013;<lpage>15068</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M108285200</pub-id>
<pub-id pub-id-type="pmid">11847210</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Berendsen</surname><given-names>A. D.</given-names></name><name><surname>Pinnow</surname><given-names>E. L.</given-names></name><name><surname>Maeda</surname><given-names>A.</given-names></name><name><surname>Brown</surname><given-names>A. C.</given-names></name><name><surname>McCartney-Francis</surname><given-names>N.</given-names></name><name><surname>Kram</surname><given-names>V.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Biglycan modulates angiogenesis and bone formation during fracture healing</article-title>. <source>Matrix Biol.</source>
<volume>35</volume>, <fpage>223</fpage>&#x02013;<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2013.12.004</pub-id>
<pub-id pub-id-type="pmid">24373744</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bi</surname><given-names>Y.</given-names></name><name><surname>Ehirchiou</surname><given-names>D.</given-names></name><name><surname>Kilts</surname><given-names>T. M.</given-names></name><name><surname>Inkson</surname><given-names>C. A.</given-names></name><name><surname>Embree</surname><given-names>M. C.</given-names></name><name><surname>Sonoyama</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche</article-title>. <source>Nat. Med.</source>
<volume>13</volume> (<issue>10</issue>), <fpage>1219</fpage>&#x02013;<lpage>1227</lpage>. <pub-id pub-id-type="doi">10.1038/nm1630</pub-id>
<pub-id pub-id-type="pmid">17828274</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Blochberger</surname><given-names>T. C.</given-names></name><name><surname>Cornuet</surname><given-names>P. K.</given-names></name><name><surname>Hassell</surname><given-names>J. R.</given-names></name></person-group> (<year>1992</year>). <article-title>Isolation and partial characterization of lumican and decorin from adult chicken corneas. A keratan sulfate-containing isoform of decorin is developmentally regulated</article-title>. <source>J. Biol. Chem.</source>
<volume>267</volume> (<issue>29</issue>), <fpage>20613</fpage>&#x02013;<lpage>20619</lpage>.<pub-id pub-id-type="pmid">1400383</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Block</surname><given-names>L.</given-names></name><name><surname>Gosain</surname><given-names>A.</given-names></name><name><surname>King</surname><given-names>T. W.</given-names></name></person-group> (<year>2015</year>). <article-title>Emerging Therapies for Scar Prevention</article-title>. <source>Adv. In Wound Care</source>
<volume>4</volume> (<issue>10</issue>), <fpage>607</fpage>&#x02013;<lpage>614</lpage>. <pub-id pub-id-type="doi">10.1089/wound.2015.0646</pub-id>
</mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brancato</surname><given-names>S. K.</given-names></name><name><surname>Albina</surname><given-names>J. E.</given-names></name></person-group> (<year>2011</year>). <article-title>Wound macrophages as key regulators of repair: origin, phenotype, and function</article-title>. <source>Am. J. Pathol.</source>
<volume>178</volume> (<issue>1</issue>), <fpage>19</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajpath.2010.08.003</pub-id>
<pub-id pub-id-type="pmid">21224038</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brezillon</surname><given-names>S.</given-names></name><name><surname>Zeltz</surname><given-names>C.</given-names></name><name><surname>Schneider</surname><given-names>L.</given-names></name><name><surname>Terryn</surname><given-names>C.</given-names></name><name><surname>Vuillermoz</surname><given-names>B.</given-names></name><name><surname>Ramont</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Lumican inhibits B16F1 melanoma cell lung metastasis</article-title>. <source>J. Physiol. Pharmacol.</source>
<volume>60</volume> (<issue>Suppl 4</issue>), <fpage>15</fpage>&#x02013;<lpage>22</lpage>.</mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brown</surname><given-names>B. C.</given-names></name><name><surname>McKenna</surname><given-names>S. P.</given-names></name><name><surname>Siddhi</surname><given-names>K.</given-names></name><name><surname>McGrouther</surname><given-names>D. A.</given-names></name><name><surname>Bayat</surname><given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>The hidden cost of skin scars: quality of life after skin scarring</article-title>. <source>J. Plast Reconstr. Aesthet. Surg.</source>
<volume>61</volume> (<issue>9</issue>), <fpage>1049</fpage>&#x02013;<lpage>1058</lpage>. <pub-id pub-id-type="doi">10.1016/j.bjps.2008.03.020</pub-id>
<pub-id pub-id-type="pmid">18617450</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brown</surname><given-names>J. A.</given-names></name></person-group> (<year>2004</year>). <article-title>The effects of ageing on fibroblast function during proliferation</article-title>. <source>J. Wound Care</source>
<volume>13</volume> (<issue>3</issue>), <fpage>94</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.12968/jowc.2004.13.3.26586</pub-id>
<pub-id pub-id-type="pmid">15045802</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Campisi</surname><given-names>J.</given-names></name></person-group> (<year>1998</year>). <article-title>The role of cellular senescence in skin aging</article-title>. <source>J. Invest. Dermatol. Symp. Proc.</source>
<volume>3</volume> (<issue>1</issue>), <fpage>1</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1038/jidsymp.1998.2</pub-id>
</mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carlson</surname><given-names>E. C.</given-names></name><name><surname>Wang</surname><given-names>I. J.</given-names></name><name><surname>Liu</surname><given-names>C. Y.</given-names></name><name><surname>Brannan</surname><given-names>P.</given-names></name><name><surname>Kao</surname><given-names>C. W.</given-names></name><name><surname>Kao</surname><given-names>W. W.</given-names></name></person-group> (<year>2003</year>). <article-title>Altered KSPG expression by keratocytes following corneal injury</article-title>. <source>Mol. Vis.</source>
<volume>9</volume>, <fpage>615</fpage>&#x02013;<lpage>623</lpage>.<pub-id pub-id-type="pmid">14654769</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carlson</surname><given-names>E. C.</given-names></name><name><surname>Liu</surname><given-names>C.-Y.</given-names></name><name><surname>Chikama</surname><given-names>T.-I.</given-names></name><name><surname>Hayashi</surname><given-names>Y.</given-names></name><name><surname>Kao</surname><given-names>C. W. C.</given-names></name><name><surname>Birk</surname><given-names>D. E.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Keratocan, a cornea-specific keratan sulfate proteoglycan, is regulated by lumican</article-title>. <source>J. Biol. Chem.</source>
<volume>280</volume> (<issue>27</issue>), <fpage>25541</fpage>&#x02013;<lpage>25547</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M500249200</pub-id>
<pub-id pub-id-type="pmid">15849191</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carrino</surname><given-names>D. A.</given-names></name><name><surname>Sorrell</surname><given-names>J. M.</given-names></name><name><surname>Caplan</surname><given-names>A. I.</given-names></name></person-group> (<year>2000</year>). <article-title>Age-related changes in the proteoglycans of human skin</article-title>. <source>Arch. Biochem. Biophys.</source>
<volume>373</volume> (<issue>1</issue>), <fpage>91</fpage>&#x02013;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1006/abbi.1999.1545</pub-id>
<pub-id pub-id-type="pmid">10620327</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carrino</surname><given-names>D. A.</given-names></name><name><surname>&#x000d6;nnerfjord</surname><given-names>P.</given-names></name><name><surname>Sandy</surname><given-names>J. D.</given-names></name><name><surname>Cs-Szabo</surname><given-names>G.</given-names></name><name><surname>Scott</surname><given-names>P. G.</given-names></name><name><surname>Sorrell</surname><given-names>J. M.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Age-related changes in the proteoglycans of human skin Specific cleavage of decorin to yield a major catabolic fragment in adult skin</article-title>. <source>J. Biol. Chem.</source>
<volume>278</volume> (<issue>19</issue>), <fpage>17566</fpage>&#x02013;<lpage>17572</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M300124200</pub-id>
<pub-id pub-id-type="pmid">12621051</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carrino</surname><given-names>D. A.</given-names></name><name><surname>Calabro</surname><given-names>A.</given-names></name><name><surname>Darr</surname><given-names>A. B.</given-names></name><name><surname>Dours-Zimmermann</surname><given-names>M. T.</given-names></name><name><surname>Sandy</surname><given-names>J. D.</given-names></name><name><surname>Zimmermann</surname><given-names>D. R.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Age-related differences in human skin proteoglycans</article-title>. <source>Glycobiology</source>
<volume>21</volume> (<issue>2</issue>), <fpage>257</fpage>&#x02013;<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1093/glycob/cwq162</pub-id>
<pub-id pub-id-type="pmid">20947661</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cass</surname><given-names>D. L.</given-names></name><name><surname>Sylvester</surname><given-names>K. G.</given-names></name><name><surname>Yang</surname><given-names>E. Y.</given-names></name><name><surname>Crombleholme</surname><given-names>T. M.</given-names></name><name><surname>Adzick</surname><given-names>N. S.</given-names></name></person-group> (<year>1997</year>). <article-title>Myofibroblast persistence in fetal sheep wounds is associated with scar formation</article-title>. <source>J. Pediatr. Surg.</source>
<volume>32</volume> (<issue>7</issue>), <fpage>1017</fpage>&#x02013;<lpage>1022</lpage>. <pub-id pub-id-type="doi">10.1016/s0022-3468(97)90390-0</pub-id>
<pub-id pub-id-type="pmid">9247225</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chakravarti</surname><given-names>S.</given-names></name><name><surname>Magnuson</surname><given-names>T.</given-names></name><name><surname>Lass</surname><given-names>J. H.</given-names></name><name><surname>Jepsen</surname><given-names>K. J.</given-names></name><name><surname>LaMantia</surname><given-names>C.</given-names></name><name><surname>Carroll</surname><given-names>H.</given-names></name></person-group> (<year>1998</year>). <article-title>Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican</article-title>. <source>J. Cell Biol.</source>
<volume>141</volume> (<issue>5</issue>), <fpage>1277</fpage>&#x02013;<lpage>1286</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.141.5.1277</pub-id>
<pub-id pub-id-type="pmid">9606218</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chakravarti</surname><given-names>S.</given-names></name></person-group> (<year>2002</year>). <article-title>Functions of lumican and fibromodulin: lessons from knockout mice</article-title>. <source>Glycoconj. J.</source>
<volume>19</volume> (<issue>4-5</issue>), <fpage>287</fpage>&#x02013;<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1023/a:1025348417078</pub-id>
<pub-id pub-id-type="pmid">12975607</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chang</surname><given-names>C. W.</given-names></name><name><surname>Ries</surname><given-names>W. R.</given-names></name></person-group> (<year>2001</year>). <article-title>Nonoperative techniques for scar management and revision</article-title>. <source>Facial Plast Surg.</source>
<volume>17</volume> (<issue>4</issue>), <fpage>283</fpage>&#x02013;<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1055/s-2001-18826</pub-id>
<pub-id pub-id-type="pmid">11735062</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Birk</surname><given-names>D. E.</given-names></name></person-group> (<year>2011</year>). <article-title>Focus on molecules: decorin</article-title>. <source>Exp. Eye Res.</source>
<volume>92</volume> (<issue>6</issue>), <fpage>444</fpage>&#x02013;<lpage>445</lpage>. <pub-id pub-id-type="doi">10.1016/j.exer.2010.05.008</pub-id>
<pub-id pub-id-type="pmid">20493188</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Birk</surname><given-names>D. E.</given-names></name></person-group> (<year>2013</year>). <article-title>The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly</article-title>. <source>FEBS J.</source>
<volume>280</volume> (<issue>10</issue>), <fpage>2120</fpage>&#x02013;<lpage>2137</lpage>. <pub-id pub-id-type="doi">10.1111/febs.12136</pub-id>
<pub-id pub-id-type="pmid">23331954</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Wong-Chong</surname><given-names>J.</given-names></name><name><surname>SundarRaj</surname><given-names>N.</given-names></name></person-group> (<year>2011</year>). <article-title>FGF-2- and TGF-&#x003b2;1-induced downregulation of lumican and keratocan in activated corneal keratocytes by JNK signaling pathway</article-title>. <source>Invest. Ophthalmol. Visual Sci.</source>
<volume>52</volume> (<issue>12</issue>), <fpage>8957</fpage>&#x02013;<lpage>8964</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.11-8078</pub-id>
<pub-id pub-id-type="pmid">22025571</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cheng</surname><given-names>W.</given-names></name><name><surname>Yan</surname><given-names>K.</given-names></name><name><surname>Xie</surname><given-names>L.-Y.</given-names></name><name><surname>Chen</surname><given-names>F.</given-names></name><name><surname>Yu</surname><given-names>H.-C.</given-names></name><name><surname>Huang</surname><given-names>Y.-X.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>MiR-143-3p controls TGF-&#x003b2;1-induced cell proliferation and extracellular matrix production in airway smooth muscle <italic>via</italic> negative regulation of the nuclear factor of activated T cells 1</article-title>. <source>Mol. Immunol.</source>
<volume>78</volume>, <fpage>133</fpage>&#x02013;<lpage>139</lpage>. <pub-id pub-id-type="doi">10.1016/j.molimm.2016.09.004</pub-id>
<pub-id pub-id-type="pmid">27639060</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chui</surname><given-names>A.</given-names></name><name><surname>Murthi</surname><given-names>P.</given-names></name><name><surname>Gunatillake</surname><given-names>T.</given-names></name><name><surname>Brennecke</surname><given-names>S. P.</given-names></name><name><surname>Ignjatovic</surname><given-names>V.</given-names></name><name><surname>Monagle</surname><given-names>P. T.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Altered decorin leads to disrupted endothelial cell function: a possible mechanism in the pathogenesis of fetal growth restriction?</article-title>
<source>Placenta</source>
<volume>35</volume> (<issue>8</issue>), <fpage>596</fpage>&#x02013;<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1016/j.placenta.2014.05.009</pub-id>
<pub-id pub-id-type="pmid">24947404</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Clegg</surname><given-names>D. O.</given-names></name><name><surname>Reda</surname><given-names>D. J.</given-names></name><name><surname>Harris</surname><given-names>C. L.</given-names></name><name><surname>Klein</surname><given-names>M. A.</given-names></name><name><surname>O'Dell</surname><given-names>J. R.</given-names></name><name><surname>Hooper</surname><given-names>M. M.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis</article-title>. <source>N Engl. J. Med.</source>
<volume>354</volume> (<issue>8</issue>), <fpage>795</fpage>&#x02013;<lpage>808</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa052771</pub-id>
<pub-id pub-id-type="pmid">16495392</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Colwell</surname><given-names>A. S.</given-names></name><name><surname>Krummel</surname><given-names>T. M.</given-names></name><name><surname>Longaker</surname><given-names>M. T.</given-names></name><name><surname>Lorenz</surname><given-names>H. P.</given-names></name></person-group> (<year>2006</year>). <article-title>Fetal and adult fibroblasts have similar TGF-&#x003b2;&#x02013;Mediated, smad-dependent signaling pathways</article-title>. <source>Plast. Reconstr. Surg.</source>
<volume>117</volume> (<issue>7</issue>), <fpage>2277</fpage>&#x02013;<lpage>2283</lpage>. <pub-id pub-id-type="doi">10.1097/01.prs.0000224299.16523.76</pub-id>
<pub-id pub-id-type="pmid">16772929</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Corpuz</surname><given-names>L. M.</given-names></name><name><surname>Funderburgh</surname><given-names>J. L.</given-names></name><name><surname>Funderburgh</surname><given-names>M. L.</given-names></name><name><surname>Bottomley</surname><given-names>G. S.</given-names></name><name><surname>Prakash</surname><given-names>S.</given-names></name><name><surname>Conrad</surname><given-names>G. W.</given-names></name></person-group> (<year>1996</year>). <article-title>Molecular cloning and tissue distribution of keratocan. Bovine corneal keratan sulfate proteoglycan 37A</article-title>. <source>J. Biol. Chem.</source>
<volume>271</volume> (<issue>16</issue>), <fpage>9759</fpage>&#x02013;<lpage>9763</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.271.16.9759</pub-id>
<pub-id pub-id-type="pmid">8621655</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Corsi</surname><given-names>A.</given-names></name><name><surname>Xu</surname><given-names>T.</given-names></name><name><surname>Chen</surname><given-names>X. D.</given-names></name><name><surname>Boyde</surname><given-names>A.</given-names></name><name><surname>Liang</surname><given-names>J.</given-names></name><name><surname>Mankani</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues</article-title>. <source>J. Bone Miner. Res.</source>
<volume>17</volume> (<issue>7</issue>), <fpage>1180</fpage>&#x02013;<lpage>1189</lpage>. <pub-id pub-id-type="doi">10.1359/jbmr.2002.17.7.1180</pub-id>
<pub-id pub-id-type="pmid">12102052</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Daley</surname><given-names>W. P.</given-names></name><name><surname>Yamada</surname><given-names>K. M.</given-names></name></person-group> (<year>2013</year>). <article-title>ECM-modulated cellular dynamics as a driving force for tissue morphogenesis</article-title>. <source>Curr. Opin. In Genet. Dev.</source>
<volume>23</volume> (<issue>4</issue>), <fpage>408</fpage>&#x02013;<lpage>414</lpage>. <pub-id pub-id-type="doi">10.1016/j.gde.2013.05.005</pub-id>
<pub-id pub-id-type="pmid">23849799</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Daniels</surname><given-names>J. T.</given-names></name><name><surname>Schultz</surname><given-names>G. S.</given-names></name><name><surname>Blalock</surname><given-names>T. D.</given-names></name><name><surname>Garrett</surname><given-names>Q.</given-names></name><name><surname>Grotendorst</surname><given-names>G. R.</given-names></name><name><surname>Dean</surname><given-names>N. M.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Mediation of transforming growth factor-beta(1)-stimulated matrix contraction by fibroblasts: a role for connective tissue growth factor in contractile scarring</article-title>. <source>Am. J. Pathol.</source>
<volume>163</volume> (<issue>5</issue>), <fpage>2043</fpage>&#x02013;<lpage>2052</lpage>. <pub-id pub-id-type="doi">10.1016/s0002-9440(10)63562-6</pub-id>
<pub-id pub-id-type="pmid">14578203</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Danielson</surname><given-names>K. G.</given-names></name><name><surname>Baribault</surname><given-names>H.</given-names></name><name><surname>Holmes</surname><given-names>D. F.</given-names></name><name><surname>Graham</surname><given-names>H.</given-names></name><name><surname>Kadler</surname><given-names>K. E.</given-names></name><name><surname>Iozzo</surname><given-names>R. V.</given-names></name></person-group> (<year>1997</year>). <article-title>Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility</article-title>. <source>J. Cell Biol.</source>
<volume>136</volume> (<issue>3</issue>), <fpage>729</fpage>&#x02013;<lpage>743</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.136.3.729</pub-id>
<pub-id pub-id-type="pmid">9024701</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Davison-Kotler</surname><given-names>E.</given-names></name><name><surname>Marshall</surname><given-names>W. S.</given-names></name><name><surname>Garcia-Gareta</surname><given-names>E.</given-names></name></person-group> (<year>2019</year>). <article-title>Sources of collagen for biomaterials in skin wound healing</article-title>. <source>Bioeng. (Basel)</source>
<volume>6</volume> (<issue>3</issue>), <fpage>56</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.3390/bioengineering6030056</pub-id>
</mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Hemptinne</surname><given-names>I.</given-names></name><name><surname>Gallant-Behm</surname><given-names>C. L.</given-names></name><name><surname>Noack</surname><given-names>C. L.</given-names></name><name><surname>Parreno</surname><given-names>J.</given-names></name><name><surname>Hart</surname><given-names>D. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Dermal fibroblasts from red Duroc and Yorkshire pigs exhibit intrinsic differences in the contraction of collagen gels</article-title>. <source>Wound Repair Regen.</source>
<volume>16</volume> (<issue>1</issue>), <fpage>132</fpage>&#x02013;<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1111/j.1524-475X.2007.00340.x</pub-id>
<pub-id pub-id-type="pmid">18211585</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Demidova-Rice</surname><given-names>T. N.</given-names></name><name><surname>Durham</surname><given-names>J. T.</given-names></name><name><surname>Herman</surname><given-names>I. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Wound healing angiogenesis: innovations and challenges in acute and chronic wound healing</article-title>. <source>Adv. In Wound Care</source>
<volume>1</volume> (<issue>1</issue>), <fpage>17</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1089/wound.2011.0308</pub-id>
</mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Desseaux</surname><given-names>S.</given-names></name><name><surname>Klok</surname><given-names>H.-A.</given-names></name></person-group> (<year>2015</year>). <article-title>Fibroblast adhesion on ECM-derived peptide modified poly (2-hydroxyethyl methacrylate) brushes: Ligand co-presentation and 3D-localization</article-title>. <source>Biomaterials</source>
<volume>44</volume>, <fpage>24</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2014.12.011</pub-id>
<pub-id pub-id-type="pmid">25617123</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Diegelmann</surname><given-names>R. F.</given-names></name><name><surname>Evans</surname><given-names>M. C.</given-names></name></person-group> (<year>2004</year>). <article-title>Wound healing: an overview of acute, fibrotic and delayed healing</article-title>. <source>Front. Biosci.</source>
<volume>9</volume>, <fpage>283</fpage>&#x02013;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.2741/1184</pub-id>
<pub-id pub-id-type="pmid">14766366</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Droguett</surname><given-names>R.</given-names></name><name><surname>Cabello-Verrugio</surname><given-names>C.</given-names></name><name><surname>Riquelme</surname><given-names>C.</given-names></name><name><surname>Brandan</surname><given-names>E.</given-names></name></person-group> (<year>2006</year>). <article-title>Extracellular proteoglycans modify TGF-&#x003b2; bio-availability attenuating its signaling during skeletal muscle differentiation</article-title>. <source>Matrix Biol.</source>
<volume>25</volume> (<issue>6</issue>), <fpage>332</fpage>&#x02013;<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2006.04.004</pub-id>
<pub-id pub-id-type="pmid">16766169</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ekmektzoglou</surname><given-names>K. A.</given-names></name><name><surname>Zografos</surname><given-names>G. C.</given-names></name></person-group> (<year>2006</year>). <article-title>A concomitant review of the effects of diabetes mellitus and hypothyroidism in wound healing</article-title>. <source>World J. Gastroenterol.</source>
<volume>12</volume> (<issue>17</issue>), <fpage>2721</fpage>&#x02013;<lpage>2729</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v12.i17.2721</pub-id>
<pub-id pub-id-type="pmid">16718759</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eming</surname><given-names>S. A.</given-names></name><name><surname>Martin</surname><given-names>P.</given-names></name><name><surname>Tomic-Canic</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Wound repair and regeneration: mechanisms, signaling, and translation</article-title>. <source>Sci. Trans. Med.</source>
<volume>6</volume> (<issue>265</issue>), <fpage>265sr266</fpage>&#x02013;<lpage>265sr266</lpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.3009337</pub-id>
</mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Estrach</surname><given-names>S.</given-names></name><name><surname>Cailleteau</surname><given-names>L.</given-names></name><name><surname>Franco</surname><given-names>C. A.</given-names></name><name><surname>Gerhardt</surname><given-names>H.</given-names></name><name><surname>Stefani</surname><given-names>C.</given-names></name><name><surname>Lemichez</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Laminin-binding integrins induce Dll4 expression and Notch signaling in endothelial cells</article-title>. <source>Circ. Res.</source>
<volume>109</volume> (<issue>2</issue>), <fpage>172</fpage>&#x02013;<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.240622</pub-id>
<pub-id pub-id-type="pmid">21474814</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Falanga</surname><given-names>V.</given-names></name></person-group> (<year>2005</year>). <article-title>Wound healing and its impairment in the diabetic foot</article-title>. <source>Lancet</source>
<volume>366</volume> (<issue>9498</issue>), <fpage>1736</fpage>&#x02013;<lpage>1743</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(05)67700-8</pub-id>
<pub-id pub-id-type="pmid">16291068</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Faler</surname><given-names>B. J.</given-names></name><name><surname>Macsata</surname><given-names>R. A.</given-names></name><name><surname>Plummer</surname><given-names>D.</given-names></name><name><surname>Mishra</surname><given-names>L.</given-names></name><name><surname>Sidawy</surname><given-names>A. N.</given-names></name></person-group> (<year>2006</year>). <article-title>Transforming growth factor-beta and wound healing</article-title>. <source>Perspect. Vasc. Surg. Endovasc. Ther.</source>
<volume>18</volume> (<issue>1</issue>), <fpage>55</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1177/153100350601800123</pub-id>
<pub-id pub-id-type="pmid">16628336</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fisher</surname><given-names>L. W.</given-names></name><name><surname>Termine</surname><given-names>J. D.</given-names></name><name><surname>Young</surname><given-names>M. F.</given-names></name></person-group> (<year>1989</year>). <article-title>Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species</article-title>. <source>J. Biol. Chem.</source>
<volume>264</volume> (<issue>8</issue>), <fpage>4571</fpage>&#x02013;<lpage>4576</lpage>.<pub-id pub-id-type="pmid">2647739</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fleischmajer</surname><given-names>R.</given-names></name><name><surname>Fisher</surname><given-names>L. W.</given-names></name><name><surname>MacDonald</surname><given-names>E. D.</given-names></name><name><surname>Jacobs</surname><given-names>L.</given-names><suffix>Jr.</suffix></name><name><surname>Perlish</surname><given-names>J. S.</given-names></name><name><surname>Termine</surname><given-names>J. D.</given-names></name></person-group> (<year>1991</year>). <article-title>Decorin interacts with fibrillar collagen of embryonic and adult human skin</article-title>. <source>J. Struct. Biol.</source>
<volume>106</volume> (<issue>1</issue>), <fpage>82</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/1047-8477(91)90065-5</pub-id>
<pub-id pub-id-type="pmid">2059554</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frikeche</surname><given-names>J.</given-names></name><name><surname>Maiti</surname><given-names>G.</given-names></name><name><surname>Chakravarti</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Small leucine-rich repeat proteoglycans in corneal inflammation and wound healing</article-title>. <source>Exp. Eye Res.</source>
<volume>151</volume>, <fpage>142</fpage>&#x02013;<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1016/j.exer.2016.08.015</pub-id>
<pub-id pub-id-type="pmid">27569372</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Funderburgh</surname><given-names>J. L.</given-names></name><name><surname>Corpuz</surname><given-names>L. M.</given-names></name><name><surname>Roth</surname><given-names>M. R.</given-names></name><name><surname>Funderburgh</surname><given-names>M. L.</given-names></name><name><surname>Tasheva</surname><given-names>E. S.</given-names></name><name><surname>Conrad</surname><given-names>G. W.</given-names></name></person-group> (<year>1997</year>). <article-title>Mimecan, the 25-kDa corneal keratan sulfate proteoglycan, is a product of the gene producing osteoglycin</article-title>. <source>J. Biol. Chem.</source>
<volume>272</volume> (<issue>44</issue>), <fpage>28089</fpage>&#x02013;<lpage>28095</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.272.44.28089</pub-id>
<pub-id pub-id-type="pmid">9346963</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="other">
<person-group person-group-type="author"><name><surname>Galiano</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <source>Overivew of Phase 2 Clinical Trial Results of RXI-109 Treatment to Reduce the Formation of Hypertrophic Dermal Scars RXi Pharmaceuticals</source>.</mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gallant</surname><given-names>C. L.</given-names></name><name><surname>Olson</surname><given-names>M. E.</given-names></name><name><surname>Hart</surname><given-names>D. A.</given-names></name></person-group> (<year>2004</year>). <article-title>Molecular, histologic, and gross phenotype of skin wound healing in red Duroc pigs reveals an abnormal healing phenotype of hypercontracted, hyperpigmented scarring</article-title>. <source>Wound Repair Regener.</source>
<volume>12</volume> (<issue>3</issue>), <fpage>305</fpage>&#x02013;<lpage>319</lpage>. <pub-id pub-id-type="doi">10.1111/j.1067-1927.2004.012311.x</pub-id>
</mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Galli</surname><given-names>S. J.</given-names></name><name><surname>Borregaard</surname><given-names>N.</given-names></name><name><surname>Wynn</surname><given-names>T. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils</article-title>. <source>Nat. Immunol.</source>
<volume>12</volume> (<issue>11</issue>), <fpage>1035</fpage>. <pub-id pub-id-type="doi">10.1038/ni.2109</pub-id>
<pub-id pub-id-type="pmid">22012443</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gauglitz</surname><given-names>G. G.</given-names></name><name><surname>Korting</surname><given-names>H. C.</given-names></name><name><surname>Pavicic</surname><given-names>T.</given-names></name><name><surname>Ruzicka</surname><given-names>T.</given-names></name><name><surname>Jeschke</surname><given-names>M. G.</given-names></name></person-group> (<year>2011</year>). <article-title>Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies</article-title>. <source>Mol. Med.</source>
<volume>17</volume> (<issue>1</issue>), <fpage>113</fpage>. <pub-id pub-id-type="doi">10.2119/molmed.2009.00153</pub-id>
<pub-id pub-id-type="pmid">20927486</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gerstein</surname><given-names>A. D.</given-names></name><name><surname>Phillips</surname><given-names>T. J.</given-names></name><name><surname>Rogers</surname><given-names>G. S.</given-names></name><name><surname>Gilchrest</surname><given-names>B. A.</given-names></name></person-group> (<year>1993</year>). <article-title>Wound healing and aging</article-title>. <source>Dermatol. Clin.</source>
<volume>11</volume> (<issue>4</issue>), <fpage>749</fpage>&#x02013;<lpage>757</lpage>. <pub-id pub-id-type="doi">10.1016/S0733-8635(18)30227-4</pub-id>
<pub-id pub-id-type="pmid">8222358</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ghatak</surname><given-names>S.</given-names></name><name><surname>Maytin</surname><given-names>E. V.</given-names></name><name><surname>Mack</surname><given-names>J. A.</given-names></name><name><surname>Hascall</surname><given-names>V. C.</given-names></name><name><surname>Atanelishvili</surname><given-names>I.</given-names></name><name><surname>Moreno Rodriguez</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Roles of Proteoglycans and Glycosaminoglycans in wound healing and fibrosis</article-title>. <source>Int. J. Cell Biol.</source>
<volume>2015</volume>, <fpage>834893</fpage>&#x02013;<lpage>834893</lpage>. <pub-id pub-id-type="doi">10.1155/2015/834893</pub-id>
<pub-id pub-id-type="pmid">26448760</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gibran</surname><given-names>N. S.</given-names></name><name><surname>Boyce</surname><given-names>S.</given-names></name><name><surname>Greenhalgh</surname><given-names>D. G.</given-names></name></person-group> (<year>2007</year>). <article-title>Cutaneous wound healing</article-title>. <source>J. Burn Care Res.</source>
<volume>28</volume> (<issue>4</issue>), <fpage>577</fpage>&#x02013;<lpage>579</lpage>. <pub-id pub-id-type="doi">10.1097/bcr.0b013e318093e44c</pub-id>
<pub-id pub-id-type="pmid">17665518</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gotte</surname><given-names>M.</given-names></name><name><surname>Kresse</surname><given-names>H.</given-names></name></person-group> (<year>2005</year>). <article-title>Defective glycosaminoglycan substitution of decorin in a patient with progeroid syndrome is a direct consequence of two point mutations in the galactosyltransferase I (beta4GalT-7) gene</article-title>. <source>Biochem. Genet.</source>
<volume>43</volume> (<issue>1-2</issue>), <fpage>65</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1007/s10528-005-1068-2</pub-id>
<pub-id pub-id-type="pmid">15859521</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gould</surname><given-names>L.</given-names></name><name><surname>Abadir</surname><given-names>P.</given-names></name><name><surname>Brem</surname><given-names>H.</given-names></name><name><surname>Carter</surname><given-names>M.</given-names></name><name><surname>Conner-Kerr</surname><given-names>T.</given-names></name><name><surname>Davidson</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Chronic wound repair and healing in older adults: current status and future research</article-title>. <source>J. Am. Geriatr. Soc.</source>
<volume>63</volume> (<issue>3</issue>), <fpage>427</fpage>&#x02013;<lpage>438</lpage>. <pub-id pub-id-type="doi">10.1111/jgs.13332</pub-id>
<pub-id pub-id-type="pmid">25753048</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grover</surname><given-names>J.</given-names></name><name><surname>Roughley</surname><given-names>P. J.</given-names></name></person-group> (<year>1998</year>). <article-title>Characterization of the human proline/arginine-rich end leucine-rich repeat protein (PRELP) gene promoter and identification of a repressor element</article-title>. <source>Biochem. J.</source>
<volume>336</volume> (<issue>Pt 1</issue>), <fpage>77</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1042/bj3360077</pub-id>
<pub-id pub-id-type="pmid">9806887</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grover</surname><given-names>J.</given-names></name><name><surname>Roughley</surname><given-names>P. J.</given-names></name></person-group> (<year>2001</year>). <article-title>Characterization and expression of murine PRELP</article-title>. <source>Matrix Biol.</source>
<volume>20</volume> (<issue>8</issue>), <fpage>555</fpage>&#x02013;<lpage>564</lpage>. <pub-id pub-id-type="doi">10.1016/s0945-053x(01)00165-2</pub-id>
<pub-id pub-id-type="pmid">11731272</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grover</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>E. R.</given-names></name><name><surname>Mounkes</surname><given-names>L. C.</given-names></name><name><surname>Stewart</surname><given-names>C. L.</given-names></name><name><surname>Roughley</surname><given-names>P. J.</given-names></name></person-group> (<year>2007</year>). <article-title>The consequence of PRELP overexpression on skin</article-title>. <source>Matrix Biol.</source>
<volume>26</volume> (<issue>2</issue>), <fpage>140</fpage>&#x02013;<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2006.10.005</pub-id>
<pub-id pub-id-type="pmid">17123807</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Haglund</surname><given-names>L.</given-names></name><name><surname>Tillgren</surname><given-names>V.</given-names></name><name><surname>Addis</surname><given-names>L.</given-names></name><name><surname>Wenglen</surname><given-names>C.</given-names></name><name><surname>Recklies</surname><given-names>A.</given-names></name><name><surname>Heinegard</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>Identification and characterization of the integrin alpha2beta1 binding motif in chondroadherin mediating cell attachment</article-title>. <source>J. Biol. Chem.</source>
<volume>286</volume> (<issue>5</issue>), <fpage>3925</fpage>&#x02013;<lpage>3934</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.161141</pub-id>
<pub-id pub-id-type="pmid">21127050</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Han</surname><given-names>A.</given-names></name><name><surname>Bandyopadhyay</surname><given-names>B.</given-names></name><name><surname>Jayaprakash</surname><given-names>P.</given-names></name><name><surname>Lua</surname><given-names>I.</given-names></name><name><surname>Sahu</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>The anti-motility signaling mechanism of TGF&#x003b2;3 that controls cell traffic during skin wound healing</article-title>. <source>Biol. Open</source>
<volume>1</volume> (<issue>12</issue>), <fpage>1169</fpage>&#x02013;<lpage>1177</lpage>. <pub-id pub-id-type="doi">10.1242/bio.20122246</pub-id>
<pub-id pub-id-type="pmid">23259050</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harunari</surname><given-names>N.</given-names></name><name><surname>Zhu</surname><given-names>K. Q.</given-names></name><name><surname>Armendariz</surname><given-names>R. T.</given-names></name><name><surname>Deubner</surname><given-names>H.</given-names></name><name><surname>Muangman</surname><given-names>P.</given-names></name><name><surname>Carrougher</surname><given-names>G. J.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Histology of the thick scar on the female, red Duroc pig: final similarities to human hypertrophic scar</article-title>. <source>Burns</source>
<volume>32</volume> (<issue>6</issue>), <fpage>669</fpage>&#x02013;<lpage>677</lpage>. <pub-id pub-id-type="doi">10.1016/j.burns.2006.03.015</pub-id>
<pub-id pub-id-type="pmid">16905264</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hattori</surname><given-names>N.</given-names></name><name><surname>Carrino</surname><given-names>D. A.</given-names></name><name><surname>Lauer</surname><given-names>M. E.</given-names></name><name><surname>Vasanji</surname><given-names>A.</given-names></name><name><surname>Wylie</surname><given-names>J. D.</given-names></name><name><surname>Nelson</surname><given-names>C. M.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Pericellular versican regulates the fibroblast-myofibroblast transition: a role for ADAMTS5 protease-mediated proteolysis</article-title>. <source>J. Biol. Chem.</source>
<volume>286</volume> (<issue>39</issue>), <fpage>34298</fpage>&#x02013;<lpage>34310</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.254938</pub-id>
<pub-id pub-id-type="pmid">21828051</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Haubner</surname><given-names>F.</given-names></name><name><surname>Ohmann</surname><given-names>E.</given-names></name><name><surname>Pohl</surname><given-names>F.</given-names></name><name><surname>Strutz</surname><given-names>J.</given-names></name><name><surname>Gassner</surname><given-names>H. G.</given-names></name></person-group> (<year>2012</year>). <article-title>Wound healing after radiation therapy: review of the literature</article-title>. <source>Radiat. Oncol.</source>
<volume>7</volume>, <fpage>162</fpage>. <pub-id pub-id-type="doi">10.1186/1748-717x-7-162</pub-id>
<pub-id pub-id-type="pmid">23006548</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>Y.</given-names></name><name><surname>Call</surname><given-names>M. K.</given-names></name><name><surname>Chikama</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Carlson</surname><given-names>E. C.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Lumican is required for neutrophil extravasation following corneal injury and wound healing</article-title>. <source>J. Cell Sci.</source>
<volume>123</volume> (<issue>Pt 17</issue>), <fpage>2987</fpage>&#x02013;<lpage>2995</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.068221</pub-id>
<pub-id pub-id-type="pmid">20699360</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henry</surname><given-names>S. P.</given-names></name><name><surname>Takanosu</surname><given-names>M.</given-names></name><name><surname>Boyd</surname><given-names>T. C.</given-names></name><name><surname>Mayne</surname><given-names>P. M.</given-names></name><name><surname>Eberspaecher</surname><given-names>H.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Expression pattern and gene characterization of asporin. a newly discovered member of the leucine-rich repeat protein family</article-title>. <source>J. Biol. Chem.</source>
<volume>276</volume> (<issue>15</issue>), <fpage>12212</fpage>&#x02013;<lpage>12221</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M011290200</pub-id>
<pub-id pub-id-type="pmid">11152695</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hildebrand</surname><given-names>A.</given-names></name><name><surname>Romar&#x000ed;s</surname><given-names>M.</given-names></name><name><surname>Rasmussen</surname><given-names>L. M.</given-names></name><name><surname>Heineg&#x000e5;rd</surname><given-names>D.</given-names></name><name><surname>Twardzik</surname><given-names>D. R.</given-names></name><name><surname>Border</surname><given-names>W. A.</given-names></name><etal/></person-group> (<year>1994</year>). <article-title>Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta</article-title>. <source>Biochem. J.</source>
<volume>302</volume> (<issue>Pt 2</issue>), <fpage>527</fpage>&#x02013;<lpage>534</lpage>. <pub-id pub-id-type="doi">10.1042/bj3020527</pub-id>
<pub-id pub-id-type="pmid">8093006</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hinz</surname><given-names>B.</given-names></name></person-group> (<year>2006</year>). <article-title>Masters and servants of the force: the role of matrix adhesions in myofibroblast force perception and transmission</article-title>. <source>Eur. J. Cell Biol.</source>
<volume>85</volume> (<issue>3-4</issue>), <fpage>175</fpage>&#x02013;<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejcb.2005.09.004</pub-id>
<pub-id pub-id-type="pmid">16546559</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Honardoust</surname><given-names>D.</given-names></name><name><surname>Varkey</surname><given-names>M.</given-names></name><name><surname>Hori</surname><given-names>K.</given-names></name><name><surname>Ding</surname><given-names>J.</given-names></name><name><surname>Shankowsky</surname><given-names>H. A.</given-names></name><name><surname>Tredget</surname><given-names>E. E.</given-names></name></person-group> (<year>2011</year>). <article-title>Small leucine-rich proteoglycans, decorin and fibromodulin, are reduced in postburn hypertrophic scar</article-title>. <source>Wound Repair Regener.</source>
<volume>19</volume> (<issue>3</issue>), <fpage>368</fpage>&#x02013;<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1111/j.1524-475X.2011.00677.x</pub-id>
</mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Honardoust</surname><given-names>D.</given-names></name><name><surname>Ding</surname><given-names>J.</given-names></name><name><surname>Varkey</surname><given-names>M.</given-names></name><name><surname>Shankowsky</surname><given-names>H. A.</given-names></name><name><surname>Tredget</surname><given-names>E. E.</given-names></name></person-group> (<year>2012</year>a). <article-title>Deep dermal fibroblasts refractory to migration and decorin-induced apoptosis contribute to hypertrophic scarring</article-title>. <source>J. Burn Care Res.</source>
<volume>33</volume> (<issue>5</issue>), <fpage>668</fpage>&#x02013;<lpage>677</lpage>. <pub-id pub-id-type="doi">10.1097/BCR.0b013e31824088e3</pub-id>
<pub-id pub-id-type="pmid">22210076</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Honardoust</surname><given-names>D.</given-names></name><name><surname>Varkey</surname><given-names>M.</given-names></name><name><surname>Marcoux</surname><given-names>Y.</given-names></name><name><surname>Shankowsky</surname><given-names>H. A.</given-names></name><name><surname>Tredget</surname><given-names>E. E.</given-names></name></person-group> (<year>2012</year>b). <article-title>Reduced decorin, fibromodulin, and transforming growth factor-beta3 in deep dermis leads to hypertrophic scarring</article-title>. <source>J. Burn Care Res.</source>
<volume>33</volume> (<issue>2</issue>), <fpage>218</fpage>&#x02013;<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1097/BCR.0b013e3182335980</pub-id>
<pub-id pub-id-type="pmid">22079916</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hoshiba</surname><given-names>T.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Endo</surname><given-names>C.</given-names></name><name><surname>Maruyama</surname><given-names>H.</given-names></name><name><surname>Wakui</surname><given-names>M.</given-names></name><name><surname>Nemoto</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Decellularized extracellular matrix as an <italic>in vitro</italic> model to study the comprehensive roles of the ECM in stem cell differentiation</article-title>. <source>Stem Cells Int.</source>
<volume>2016</volume>. <pub-id pub-id-type="doi">10.1155/2016/6397820</pub-id>
</mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hultgardh-Nilsson</surname><given-names>A.</given-names></name><name><surname>Boren</surname><given-names>J.</given-names></name><name><surname>Chakravarti</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis</article-title>. <source>J. Intern. Med.</source>
<volume>278</volume> (<issue>5</issue>), <fpage>447</fpage>&#x02013;<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1111/joim.12400</pub-id>
<pub-id pub-id-type="pmid">26477596</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hunzelmann</surname><given-names>N.</given-names></name><name><surname>Anders</surname><given-names>S.</given-names></name><name><surname>Sollberg</surname><given-names>S.</given-names></name><name><surname>Schonherr</surname><given-names>E.</given-names></name><name><surname>Krieg</surname><given-names>T.</given-names></name></person-group> (<year>1996</year>). <article-title>Co-ordinate induction of collagen type I and biglycan expression in keloids</article-title>. <source>Br. J. Dermatol.</source>
<volume>135</volume> (<issue>3</issue>), <fpage>394</fpage>&#x02013;<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2133.1996.d01-1011.x</pub-id>
<pub-id pub-id-type="pmid">8949432</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ii</surname><given-names>M.</given-names></name><name><surname>Yamamoto</surname><given-names>H.</given-names></name><name><surname>Adachi</surname><given-names>Y.</given-names></name><name><surname>Maruyama</surname><given-names>Y.</given-names></name><name><surname>Shinomura</surname><given-names>Y.</given-names></name></person-group> (<year>2006</year>). <article-title>Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis</article-title>. <source>Exp. Biol. Med.</source>
<volume>231</volume> (<issue>1</issue>), <fpage>20</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1177/153537020623100103</pub-id>
</mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iozzo</surname><given-names>R. V.</given-names></name><name><surname>Schaefer</surname><given-names>L.</given-names></name></person-group> (<year>2015</year>). <article-title>Proteoglycan form and function: a comprehensive nomenclature of proteoglycans</article-title>. <source>Matrix Biol.</source>
<volume>42</volume>, <fpage>11</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2015.02.003</pub-id>
<pub-id pub-id-type="pmid">25701227</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iozzo</surname><given-names>R. V.</given-names></name></person-group> (<year>1998</year>). <article-title>Matrix proteoglycans: from molecular design to cellular function.</article-title>
<source>Annu. Rev. Biochem</source>. <volume>67</volume>, <fpage>609</fpage>&#x02013;<lpage>652</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.biochem.67.1.609</pub-id>
<pub-id pub-id-type="pmid">9759499</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iozzo</surname><given-names>R. V.</given-names></name></person-group> (<year>1999</year>). <article-title>The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins</article-title>. <source>J. Biol. Chem.</source>
<volume>274</volume> (<issue>27</issue>), <fpage>18843</fpage>&#x02013;<lpage>18846</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.274.27.18843</pub-id>
<pub-id pub-id-type="pmid">10383378</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ito</surname><given-names>Y.</given-names></name><name><surname>Takeuchi</surname><given-names>J.</given-names></name><name><surname>Yamamoto</surname><given-names>K.</given-names></name><name><surname>Hashizume</surname><given-names>Y.</given-names></name><name><surname>Sato</surname><given-names>T.</given-names></name><name><surname>Tauchi</surname><given-names>H.</given-names></name></person-group> (<year>2001</year>). <article-title>Age differences in immunohistochemical localizations of large proteoglycan, PG-M/versican, and small roteoglycan, decorin, in the dermis of rats</article-title>. <source>Exp. Anim.</source>
<volume>50</volume> (<issue>2</issue>), <fpage>159</fpage>&#x02013;<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1538/expanim.50.159</pub-id>
<pub-id pub-id-type="pmid">11381620</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Izumi</surname><given-names>T.</given-names></name><name><surname>Tajima</surname><given-names>S.</given-names></name><name><surname>Nishikawa</surname><given-names>T.</given-names></name></person-group> (<year>1995</year>). <article-title>Stimulated expression of decorin and the decorin gene in fibroblasts cultured from patients with localized scleroderma</article-title>. <source>Arch. Dermatol. Res.</source>
<volume>287</volume> (<issue>5</issue>), <fpage>417</fpage>&#x02013;<lpage>420</lpage>. <pub-id pub-id-type="doi">10.1007/bf00373421</pub-id>
<pub-id pub-id-type="pmid">7625849</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>J&#x000e4;rvel&#x000e4;inen</surname><given-names>H.</given-names></name><name><surname>Sainio</surname><given-names>A.</given-names></name><name><surname>Wight</surname><given-names>T. N.</given-names></name></person-group> (<year>2015</year>). <article-title>Pivotal role for decorin in angiogenesis</article-title>. <source>Matrix Biol.: J. Int. Soc. Matrix Biol.</source>
<volume>43</volume>, <fpage>15</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2015.01.023</pub-id>
</mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jarvelainen</surname><given-names>H.</given-names></name><name><surname>Puolakkainen</surname><given-names>P.</given-names></name><name><surname>Pakkanen</surname><given-names>S.</given-names></name><name><surname>Brown</surname><given-names>E. L.</given-names></name><name><surname>Hook</surname><given-names>M.</given-names></name><name><surname>Iozzo</surname><given-names>R. V.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>A role for decorin in cutaneous wound healing and angiogenesis</article-title>. <source>Wound Repair Regener.</source>
<volume>14</volume> (<issue>4</issue>), <fpage>443</fpage>&#x02013;<lpage>452</lpage>. <pub-id pub-id-type="doi">10.1111/j.1743-6109.2006.00150.x</pub-id>
</mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jepsen</surname><given-names>K. J.</given-names></name><name><surname>Wu</surname><given-names>F.</given-names></name><name><surname>Peragallo</surname><given-names>J. H.</given-names></name><name><surname>Paul</surname><given-names>J.</given-names></name><name><surname>Roberts</surname><given-names>L.</given-names></name><name><surname>Ezura</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>A syndrome of joint laxity and impaired tendon integrity in lumican- and fibromodulin-deficient mice</article-title>. <source>J. Biol. Chem.</source>
<volume>277</volume> (<issue>38</issue>), <fpage>35532</fpage>&#x02013;<lpage>35540</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M205398200</pub-id>
<pub-id pub-id-type="pmid">12089156</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jian</surname><given-names>J.</given-names></name><name><surname>Zheng</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>K.</given-names></name><name><surname>Rackohn</surname><given-names>T. M.</given-names></name><name><surname>Hsu</surname><given-names>C.</given-names></name><name><surname>Levin</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Fibromodulin promoted <italic>in vitro</italic> and <italic>in vivo</italic> angiogenesis</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<volume>436</volume> (<issue>3</issue>), <fpage>530</fpage>&#x02013;<lpage>535</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2013.06.005</pub-id>.<pub-id pub-id-type="pmid">23770359</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jiang</surname><given-names>W.</given-names></name><name><surname>Ting</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Zara</surname><given-names>J. N.</given-names></name><name><surname>Song</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Fibromodulin reduces scar size and increases scar tensile strength in normal and excessive-mechanical-loading porcine cutaneous wounds</article-title>. <source>J. Cell Mol. Med.</source>
<volume>22</volume> (<issue>4</issue>), <fpage>2510</fpage>&#x02013;<lpage>2513</lpage>. <pub-id pub-id-type="doi">10.1111/jcmm.13516</pub-id>
<pub-id pub-id-type="pmid">29392829</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Johnson</surname><given-names>H. J.</given-names></name><name><surname>Rosenberg</surname><given-names>L.</given-names></name><name><surname>Choi</surname><given-names>H. U.</given-names></name><name><surname>Garza</surname><given-names>S.</given-names></name><name><surname>Hook</surname><given-names>M.</given-names></name><name><surname>Neame</surname><given-names>P. J.</given-names></name></person-group> (<year>1997</year>). <article-title>Characterization of epiphycan, a small proteoglycan with a leucine-rich repeat core protein</article-title>. <source>J. Biol. Chem.</source>
<volume>272</volume> (<issue>30</issue>), <fpage>18709</fpage>&#x02013;<lpage>18717</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.272.30.18709</pub-id>
<pub-id pub-id-type="pmid">9228042</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Johnstone</surname><given-names>B.</given-names></name><name><surname>Markopoulos</surname><given-names>M.</given-names></name><name><surname>Neame</surname><given-names>P.</given-names></name><name><surname>Caterson</surname><given-names>B.</given-names></name></person-group> (<year>1993</year>). <article-title>Identification and characterization of glycanated and non-glycanated forms of biglycan and decorin in the human intervertebral disc</article-title>. <source>Biochem. J.</source>
<volume>292</volume> (<issue>Pt 3</issue>), <fpage>661</fpage>&#x02013;<lpage>666</lpage>. <pub-id pub-id-type="doi">10.1042/bj2920661</pub-id>
<pub-id pub-id-type="pmid">8317997</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kalamajski</surname><given-names>S.</given-names></name><name><surname>Oldberg</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>The role of small leucine-rich proteoglycans in collagen fibrillogenesis</article-title>. <source>Matrix Biol.</source>
<volume>29</volume> (<issue>4</issue>), <fpage>248</fpage>&#x02013;<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2010.01.001</pub-id>
<pub-id pub-id-type="pmid">20080181</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kalamajski</surname><given-names>S.</given-names></name><name><surname>Aspberg</surname><given-names>A.</given-names></name><name><surname>Lindblom</surname><given-names>K.</given-names></name><name><surname>Heinegard</surname><given-names>D.</given-names></name><name><surname>Oldberg</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>Asporin competes with decorin for collagen binding, binds calcium and promotes osteoblast collagen mineralization</article-title>. <source>Biochem. J.</source>
<volume>423</volume> (<issue>1</issue>), <fpage>53</fpage>&#x02013;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1042/bj20090542</pub-id>
<pub-id pub-id-type="pmid">19589127</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kao</surname><given-names>W. W.</given-names></name><name><surname>Liu</surname><given-names>C. Y.</given-names></name></person-group> (<year>2002</year>). <article-title>Roles of lumican and keratocan on corneal transparency</article-title>. <source>Glycoconj. J.</source>
<volume>19</volume> (<issue>4-5</issue>), <fpage>275</fpage>&#x02013;<lpage>285</lpage>. <pub-id pub-id-type="doi">10.1023/a:1025396316169</pub-id>
<pub-id pub-id-type="pmid">12975606</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karamanou</surname><given-names>K.</given-names></name><name><surname>Perrot</surname><given-names>G.</given-names></name><name><surname>Maquart</surname><given-names>F.-X.</given-names></name><name><surname>Br&#x000e9;zillon</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Lumican as a multivalent effector in wound healing</article-title>. <source>Adv. Drug Deliv. Rev.</source>
<volume>129</volume>, <fpage>344</fpage>&#x02013;<lpage>351</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2018.02.011</pub-id>
<pub-id pub-id-type="pmid">29501701</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karsdal</surname><given-names>M. A.</given-names></name><name><surname>Nielsen</surname><given-names>M. J.</given-names></name><name><surname>Sand</surname><given-names>J. M.</given-names></name><name><surname>Henriksen</surname><given-names>K.</given-names></name><name><surname>Genovese</surname><given-names>F.</given-names></name><name><surname>Bay-Jensen</surname><given-names>A. C.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Extracellular matrix remodeling: the common denominator in connective tissue diseases. possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure</article-title>. <source>Assay Drug Dev. Technol.</source>
<volume>11</volume> (<issue>2</issue>), <fpage>70</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1089/adt.2012.474</pub-id>
<pub-id pub-id-type="pmid">23046407</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khorasani</surname><given-names>H.</given-names></name><name><surname>Zheng</surname><given-names>Z.</given-names></name><name><surname>Nguyen</surname><given-names>C.</given-names></name><name><surname>Zara</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>A quantitative approach to scar analysis</article-title>. <source>Am. J. Pathol.</source>
<volume>178</volume> (<issue>2</issue>), <fpage>621</fpage>&#x02013;<lpage>628</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajpath.2010.10.019</pub-id>
<pub-id pub-id-type="pmid">21281794</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kieran</surname><given-names>I.</given-names></name><name><surname>Knock</surname><given-names>A.</given-names></name><name><surname>Bush</surname><given-names>J.</given-names></name><name><surname>So</surname><given-names>K.</given-names></name><name><surname>Metcalfe</surname><given-names>A.</given-names></name><name><surname>Hobson</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Interleukin-10 reduces scar formation in both animal and human cutaneous wounds: Results of two preclinical and phase II randomized control studies</article-title>. <source>Wound Repair And Regen.</source>
<volume>21</volume> (<issue>3</issue>), <fpage>428</fpage>&#x02013;<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1111/wrr.12043</pub-id>
</mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kieran</surname><given-names>I.</given-names></name><name><surname>Taylor</surname><given-names>C.</given-names></name><name><surname>Bush</surname><given-names>J.</given-names></name><name><surname>Rance</surname><given-names>M.</given-names></name><name><surname>So</surname><given-names>K.</given-names></name><name><surname>Boanas</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Effects of interleukin-10 on cutaneous wounds and scars in humans of African continental ancestral origin</article-title>. <source>Wound Repair Regener.</source>
<volume>22</volume> (<issue>3</issue>), <fpage>326</fpage>&#x02013;<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1111/wrr.12178</pub-id>
</mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Klingberg</surname><given-names>F.</given-names></name><name><surname>Hinz</surname><given-names>B.</given-names></name><name><surname>White</surname><given-names>E. S.</given-names></name></person-group> (<year>2013</year>). <article-title>The myofibroblast matrix: implications for tissue repair and fibrosis</article-title>. <source>J. Pathol.</source>
<volume>229</volume> (<issue>2</issue>), <fpage>298</fpage>&#x02013;<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1002/path.4104</pub-id>
<pub-id pub-id-type="pmid">22996908</pub-id></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kou</surname><given-names>I.</given-names></name><name><surname>Nakajima</surname><given-names>M.</given-names></name><name><surname>Ikegawa</surname><given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>Expression and regulation of the osteoarthritis-associated protein asporin</article-title>. <source>J. Biol. Chem.</source>
<volume>282</volume> (<issue>44</issue>), <fpage>32193</fpage>&#x02013;<lpage>32199</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M706262200</pub-id>
<pub-id pub-id-type="pmid">17804408</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kram</surname><given-names>V.</given-names></name><name><surname>Kilts</surname><given-names>T. M.</given-names></name><name><surname>Bhattacharyya</surname><given-names>N.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Young</surname><given-names>M. F.</given-names></name></person-group> (<year>2017</year>). <article-title>Small leucine rich proteoglycans, a novel link to osteoclastogenesis</article-title>. <source>Sci. Rep.</source>
<volume>7</volume> (<issue>1</issue>), <fpage>12627</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-12651-6</pub-id>
<pub-id pub-id-type="pmid">28974711</pub-id></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krusius</surname><given-names>T.</given-names></name><name><surname>Ruoslahti</surname><given-names>E.</given-names></name></person-group> (<year>1986</year>). <article-title>Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>83</volume> (<issue>20</issue>), <fpage>7683</fpage>&#x02013;<lpage>7687</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.83.20.7683</pub-id>
<pub-id pub-id-type="pmid">3484330</pub-id></mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kwan</surname><given-names>P.</given-names></name><name><surname>Ding</surname><given-names>J.</given-names></name><name><surname>Tredget</surname><given-names>E. E.</given-names></name></person-group> (<year>2015</year>). <article-title>MicroRNA 181b regulates decorin production by dermal fibroblasts and may be a potential therapy for hypertrophic scar</article-title>. <source>PloS One</source>
<volume>10</volume> (<issue>4</issue>), <elocation-id>e0123054</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0123054</pub-id>
<pub-id pub-id-type="pmid">25837671</pub-id></mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Laine</surname><given-names>P.</given-names></name><name><surname>Reunanen</surname><given-names>N.</given-names></name><name><surname>Ravanti</surname><given-names>L.</given-names></name><name><surname>Foschi</surname><given-names>M.</given-names></name><name><surname>Santra</surname><given-names>M.</given-names></name><name><surname>Iozzo</surname><given-names>R. V.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>Activation of extracellular signal-regulated protein kinase1,2 results in down-regulation of decorin expression in fibroblasts</article-title>. <source>Biochem. J.</source>
<volume>349</volume> (<issue>Pt 1</issue>), <fpage>19</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1042/0264-6021:3490019</pub-id>
<pub-id pub-id-type="pmid">10861206</pub-id></mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Larson</surname><given-names>B. J.</given-names></name><name><surname>Longaker</surname><given-names>M. T.</given-names></name><name><surname>Lorenz</surname><given-names>H. P.</given-names></name></person-group> (<year>2010</year>). <article-title>Scarless fetal wound healing: a basic science review</article-title>. <source>Plast. Reconstr. Surg.</source>
<volume>126</volume> (<issue>4</issue>), <fpage>1172</fpage>&#x02013;<lpage>1180</lpage>. <pub-id pub-id-type="doi">10.1097/PRS.0b013e3181eae781</pub-id>
<pub-id pub-id-type="pmid">20885241</pub-id></mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>W. J.</given-names></name><name><surname>Ahn</surname><given-names>H. M.</given-names></name><name><surname>Roh</surname><given-names>H.</given-names></name><name><surname>Na</surname><given-names>Y.</given-names></name><name><surname>Choi</surname><given-names>I. K.</given-names></name><name><surname>Lee</surname><given-names>J. H.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Decorin-expressing adenovirus decreases collagen synthesis and upregulates MMP expression in keloid fibroblasts and keloid spheroids</article-title>. <source>Exp. Dermatol.</source>
<volume>24</volume> (<issue>8</issue>), <fpage>591</fpage>&#x02013;<lpage>597</lpage>. <pub-id pub-id-type="doi">10.1111/exd.12719</pub-id>
<pub-id pub-id-type="pmid">25865370</pub-id></mixed-citation></ref><ref id="B118"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leiton</surname><given-names>C. V.</given-names></name><name><surname>Aranmolate</surname><given-names>A.</given-names></name><name><surname>Eyermann</surname><given-names>C.</given-names></name><name><surname>Menezes</surname><given-names>M. J.</given-names></name><name><surname>Escobar-Hoyos</surname><given-names>L. F.</given-names></name><name><surname>Husain</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Laminin promotes metalloproteinase-mediated dystroglycan processing to regulate oligodendrocyte progenitor cell proliferation</article-title>. <source>J. Neurochem.</source>
<volume>135</volume> (<issue>3</issue>), <fpage>522</fpage>&#x02013;<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13241</pub-id>
<pub-id pub-id-type="pmid">26171643</pub-id></mixed-citation></ref><ref id="B119"><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Levin</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <source>Derma Sciences Announces Results of Futility Analyses for Phase 3 Clinical Trials of Aclerastide in Diabetic Foot Ulcer Healing [Online]</source>. <publisher-name>(FierceBiotech) USA</publisher-name> Available: <uri xlink:type="simple" xlink:href="https://www.fiercebiotech.com/biotech/derma-sciences-announces-results-of-futility-analyses-for-phase-3-clinical-trials-of">https://www.fiercebiotech.com/biotech/derma-sciences-announces-results-of-futility-analyses-for-phase-3-clinical-trials-of</uri> [Accessed].</mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Xia</surname><given-names>W.</given-names></name><name><surname>Lei</surname><given-names>D.</given-names></name><name><surname>Voorhees</surname><given-names>J. J.</given-names></name><name><surname>Fisher</surname><given-names>G. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Age-dependent alterations of decorin glycosaminoglycans in human skin</article-title>. <source>Sci. Rep.</source>
<volume>3</volume>, <fpage>2422</fpage>&#x02013;<lpage>2422</lpage>. <pub-id pub-id-type="doi">10.1038/srep02422</pub-id>
<pub-id pub-id-type="pmid">23939413</pub-id></mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>C.-S.</given-names></name><name><surname>Yang</surname><given-names>P.</given-names></name><name><surname>Ting</surname><given-names>K.</given-names></name><name><surname>Aghaloo</surname><given-names>T.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Fibromodulin reprogrammed cells: a novel cell source for bone regeneration</article-title>. <source>Biomaterials</source>
<volume>83</volume>, <fpage>194</fpage>&#x02013;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2016.01.013</pub-id>
<pub-id pub-id-type="pmid">26774565</pub-id></mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lichtman</surname><given-names>M. K.</given-names></name><name><surname>Otero-Vinas</surname><given-names>M.</given-names></name><name><surname>Falanga</surname><given-names>V.</given-names></name></person-group> (<year>2016</year>). <article-title>Transforming growth factor beta (TGF-&#x003b2;) isoforms in wound healing and fibrosis</article-title>. <source>Wound Repair Regen.</source>
<volume>24</volume> (<issue>2</issue>), <fpage>215</fpage>&#x02013;<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1111/wrr.12398</pub-id>
<pub-id pub-id-type="pmid">26704519</pub-id></mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>C. Y.</given-names></name><name><surname>Birk</surname><given-names>D. E.</given-names></name><name><surname>Hassell</surname><given-names>J. R.</given-names></name><name><surname>Kane</surname><given-names>B.</given-names></name><name><surname>Kao</surname><given-names>W. W.</given-names></name></person-group> (<year>2003</year>). <article-title>Keratocan-deficient mice display alterations in corneal structure</article-title>. <source>J. Biol. Chem.</source>
<volume>278</volume> (<issue>24</issue>), <fpage>21672</fpage>&#x02013;<lpage>21677</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M301169200</pub-id>
<pub-id pub-id-type="pmid">12665512</pub-id></mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>X. J.</given-names></name><name><surname>Kong</surname><given-names>F. Z.</given-names></name><name><surname>Wang</surname><given-names>Y. H.</given-names></name><name><surname>Zheng</surname><given-names>J. H.</given-names></name><name><surname>Wan</surname><given-names>W. D.</given-names></name><name><surname>Deng</surname><given-names>C. L.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Lumican Accelerates wound healing by enhancing alpha2beta1 integrin-mediated fibroblast contractility</article-title>. <source>PloS One</source>
<volume>8</volume> (<issue>6</issue>), <elocation-id>e67124</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0067124</pub-id>
<pub-id pub-id-type="pmid">23840601</pub-id></mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ljubimov</surname><given-names>A. V.</given-names></name><name><surname>Saghizadeh</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Progress in corneal wound healing</article-title>. <source>Prog. In Retinal Eye Res.</source>
<volume>49</volume>, <fpage>17</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.preteyeres.2015.07.002</pub-id>
</mixed-citation></ref><ref id="B126"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lochner</surname><given-names>K.</given-names></name><name><surname>Gaemlich</surname><given-names>A.</given-names></name><name><surname>S&#x000fc;del</surname><given-names>K. M.</given-names></name><name><surname>Venzke</surname><given-names>K.</given-names></name><name><surname>Moll</surname><given-names>I.</given-names></name><name><surname>Knott</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Expression of decorin and collagens I and III in different layers of human skin <italic>in vivo</italic>: a laser capture microdissection study</article-title>. <source>Biogerontology</source>
<volume>8</volume> (<issue>3</issue>), <fpage>269</fpage>&#x02013;<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1007/s10522-006-9070-6</pub-id>
<pub-id pub-id-type="pmid">17146610</pub-id></mixed-citation></ref><ref id="B127"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lohr</surname><given-names>K.</given-names></name><name><surname>Sardana</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Wu</surname><given-names>F.</given-names></name><name><surname>Huso</surname><given-names>D. L.</given-names></name><name><surname>Hamad</surname><given-names>A. R.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Extracellular matrix protein lumican regulates inflammation in a mouse model of colitis</article-title>. <source>Inflammation Bowel Dis.</source>
<volume>18</volume> (<issue>1</issue>), <fpage>143</fpage>&#x02013;<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1002/ibd.21713</pub-id>
</mixed-citation></ref><ref id="B128"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lorenzo</surname><given-names>P.</given-names></name><name><surname>Aspberg</surname><given-names>A.</given-names></name><name><surname>Onnerfjord</surname><given-names>P.</given-names></name><name><surname>Bayliss</surname><given-names>M. T.</given-names></name><name><surname>Neame</surname><given-names>P. J.</given-names></name><name><surname>Heinegard</surname><given-names>D.</given-names></name></person-group> (<year>2001</year>). <article-title>Identification and characterization of asporin. a novel member of the leucine-rich repeat protein family closely related to decorin and biglycan</article-title>. <source>J. Biol. Chem.</source>
<volume>276</volume> (<issue>15</issue>), <fpage>12201</fpage>&#x02013;<lpage>12211</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M010932200</pub-id>
<pub-id pub-id-type="pmid">11152692</pub-id></mixed-citation></ref><ref id="B129"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lu</surname><given-names>X.-M.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Jin</surname><given-names>Y.-N.</given-names></name><name><surname>Yu</surname><given-names>Y.-Q.</given-names></name></person-group> (<year>2015</year>). <article-title>Lumican overexpression exacerbates lipopolysaccharide-induced renal injury in mice</article-title>. <source>Mol. Med. Rep.</source>
<volume>12</volume> (<issue>3</issue>), <fpage>4089</fpage>&#x02013;<lpage>4094</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2015.3940</pub-id>
<pub-id pub-id-type="pmid">26081832</pub-id></mixed-citation></ref><ref id="B130"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maccarana</surname><given-names>M.</given-names></name><name><surname>Svensson</surname><given-names>R. B.</given-names></name><name><surname>Knutsson</surname><given-names>A.</given-names></name><name><surname>Giannopoulos</surname><given-names>A.</given-names></name><name><surname>Pelkonen</surname><given-names>M.</given-names></name><name><surname>Weis</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Asporin-deficient mice have tougher skin and altered skin glycosaminoglycan content and structure</article-title>. <source>PloS One</source>
<volume>12</volume> (<issue>8</issue>), <elocation-id>e0184028</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0184028</pub-id>
<pub-id pub-id-type="pmid">28859141</pub-id></mixed-citation></ref><ref id="B131"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Malgouries</surname><given-names>S.</given-names></name><name><surname>Thibaut</surname><given-names>S.</given-names></name><name><surname>Bernard</surname><given-names>B. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Proteoglycan expression patterns in human hair follicle</article-title>. <source>Br. J. Dermatol.</source>
<volume>158</volume> (<issue>2</issue>), <fpage>234</fpage>&#x02013;<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2133.2007.08339.x</pub-id>
<pub-id pub-id-type="pmid">18067481</pub-id></mixed-citation></ref><ref id="B132"><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Maquart</surname><given-names>F.-X.</given-names></name><name><surname>Br&#x000e9;zillon</surname><given-names>S.</given-names></name><name><surname>Wegrowski</surname><given-names>Y.</given-names></name></person-group> (<year>2010</year>). &#x0201c;<article-title>Proteoglycans in Skin Aging</article-title>,&#x0201d; in <source>Textbook of Aging Skin</source>. Eds. <person-group person-group-type="editor"><name><surname>Farage</surname><given-names>M. A.</given-names></name><name><surname>Maibach</surname><given-names>H. I.</given-names></name></person-group> (<publisher-loc>Berlin, Heidelberg</publisher-loc>: <publisher-name>Springer Berlin Heidelberg</publisher-name>), <fpage>109</fpage>&#x02013;<lpage>120</lpage>.</mixed-citation></ref><ref id="B133"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marshall</surname><given-names>C. D.</given-names></name><name><surname>Hu</surname><given-names>M. S.</given-names></name><name><surname>Leavitt</surname><given-names>T.</given-names></name><name><surname>Barnes</surname><given-names>L. A.</given-names></name><name><surname>Lorenz</surname><given-names>H. P.</given-names></name><name><surname>Longaker</surname><given-names>M. T.</given-names></name></person-group> (<year>2018</year>). <article-title>Cutaneous scarring: basic science, current treatments, and future directions</article-title>. <source>Adv. In Wound Care</source>
<volume>7</volume> (<issue>2</issue>), <fpage>29</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1089/wound.2016.0696</pub-id>
</mixed-citation></ref><ref id="B134"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Martin</surname><given-names>P.</given-names></name></person-group> (<year>1997</year>). <article-title>Wound healing&#x02013;aiming for perfect skin regeneration</article-title>. <source>Science</source>
<volume>276</volume> (<issue>5309</issue>), <fpage>75</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1126/science.276.5309.75</pub-id>
<pub-id pub-id-type="pmid">9082989</pub-id></mixed-citation></ref><ref id="B135"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mary</surname><given-names>S. M.</given-names></name><name><surname>James</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Proteoglycans in normal and healing skin</article-title>. <source>Adv. In Wound Care</source>
<volume>4</volume> (<issue>3</issue>), <fpage>152</fpage>&#x02013;<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1089/wound.2013.0464</pub-id>
</mixed-citation></ref><ref id="B136"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McEwan</surname><given-names>P. A.</given-names></name><name><surname>Scott</surname><given-names>P. G.</given-names></name><name><surname>Bishop</surname><given-names>P. N.</given-names></name><name><surname>Bella</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans</article-title>. <source>J. Struct. Biol.</source>
<volume>155</volume> (<issue>2</issue>), <fpage>294</fpage>&#x02013;<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsb.2006.01.016</pub-id>
<pub-id pub-id-type="pmid">16884925</pub-id></mixed-citation></ref><ref id="B137"><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>McKee</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>). <source>Renovo stock demolished by Justiva trial failure [Online]</source>. (<publisher-name>PharmaTimes</publisher-name>). <publisher-loc>England</publisher-loc> Available: <uri xlink:type="simple" xlink:href="http://www.pharmatimes.com/news/renovo_stock_demolished_by_justiva_trial_failure_979597">http://www.pharmatimes.com/news/renovo_stock_demolished_by_justiva_trial_failure_979597</uri> [Accessed].</mixed-citation></ref><ref id="B138"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McKenzie</surname><given-names>E. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Heparanase: a target for drug discovery in cancer and inflammation</article-title>. <source>Br. J. Pharmacol.</source>
<volume>151</volume> (<issue>1</issue>), <fpage>1</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjp.0707182</pub-id>
<pub-id pub-id-type="pmid">17339837</pub-id></mixed-citation></ref><ref id="B139"><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Mecham</surname><given-names>R.</given-names></name></person-group> (<year>2011</year>). <source>The extracellular matrix: an overview</source> (<publisher-loc>Germany</publisher-loc>: <publisher-name>Springer</publisher-name>).</mixed-citation></ref><ref id="B140"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meenakshi</surname><given-names>J.</given-names></name><name><surname>Vidyameenakshi</surname><given-names>S.</given-names></name><name><surname>Ananthram</surname><given-names>D.</given-names></name><name><surname>Ramakrishnan</surname><given-names>K. M.</given-names></name><name><surname>Jayaraman</surname><given-names>V.</given-names></name><name><surname>Babu</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Low decorin expression along with inherent activation of ERK1,2 in ear lobe keloids</article-title>. <source>Burns</source>
<volume>35</volume> (<issue>4</issue>), <fpage>519</fpage>&#x02013;<lpage>526</lpage>. <pub-id pub-id-type="doi">10.1016/j.burns.2008.07.012</pub-id>
<pub-id pub-id-type="pmid">19268470</pub-id></mixed-citation></ref><ref id="B141"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Merline</surname><given-names>R.</given-names></name><name><surname>Schaefer</surname><given-names>R. M.</given-names></name><name><surname>Schaefer</surname><given-names>L.</given-names></name></person-group> (<year>2009</year>). <article-title>The matricellular functions of small leucine-rich proteoglycans (SLRPs)</article-title>. <source>J. Cell Commun. Signaling</source>
<volume>3</volume> (<issue>3-4</issue>), <fpage>323</fpage>&#x02013;<lpage>335</lpage>. <pub-id pub-id-type="doi">10.1007/s12079-009-0066-2</pub-id>
</mixed-citation></ref><ref id="B142"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Merline</surname><given-names>R.</given-names></name><name><surname>Moreth</surname><given-names>K.</given-names></name><name><surname>Beckmann</surname><given-names>J.</given-names></name><name><surname>Nastase</surname><given-names>M. V.</given-names></name><name><surname>Zeng-Brouwers</surname><given-names>J.</given-names></name><name><surname>Tralh&#x000e3;o</surname><given-names>J. G.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21</article-title>. <source>Sci. Signaling</source>
<volume>4</volume> (<issue>199</issue>), <fpage>ra75</fpage>&#x02013;<lpage>ra75</lpage>. <pub-id pub-id-type="doi">10.1126/scisignal.2001868</pub-id>
</mixed-citation></ref><ref id="B143"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Midwood</surname><given-names>K. S.</given-names></name><name><surname>Williams</surname><given-names>L. V.</given-names></name><name><surname>Schwarzbauer</surname><given-names>J. E.</given-names></name></person-group> (<year>2004</year>). <article-title>Tissue repair and the dynamics of the extracellular matrix</article-title>. <source>Int. J. Biochem. Cell Biol.</source>
<volume>36</volume> (<issue>6</issue>), <fpage>1031</fpage>&#x02013;<lpage>1037</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2003.12.003</pub-id>
<pub-id pub-id-type="pmid">15094118</pub-id></mixed-citation></ref><ref id="B144"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mochida</surname><given-names>Y.</given-names></name><name><surname>Kaku</surname><given-names>M.</given-names></name><name><surname>Yoshida</surname><given-names>K.</given-names></name><name><surname>Katafuchi</surname><given-names>M.</given-names></name><name><surname>Atsawasuwan</surname><given-names>P.</given-names></name><name><surname>Yamauchi</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Podocan-like protein: a novel small leucine-rich repeat matrix protein in bone</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<volume>410</volume> (<issue>2</issue>), <fpage>333</fpage>&#x02013;<lpage>338</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2011.05.150</pub-id>
<pub-id pub-id-type="pmid">21672516</pub-id></mixed-citation></ref><ref id="B145"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mohan</surname><given-names>R. R.</given-names></name><name><surname>Tripathi</surname><given-names>R.</given-names></name><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Sinha</surname><given-names>P. R.</given-names></name><name><surname>Giuliano</surname><given-names>E. A.</given-names></name><name><surname>Hesemann</surname><given-names>N. P.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Decorin antagonizes corneal fibroblast migration <italic>via</italic> caveolae-mediated endocytosis of epidermal growth factor receptor</article-title>. <source>Exp. Eye Res.</source>
<volume>180</volume>, <fpage>200</fpage>&#x02013;<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1016/j.exer.2019.01.001</pub-id>
<pub-id pub-id-type="pmid">30611736</pub-id></mixed-citation></ref><ref id="B146"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moscatello</surname><given-names>D. K.</given-names></name><name><surname>Santra</surname><given-names>M.</given-names></name><name><surname>Mann</surname><given-names>D. M.</given-names></name><name><surname>McQuillan</surname><given-names>D. J.</given-names></name><name><surname>Wong</surname><given-names>A. J.</given-names></name><name><surname>Iozzo</surname><given-names>R. V.</given-names></name></person-group> (<year>1998</year>). <article-title>Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor</article-title>. <source>J. Clin. Invest.</source>
<volume>101</volume> (<issue>2</issue>), <fpage>406</fpage>&#x02013;<lpage>412</lpage>. <pub-id pub-id-type="doi">10.1172/jci846</pub-id>
<pub-id pub-id-type="pmid">9435313</pub-id></mixed-citation></ref><ref id="B147"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mounkes</surname><given-names>L. C.</given-names></name><name><surname>Kozlov</surname><given-names>S.</given-names></name><name><surname>Hernandez</surname><given-names>L.</given-names></name><name><surname>Sullivan</surname><given-names>T.</given-names></name><name><surname>Stewart</surname><given-names>C. L.</given-names></name></person-group> (<year>2003</year>). <article-title>A progeroid syndrome in mice is caused by defects in A-type lamins</article-title>. <source>Nature</source>
<volume>423</volume> (<issue>6937</issue>), <fpage>298</fpage>. <pub-id pub-id-type="doi">10.1038/nature01631</pub-id>
<pub-id pub-id-type="pmid">12748643</pub-id></mixed-citation></ref><ref id="B148"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mukhopadhyay</surname><given-names>A.</given-names></name><name><surname>Wong</surname><given-names>M. Y.</given-names></name><name><surname>Chan</surname><given-names>S. Y.</given-names></name><name><surname>Do</surname><given-names>D. V.</given-names></name><name><surname>Khoo</surname><given-names>A.</given-names></name><name><surname>Ong</surname><given-names>C. T.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Syndecan-2 and decorin: proteoglycans with a difference&#x02013;implications in keloid pathogenesis</article-title>. <source>J. Trauma</source>
<volume>68</volume> (<issue>4</issue>), <fpage>999</fpage>&#x02013;<lpage>1008</lpage>. <pub-id pub-id-type="doi">10.1097/TA.0b013e3181c4070d</pub-id>
<pub-id pub-id-type="pmid">20386290</pub-id></mixed-citation></ref><ref id="B149"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Myren</surname><given-names>M.</given-names></name><name><surname>Kirby</surname><given-names>D. J.</given-names></name><name><surname>Noonan</surname><given-names>M. L.</given-names></name><name><surname>Maeda</surname><given-names>A.</given-names></name><name><surname>Owens</surname><given-names>R. T.</given-names></name><name><surname>Ricard-Blum</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Biglycan potentially regulates angiogenesis during fracture repair by altering expression and function of endostatin</article-title>. <source>Matrix Biol.</source>
<volume>52-54</volume>, <fpage>141</fpage>&#x02013;<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2016.03.008</pub-id>
<pub-id pub-id-type="pmid">27072616</pub-id></mixed-citation></ref><ref id="B150"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Naitoh</surname><given-names>M.</given-names></name><name><surname>Kubota</surname><given-names>H.</given-names></name><name><surname>Ikeda</surname><given-names>M.</given-names></name><name><surname>Tanaka</surname><given-names>T.</given-names></name><name><surname>Shirane</surname><given-names>H.</given-names></name><name><surname>Suzuki</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Gene expression in human keloids is altered from dermal to chondrocytic and osteogenic lineage</article-title>. <source>Genes Cells</source>
<volume>10</volume> (<issue>11</issue>), <fpage>1081</fpage>&#x02013;<lpage>1091</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2443.2005.00902.x</pub-id>
<pub-id pub-id-type="pmid">16236136</pub-id></mixed-citation></ref><ref id="B151"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nayak</surname><given-names>S.</given-names></name><name><surname>Goel</surname><given-names>M. M.</given-names></name><name><surname>Bhatia</surname><given-names>V.</given-names></name><name><surname>Chandra</surname><given-names>S.</given-names></name><name><surname>Makker</surname><given-names>A.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Molecular and phenotypic expression of decorin as modulator of angiogenesis in human potentially malignant oral lesions and oral squamous cell carcinomas</article-title>. <source>Indian J. Pathol. Microbiol.</source>
<volume>56</volume> (<issue>3</issue>), <fpage>204</fpage>&#x02013;<lpage>210</lpage>. <pub-id pub-id-type="doi">10.4103/0377-4929.120366</pub-id>
<pub-id pub-id-type="pmid">24152495</pub-id></mixed-citation></ref><ref id="B152"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Naylor</surname><given-names>M. C.</given-names></name><name><surname>Brissett</surname><given-names>A. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Current concepts in the etiology and treatment of keloids</article-title>. <source>Facial Plast Surg.</source>
<volume>28</volume> (<issue>5</issue>), <fpage>504</fpage>&#x02013;<lpage>512</lpage>. <pub-id pub-id-type="doi">10.1055/s-0032-1325644</pub-id>
<pub-id pub-id-type="pmid">23027217</pub-id></mixed-citation></ref><ref id="B153"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Niewiarowska</surname><given-names>J.</given-names></name><name><surname>Br&#x000e9;zillon</surname><given-names>S.</given-names></name><name><surname>Sacewicz-Hofman</surname><given-names>I.</given-names></name><name><surname>Bednarek</surname><given-names>R.</given-names></name><name><surname>Maquart</surname><given-names>F.-X.</given-names></name><name><surname>Malinowski</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Lumican inhibits angiogenesis by interfering with &#x003b1;2&#x003b2;1 receptor activity and downregulating MMP-14 expression</article-title>. <source>Thromb. Res.</source>
<volume>128</volume> (<issue>5</issue>), <fpage>452</fpage>&#x02013;<lpage>457</lpage>. <pub-id pub-id-type="doi">10.1016/j.thromres.2011.06.011</pub-id>
<pub-id pub-id-type="pmid">21752432</pub-id></mixed-citation></ref><ref id="B154"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Niimori</surname><given-names>D.</given-names></name><name><surname>Kawano</surname><given-names>R.</given-names></name><name><surname>Niimori-Kita</surname><given-names>K.</given-names></name><name><surname>Ihn</surname><given-names>H.</given-names></name><name><surname>Ohta</surname><given-names>K.</given-names></name></person-group> (<year>2014</year>). <article-title>Tsukushi is involved in the wound healing by regulating the expression of cytokines and growth factors</article-title>. <source>J. Cell Commun. Signaling</source>
<volume>8</volume> (<issue>3</issue>), <fpage>173</fpage>&#x02013;<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1007/s12079-014-0241-y</pub-id>
</mixed-citation></ref><ref id="B155"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nishiu</surname><given-names>J.</given-names></name><name><surname>Tanaka</surname><given-names>T.</given-names></name><name><surname>Nakamura</surname><given-names>Y.</given-names></name></person-group> (<year>1998</year>). <article-title>Identification of a novel gene (ECM2) encoding a putative extracellular matrix protein expressed predominantly in adipose and female-specific tissues and its chromosomal localization to 9q22. 3</article-title>. <source>Genomics</source>
<volume>52</volume> (<issue>3</issue>), <fpage>378</fpage>&#x02013;<lpage>381</lpage>. <pub-id pub-id-type="doi">10.1006/geno.1998.5455</pub-id>
<pub-id pub-id-type="pmid">9790758</pub-id></mixed-citation></ref><ref id="B156"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nomura</surname><given-names>Y.</given-names></name><name><surname>Abe</surname><given-names>Y.</given-names></name><name><surname>Ishii</surname><given-names>Y.</given-names></name><name><surname>Watanabe</surname><given-names>M.</given-names></name><name><surname>Kobayashi</surname><given-names>M.</given-names></name><name><surname>Hattori</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Structural changes in the glycosaminoglycan chain of rat skin decorin with growth</article-title>. <source>J. Dermatol.</source>
<volume>30</volume> (<issue>9</issue>), <fpage>655</fpage>&#x02013;<lpage>664</lpage>. <pub-id pub-id-type="doi">10.1111/j.1346-8138.2003.tb00454.x</pub-id>
<pub-id pub-id-type="pmid">14578555</pub-id></mixed-citation></ref><ref id="B157"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ohta</surname><given-names>K.</given-names></name><name><surname>Lupo</surname><given-names>G.</given-names></name><name><surname>Kuriyama</surname><given-names>S.</given-names></name><name><surname>Keynes</surname><given-names>R.</given-names></name><name><surname>Holt</surname><given-names>C. E.</given-names></name><name><surname>Harris</surname><given-names>W. A.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Tsukushi functions as an organizer inducer by inhibition of BMP activity in cooperation with chordin</article-title>. <source>Dev. Cell</source>
<volume>7</volume> (<issue>3</issue>), <fpage>347</fpage>&#x02013;<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2004.08.014</pub-id>
<pub-id pub-id-type="pmid">15363410</pub-id></mixed-citation></ref><ref id="B158"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Olson</surname><given-names>M. E.</given-names></name><name><surname>Reno</surname><given-names>C. R.</given-names></name><name><surname>Kulyk</surname><given-names>W.</given-names></name><name><surname>Wright</surname><given-names>J. B.</given-names></name><name><surname>Hart</surname><given-names>D. A.</given-names></name></person-group> (<year>2000</year>). <article-title>Molecular and cell biology of skin wound healing in a pig model AU - Wang, Jian Fei</article-title>. <source>Connect. Tissue Res.</source>
<volume>41</volume> (<issue>3</issue>), <fpage>195</fpage>&#x02013;<lpage>211</lpage>. <pub-id pub-id-type="doi">10.3109/03008200009005290</pub-id>
<pub-id pub-id-type="pmid">11264869</pub-id></mixed-citation></ref><ref id="B159"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ong</surname><given-names>C. T.</given-names></name><name><surname>Khoo</surname><given-names>Y. T.</given-names></name><name><surname>Mukhopadhyay</surname><given-names>A.</given-names></name><name><surname>Masilamani</surname><given-names>J.</given-names></name><name><surname>Do</surname><given-names>D. V.</given-names></name><name><surname>Lim</surname><given-names>I. J.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Comparative proteomic analysis between normal skin and keloid scar</article-title>. <source>Br. J. Dermatol.</source>
<volume>162</volume> (<issue>6</issue>), <fpage>1302</fpage>&#x02013;<lpage>1315</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2133.2010.09660.x</pub-id>
<pub-id pub-id-type="pmid">20128793</pub-id></mixed-citation></ref><ref id="B160"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oskarsson</surname><given-names>M. E.</given-names></name><name><surname>Singh</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Vlodavsky</surname><given-names>I.</given-names></name><name><surname>Li</surname><given-names>J.-P.</given-names></name><name><surname>Westermark</surname><given-names>G. T.</given-names></name></person-group> (<year>2015</year>). <article-title>Heparan sulfate proteoglycans are important for islet amyloid formation and islet amyloid polypeptide-induced apoptosis</article-title>. <source>J. Biol. Chem.</source>
<volume>290</volume> (<issue>24</issue>), <fpage>15121</fpage>&#x02013;<lpage>15132</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M114.631697</pub-id>
<pub-id pub-id-type="pmid">25922077</pub-id></mixed-citation></ref><ref id="B161"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pakyari</surname><given-names>M.</given-names></name><name><surname>Farrokhi</surname><given-names>A.</given-names></name><name><surname>Maharlooei</surname><given-names>M. K.</given-names></name><name><surname>Ghahary</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Critical role of transforming growth factor beta in different phases of wound healing</article-title>. <source>Adv. In Wound Care</source>
<volume>2</volume> (<issue>5</issue>), <fpage>215</fpage>&#x02013;<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1089/wound.2012.0406</pub-id>
</mixed-citation></ref><ref id="B162"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>W. C.</given-names></name><name><surname>Tseng</surname><given-names>S. C.</given-names></name></person-group> (<year>2000</year>). <article-title>Modulation of acute inflammation and keratocyte death by suturing, blood, and amniotic membrane in PRK</article-title>. <source>Invest. Ophthalmol. Vis. Sci.</source>
<volume>41</volume> (<issue>10</issue>), <fpage>2906</fpage>&#x02013;<lpage>2914</lpage>.<pub-id pub-id-type="pmid">10967044</pub-id></mixed-citation></ref><ref id="B163"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Patel</surname><given-names>S.</given-names></name><name><surname>Santra</surname><given-names>M.</given-names></name><name><surname>McQuillan</surname><given-names>D. J.</given-names></name><name><surname>Iozzo</surname><given-names>R. V.</given-names></name><name><surname>Thomas</surname><given-names>A. P.</given-names></name></person-group> (<year>1998</year>). <article-title>Decorin activates the epidermal growth factor receptor and elevates cytosolic Ca2+ in A431 carcinoma cells</article-title>. <source>J. Biol. Chem.</source>
<volume>273</volume> (<issue>6</issue>), <fpage>3121</fpage>&#x02013;<lpage>3124</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.273.6.3121</pub-id>
<pub-id pub-id-type="pmid">9452417</pub-id></mixed-citation></ref><ref id="B164"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Penn</surname><given-names>J. W.</given-names></name><name><surname>Grobbelaar</surname><given-names>A. O.</given-names></name><name><surname>Rolfe</surname><given-names>K. J.</given-names></name></person-group> (<year>2012</year>). <article-title>The role of the TGF-&#x003b2; family in wound healing, burns and scarring: a review</article-title>. <source>Int. J. Burns Trauma</source>
<volume>2</volume> (<issue>1</issue>), <fpage>18</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="pmid">22928164</pub-id></mixed-citation></ref><ref id="B165"><mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>Pfizer</collab></person-group> (<year>2011</year>). <source>Pfizer completes acquisition of excaliard</source> [Online]. <publisher-name>Pfizer Inc.</publisher-name> Available: <uri xlink:type="simple" xlink:href="https://www.pfizer.com/news/press-release/press-release-detail/pfizer_completes_acquisition_of_excaliard">https://www.pfizer.com/news/press-release/press-release-detail/pfizer_completes_acquisition_of_excaliard</uri> [Accessed].</mixed-citation></ref><ref id="B166"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pietraszek-Gremplewicz</surname><given-names>K.</given-names></name><name><surname>Karamanou</surname><given-names>K.</given-names></name><name><surname>Niang</surname><given-names>A.</given-names></name><name><surname>Dauchez</surname><given-names>M.</given-names></name><name><surname>Belloy</surname><given-names>N.</given-names></name><name><surname>Maquart</surname><given-names>F.-X.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Small leucine-rich proteoglycans and matrix metalloproteinase-14: Key partners?</article-title>
<source>Matrix Biol.</source>
<volume>75-76</volume>, <fpage>271</fpage>&#x02013;<lpage>285</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2017.12.006</pub-id>
<pub-id pub-id-type="pmid">29253518</pub-id></mixed-citation></ref><ref id="B167"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Proksch</surname><given-names>E.</given-names></name><name><surname>Brandner</surname><given-names>J. M.</given-names></name><name><surname>Jensen</surname><given-names>J. M.</given-names></name></person-group> (<year>2008</year>). <article-title>The skin: an indispensable barrier</article-title>. <source>Exp. Dermatol.</source>
<volume>17</volume> (<issue>12</issue>), <fpage>1063</fpage>&#x02013;<lpage>1072</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0625.2008.00786.x</pub-id>
<pub-id pub-id-type="pmid">19043850</pub-id></mixed-citation></ref><ref id="B168"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rada</surname><given-names>J. A.</given-names></name><name><surname>Cornuet</surname><given-names>P. K.</given-names></name><name><surname>Hassell</surname><given-names>J. R.</given-names></name></person-group> (<year>1993</year>). <article-title>Regulation of corneal collagen fibrillogenesis <italic>in vitro</italic> by corneal proteoglycan (lumican and decorin) core proteins</article-title>. <source>Exp. Eye Res.</source>
<volume>56</volume> (<issue>6</issue>), <fpage>635</fpage>&#x02013;<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1006/exer.1993.1081</pub-id>
<pub-id pub-id-type="pmid">8595806</pub-id></mixed-citation></ref><ref id="B169"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Raghunath</surname><given-names>M.</given-names></name><name><surname>Superti-Furga</surname><given-names>A.</given-names></name><name><surname>Godfrey</surname><given-names>M.</given-names></name><name><surname>Steinmann</surname><given-names>B.</given-names></name></person-group> (<year>1993</year>). <article-title>Decreased extracellular deposition of fibrillin and decorin in neonatal Marfan syndrome fibroblasts</article-title>. <source>Hum. Genet.</source>
<volume>90</volume> (<issue>5</issue>), <fpage>511</fpage>&#x02013;<lpage>515</lpage>. <pub-id pub-id-type="doi">10.1007/bf00217450</pub-id>
<pub-id pub-id-type="pmid">8428751</pub-id></mixed-citation></ref><ref id="B170"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reardon</surname><given-names>A. J.</given-names></name><name><surname>Le Goff</surname><given-names>M.</given-names></name><name><surname>Briggs</surname><given-names>M. D.</given-names></name><name><surname>McLeod</surname><given-names>D.</given-names></name><name><surname>Sheehan</surname><given-names>J. K.</given-names></name><name><surname>Thornton</surname><given-names>D. J.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>Identification in vitreous and molecular cloning of opticin, a novel member of the family of leucine-rich repeat proteins of the extracellular matrix</article-title>. <source>J. Biol. Chem.</source>
<volume>275</volume> (<issue>3</issue>), <fpage>2123</fpage>&#x02013;<lpage>2129</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.275.3.2123</pub-id>
<pub-id pub-id-type="pmid">10636917</pub-id></mixed-citation></ref><ref id="B171"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ross</surname><given-names>M. D.</given-names></name><name><surname>Bruggeman</surname><given-names>L. A.</given-names></name><name><surname>Hanss</surname><given-names>B.</given-names></name><name><surname>Sunamoto</surname><given-names>M.</given-names></name><name><surname>Marras</surname><given-names>D.</given-names></name><name><surname>Klotman</surname><given-names>M. E.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Podocan, a novel small leucine-rich repeat protein expressed in the sclerotic glomerular lesion of experimental HIV-associated nephropathy</article-title>. <source>J. Biol. Chem.</source>
<volume>278</volume> (<issue>35</issue>), <fpage>33248</fpage>&#x02013;<lpage>33255</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M301299200</pub-id>
<pub-id pub-id-type="pmid">12796502</pub-id></mixed-citation></ref><ref id="B172"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roughley</surname><given-names>P. J.</given-names></name></person-group> (<year>2006</year>). <article-title>The structure and function of cartilage proteoglycans</article-title>. <source>Eur. Cell Mater.</source>
<volume>12</volume>, <fpage>92</fpage>&#x02013;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.22203/ecm.v012a11</pub-id>
<pub-id pub-id-type="pmid">17136680</pub-id></mixed-citation></ref><ref id="B173"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ruszczak</surname><given-names>Z.</given-names></name></person-group> (<year>2003</year>). <article-title>Effect of collagen matrices on dermal wound healing</article-title>. <source>Adv. Drug Delivery Rev.</source>
<volume>55</volume> (<issue>12</issue>), <fpage>1595</fpage>&#x02013;<lpage>1611</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2003.08.003</pub-id>
</mixed-citation></ref><ref id="B174"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saika</surname><given-names>S.</given-names></name><name><surname>Shiraishi</surname><given-names>A.</given-names></name><name><surname>Liu</surname><given-names>C. Y.</given-names></name><name><surname>Funderburgh</surname><given-names>J. L.</given-names></name><name><surname>Kao</surname><given-names>C. W.</given-names></name><name><surname>Converse</surname><given-names>R. L.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>Role of lumican in the corneal epithelium during wound healing</article-title>. <source>J. Biol. Chem.</source>
<volume>275</volume> (<issue>4</issue>), <fpage>2607</fpage>&#x02013;<lpage>2612</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.275.4.2607</pub-id>
<pub-id pub-id-type="pmid">10644720</pub-id></mixed-citation></ref><ref id="B175"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Salomaki</surname><given-names>H. H.</given-names></name><name><surname>Sainio</surname><given-names>A. O.</given-names></name><name><surname>Soderstrom</surname><given-names>M.</given-names></name><name><surname>Pakkanen</surname><given-names>S.</given-names></name><name><surname>Laine</surname><given-names>J.</given-names></name><name><surname>Jarvelainen</surname><given-names>H. T.</given-names></name></person-group> (<year>2008</year>). <article-title>Differential expression of decorin by human malignant and benign vascular tumors</article-title>. <source>J. Histochem. Cytochem.</source>
<volume>56</volume> (<issue>7</issue>), <fpage>639</fpage>&#x02013;<lpage>646</lpage>. <pub-id pub-id-type="doi">10.1369/jhc.2008.950287</pub-id>
<pub-id pub-id-type="pmid">18413650</pub-id></mixed-citation></ref><ref id="B176"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sandulache</surname><given-names>V. C.</given-names></name><name><surname>Parekh</surname><given-names>A.</given-names></name><name><surname>Dohar</surname><given-names>J. E.</given-names></name><name><surname>Hebda</surname><given-names>P. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Fetal dermal fibroblasts retain a hyperactive migratory and contractile phenotype under 2-and 3-dimensional constraints compared to normal adult fibroblasts</article-title>. <source>Tissue Eng.</source>
<volume>13</volume> (<issue>11</issue>), <fpage>2791</fpage>&#x02013;<lpage>2801</lpage>. <pub-id pub-id-type="doi">10.1089/ten.2006.0412</pub-id>
<pub-id pub-id-type="pmid">17764403</pub-id></mixed-citation></ref><ref id="B177"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sato</surname><given-names>E.</given-names></name><name><surname>Zhang</surname><given-names>L.-J.</given-names></name><name><surname>Dorschner</surname><given-names>R. A.</given-names></name><name><surname>Adase</surname><given-names>C. A.</given-names></name><name><surname>Choudhury</surname><given-names>B. P.</given-names></name><name><surname>Gallo</surname><given-names>R. L.</given-names></name></person-group> (<year>2017</year>). <article-title>Activation of parathyroid hormone 2 receptor induces decorin expression and promotes wound repair</article-title>. <source>J. Invest. Dermatol.</source>
<volume>137</volume> (<issue>8</issue>), <fpage>1774</fpage>&#x02013;<lpage>1783</lpage>. <pub-id pub-id-type="doi">10.1016/j.jid.2017.03.034</pub-id>
<pub-id pub-id-type="pmid">28454729</pub-id></mixed-citation></ref><ref id="B178"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sayani</surname><given-names>K.</given-names></name><name><surname>Dodd</surname><given-names>C. M.</given-names></name><name><surname>Nedelec</surname><given-names>B.</given-names></name><name><surname>Shen</surname><given-names>Y. J.</given-names></name><name><surname>Ghahary</surname><given-names>A.</given-names></name><name><surname>Tredget</surname><given-names>E. E.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>Delayed appearance of decorin in healing burn scars</article-title>. <source>Histopathology</source>
<volume>36</volume> (<issue>3</issue>), <fpage>262</fpage>&#x02013;<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2559.2000.00824.x</pub-id>
<pub-id pub-id-type="pmid">10692030</pub-id></mixed-citation></ref><ref id="B179"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Scarpa</surname><given-names>E.</given-names></name><name><surname>Mayor</surname><given-names>R.</given-names></name></person-group> (<year>2016</year>). <article-title>Collective cell migration in development</article-title>. <source>J. Cell Biol.</source>
<volume>212</volume> (<issue>2</issue>), <fpage>143</fpage>&#x02013;<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201508047</pub-id>
<pub-id pub-id-type="pmid">26783298</pub-id></mixed-citation></ref><ref id="B180"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schaefer</surname><given-names>L.</given-names></name><name><surname>Iozzo</surname><given-names>R. V.</given-names></name></person-group> (<year>2008</year>). <article-title>Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction</article-title>. <source>J. Biol. Chem.</source>
<volume>283</volume> (<issue>31</issue>), <fpage>21305</fpage>&#x02013;<lpage>21309</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.R800020200</pub-id>
<pub-id pub-id-type="pmid">18463092</pub-id></mixed-citation></ref><ref id="B181"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schaefer</surname><given-names>L.</given-names></name><name><surname>Babelova</surname><given-names>A.</given-names></name><name><surname>Kiss</surname><given-names>E.</given-names></name><name><surname>Hausser</surname><given-names>H.-J.</given-names></name><name><surname>Baliova</surname><given-names>M.</given-names></name><name><surname>Krzyzankova</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages</article-title>. <source>J. Clin. Invest.</source>
<volume>115</volume> (<issue>8</issue>), <fpage>2223</fpage>&#x02013;<lpage>2233</lpage>. <pub-id pub-id-type="doi">10.1172/JCI23755</pub-id>
<pub-id pub-id-type="pmid">16025156</pub-id></mixed-citation></ref><ref id="B182"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schaefer</surname><given-names>L.</given-names></name></person-group> (<year>2011</year>). <article-title>Small leucine-rich proteoglycans in kidney disease</article-title>. <source>J. Am. Soc. Nephrol.</source>
<volume>22</volume> (<issue>7</issue>), <fpage>1200</fpage>&#x02013;<lpage>1207</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2010050570</pub-id>
<pub-id pub-id-type="pmid">21719787</pub-id></mixed-citation></ref><ref id="B183"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schonherr</surname><given-names>E.</given-names></name><name><surname>Sunderkotter</surname><given-names>C.</given-names></name><name><surname>Schaefer</surname><given-names>L.</given-names></name><name><surname>Thanos</surname><given-names>S.</given-names></name><name><surname>Grassel</surname><given-names>S.</given-names></name><name><surname>Oldberg</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Decorin deficiency leads to impaired angiogenesis in injured mouse cornea</article-title>. <source>J. Vasc. Res.</source>
<volume>41</volume> (<issue>6</issue>), <fpage>499</fpage>&#x02013;<lpage>508</lpage>. <pub-id pub-id-type="doi">10.1159/000081806</pub-id>
<pub-id pub-id-type="pmid">15528932</pub-id></mixed-citation></ref><ref id="B184"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Scott</surname><given-names>P. G.</given-names></name><name><surname>Dodd</surname><given-names>C. M.</given-names></name><name><surname>Tredget</surname><given-names>E. E.</given-names></name><name><surname>Ghahary</surname><given-names>A.</given-names></name><name><surname>Rahemtulla</surname><given-names>F.</given-names></name></person-group> (<year>1995</year>). <article-title>Immunohistochemical localization of the proteoglycans decorin, biglycan and versican and transforming growth factor-beta in human post-burn hypertrophic and mature scars</article-title>. <source>Histopathology</source>
<volume>26</volume> (<issue>5</issue>), <fpage>423</fpage>&#x02013;<lpage>431</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2559.1995.tb00249.x</pub-id>
<pub-id pub-id-type="pmid">7544762</pub-id></mixed-citation></ref><ref id="B185"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Scott</surname><given-names>P. G.</given-names></name><name><surname>McEwan</surname><given-names>P. A.</given-names></name><name><surname>Dodd</surname><given-names>C. M.</given-names></name><name><surname>Bergmann</surname><given-names>E. M.</given-names></name><name><surname>Bishop</surname><given-names>P. N.</given-names></name><name><surname>Bella</surname><given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>Crystal structure of the dimeric protein core of decorin, the archetypal small leucine-rich repeat proteoglycan</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>101</volume> (<issue>44</issue>), <fpage>15633</fpage>&#x02013;<lpage>15638</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0402976101</pub-id>
<pub-id pub-id-type="pmid">15501918</pub-id></mixed-citation></ref><ref id="B186"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Scott</surname><given-names>J. E.</given-names></name></person-group> (<year>1996</year>). <article-title>Proteodermatan and proteokeratan sulfate (decorin, lumican/fibromodulin) proteins are horseshoe shaped. Implications for their interactions with collagen</article-title>. <source>Biochemistry</source>
<volume>35</volume> (<issue>27</issue>), <fpage>8795</fpage>&#x02013;<lpage>8799</lpage>. <pub-id pub-id-type="doi">10.1021/bi960773t</pub-id>
<pub-id pub-id-type="pmid">8688414</pub-id></mixed-citation></ref><ref id="B187"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seaton</surname><given-names>M.</given-names></name><name><surname>Hocking</surname><given-names>A.</given-names></name><name><surname>Gibran</surname><given-names>N. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Porcine Models of Cutaneous Wound Healing</article-title>. <source>ILAR J.</source>
<volume>56</volume> (<issue>1</issue>), <fpage>127</fpage>&#x02013;<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1093/ilar/ilv016</pub-id>
<pub-id pub-id-type="pmid">25991704</pub-id></mixed-citation></ref><ref id="B188"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seomun</surname><given-names>Y.</given-names></name><name><surname>Joo</surname><given-names>C. K.</given-names></name></person-group> (<year>2008</year>). <article-title>Lumican induces human corneal epithelial cell migration and integrin expression <italic>via</italic> ERK 1/2 signaling</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<volume>372</volume> (<issue>1</issue>), <fpage>221</fpage>&#x02013;<lpage>225</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2008.05.014</pub-id>
<pub-id pub-id-type="pmid">18477477</pub-id></mixed-citation></ref><ref id="B189"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sharma</surname><given-names>B.</given-names></name><name><surname>Ramus</surname><given-names>M. D.</given-names></name><name><surname>Kirkwood</surname><given-names>C. T.</given-names></name><name><surname>Sperry</surname><given-names>E. E.</given-names></name><name><surname>Chu</surname><given-names>P.-H.</given-names></name><name><surname>Kao</surname><given-names>W. W.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Lumican exhibits anti-angiogenic activity in a context specific manner</article-title>. <source>Cancer Microenviron.</source>
<volume>6</volume> (<issue>3</issue>), <fpage>263</fpage>&#x02013;<lpage>271</lpage>. <pub-id pub-id-type="doi">10.1007/s12307-013-0134-2</pub-id>
<pub-id pub-id-type="pmid">23775523</pub-id></mixed-citation></ref><ref id="B190"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sher</surname><given-names>I.</given-names></name><name><surname>Zisman-Rozen</surname><given-names>S.</given-names></name><name><surname>Eliahu</surname><given-names>L.</given-names></name><name><surname>Whitelock</surname><given-names>J. M.</given-names></name><name><surname>Maas-Szabowski</surname><given-names>N.</given-names></name><name><surname>Yamada</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Targeting perlecan in human keratinocytes reveals novel roles for perlecan in epidermal formation</article-title>. <source>J. Biol. Chem.</source>
<volume>281</volume> (<issue>8</issue>), <fpage>5178</fpage>&#x02013;<lpage>5187</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M509500200</pub-id>
<pub-id pub-id-type="pmid">16269412</pub-id></mixed-citation></ref><ref id="B191"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shih</surname><given-names>B.</given-names></name><name><surname>McGrouther</surname><given-names>D. A.</given-names></name><name><surname>Bayat</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Identification of novel keloid biomarkers through profiling of tissue biopsies versus cell cultures in keloid margin specimens compared to adjacent normal skin</article-title>. <source>Eplasty</source>
<volume>10</volume>, <fpage>e24</fpage>.<pub-id pub-id-type="pmid">20418938</pub-id></mixed-citation></ref><ref id="B192"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shih</surname><given-names>H. P.</given-names></name><name><surname>Panlasigui</surname><given-names>D.</given-names></name><name><surname>Cirulli</surname><given-names>V.</given-names></name><name><surname>Sander</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>ECM signaling regulates collective cellular dynamics to control pancreas branching morphogenesis</article-title>. <source>Cell Rep.</source>
<volume>14</volume> (<issue>2</issue>), <fpage>169</fpage>&#x02013;<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.12.027</pub-id>
<pub-id pub-id-type="pmid">26748698</pub-id></mixed-citation></ref><ref id="B193"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shi-Wen</surname><given-names>X.</given-names></name><name><surname>Leask</surname><given-names>A.</given-names></name><name><surname>Abraham</surname><given-names>D.</given-names></name></person-group> (<year>2008</year>). <article-title>Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis</article-title>. <source>Cytokine Growth Factor Rev.</source>
<volume>19</volume> (<issue>2</issue>), <fpage>133</fpage>&#x02013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1016/j.cytogfr.2008.01.002</pub-id>
<pub-id pub-id-type="pmid">18358427</pub-id></mixed-citation></ref><ref id="B194"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sifaki</surname><given-names>M.</given-names></name><name><surname>Assouti</surname><given-names>M.</given-names></name><name><surname>Nikitovic</surname><given-names>D.</given-names></name><name><surname>Krasagakis</surname><given-names>K.</given-names></name><name><surname>Karamanos</surname><given-names>N. K.</given-names></name><name><surname>Tzanakakis</surname><given-names>G. N.</given-names></name></person-group> (<year>2006</year>). <article-title>Lumican, a small leucine-rich proteoglycan substituted with keratan sulfate chains is expressed and secreted by human melanoma cells and not normal melanocytes</article-title>. <source>IUBMB Life</source>
<volume>58</volume> (<issue>10</issue>), <fpage>606</fpage>&#x02013;<lpage>610</lpage>. <pub-id pub-id-type="doi">10.1080/15216540600951605</pub-id>
<pub-id pub-id-type="pmid">17050378</pub-id></mixed-citation></ref><ref id="B195"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sindrilaru</surname><given-names>A.</given-names></name><name><surname>Scharffetter-Kochanek</surname><given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>Disclosure of the culprits: Macrophages&#x02014;Versatile regulators of wound healing</article-title>. <source>Adv. In Wound Care</source>
<volume>2</volume> (<issue>7</issue>), <fpage>357</fpage>&#x02013;<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1089/wound.2012.0407</pub-id>
</mixed-citation></ref><ref id="B196"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Smith</surname><given-names>M. M.</given-names></name><name><surname>Melrose</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Proteoglycans in normal and healing skin</article-title>. <source>Adv. In Wound Care</source>
<volume>4</volume> (<issue>3</issue>), <fpage>152</fpage>&#x02013;<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1089/wound.2013.0464</pub-id>
</mixed-citation></ref><ref id="B197"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Soo</surname><given-names>C.</given-names></name><name><surname>Hu</surname><given-names>F.-Y.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Beanes</surname><given-names>S. R.</given-names></name><name><surname>Lorenz</surname><given-names>H. P.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>Differential expression of fibromodulin, a transforming growth factor-&#x003b2; modulator, in fetal skin development and scarless repair</article-title>. <source>Am. J. Pathol.</source>
<volume>157</volume> (<issue>2</issue>), <fpage>423</fpage>&#x02013;<lpage>433</lpage>. <pub-id pub-id-type="doi">10.1016/S0002-9440(10)64555-5</pub-id>
<pub-id pub-id-type="pmid">10934147</pub-id></mixed-citation></ref><ref id="B198"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sorg</surname><given-names>H.</given-names></name><name><surname>Tilkorn</surname><given-names>D. J.</given-names></name><name><surname>Hager</surname><given-names>S.</given-names></name><name><surname>Hauser</surname><given-names>J.</given-names></name><name><surname>Mirastschijski</surname><given-names>U.</given-names></name></person-group> (<year>2017</year>). <article-title>Skin Wound healing: an update on the current knowledge and concepts</article-title>. <source>Eur. Surg. Res.</source>
<volume>58</volume> (<issue>1-2</issue>), <fpage>81</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1159/000454919</pub-id>
<pub-id pub-id-type="pmid">27974711</pub-id></mixed-citation></ref><ref id="B199"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stoch</surname><given-names>S. A.</given-names></name><name><surname>Wagner</surname><given-names>J. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Cathepsin K inhibitors: a novel target for osteoporosis therapy</article-title>. <source>Clin. Pharmacol. Ther.</source>
<volume>83</volume> (<issue>1</issue>), <fpage>172</fpage>&#x02013;<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1038/sj.clpt.6100450</pub-id>
<pub-id pub-id-type="pmid">18073778</pub-id></mixed-citation></ref><ref id="B200"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stoff</surname><given-names>A.</given-names></name><name><surname>Rivera</surname><given-names>A. A.</given-names></name><name><surname>Mathis</surname><given-names>J. M.</given-names></name><name><surname>Moore</surname><given-names>S. T.</given-names></name><name><surname>Banerjee</surname><given-names>N. S.</given-names></name><name><surname>Everts</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Effect of adenoviral mediated overexpression of fibromodulin on human dermal fibroblasts and scar formation in full-thickness incisional wounds</article-title>. <source>J. Mol. Med.</source>
<volume>85</volume> (<issue>5</issue>), <fpage>481</fpage>&#x02013;<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1007/s00109-006-0148-z</pub-id>
<pub-id pub-id-type="pmid">17219096</pub-id></mixed-citation></ref><ref id="B201"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Strbo</surname><given-names>N.</given-names></name><name><surname>Yin</surname><given-names>N.</given-names></name><name><surname>Stojadinovic</surname><given-names>O.</given-names></name></person-group> (<year>2014</year>). <article-title>Innate and adaptive immune responses in wound epithelialization</article-title>. <source>Adv. In Wound Care</source>
<volume>3</volume> (<issue>7</issue>), <fpage>492</fpage>&#x02013;<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1089/wound.2012.0435</pub-id>
</mixed-citation></ref><ref id="B202"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stuart</surname><given-names>K.</given-names></name><name><surname>Paderi</surname><given-names>J.</given-names></name><name><surname>Snyder</surname><given-names>P. W.</given-names></name><name><surname>Freeman</surname><given-names>L.</given-names></name><name><surname>Panitch</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Collagen-binding peptidoglycans inhibit MMP mediated collagen degradation and reduce dermal scarring</article-title>. <source>PloS One</source>
<volume>6</volume> (<issue>7</issue>), <elocation-id>e22139</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0022139</pub-id>
<pub-id pub-id-type="pmid">21779387</pub-id></mixed-citation></ref><ref id="B203"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Svensson</surname><given-names>L.</given-names></name><name><surname>Aszodi</surname><given-names>A.</given-names></name><name><surname>Reinholt</surname><given-names>F. P.</given-names></name><name><surname>Fassler</surname><given-names>R.</given-names></name><name><surname>Heinegard</surname><given-names>D.</given-names></name><name><surname>Oldberg</surname><given-names>A.</given-names></name></person-group> (<year>1999</year>). <article-title>Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon</article-title>. <source>J. Biol. Chem.</source>
<volume>274</volume> (<issue>14</issue>), <fpage>9636</fpage>&#x02013;<lpage>9647</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.274.14.9636</pub-id>
<pub-id pub-id-type="pmid">10092650</pub-id></mixed-citation></ref><ref id="B204"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Takanosu</surname><given-names>M.</given-names></name><name><surname>Boyd</surname><given-names>T. C.</given-names></name><name><surname>Le Goff</surname><given-names>M.</given-names></name><name><surname>Henry</surname><given-names>S. P.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Bishop</surname><given-names>P. N.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Structure, chromosomal location, and tissue-specific expression of the mouse opticin gene</article-title>. <source>Invest. Ophthalmol. Vis. Sci.</source>
<volume>42</volume> (<issue>10</issue>), <fpage>2202</fpage>&#x02013;<lpage>2210</lpage>.<pub-id pub-id-type="pmid">11527931</pub-id></mixed-citation></ref><ref id="B205"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>O.</given-names></name><name><surname>Akira</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Pattern recognition receptors and inflammation</article-title>. <source>Cell</source>
<volume>140</volume> (<issue>6</issue>), <fpage>805</fpage>&#x02013;<lpage>820</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.01.022</pub-id>
<pub-id pub-id-type="pmid">20303872</pub-id></mixed-citation></ref><ref id="B206"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tan</surname><given-names>E. M. L.</given-names></name><name><surname>Hoffren</surname><given-names>J.</given-names></name><name><surname>Rouda</surname><given-names>S.</given-names></name><name><surname>Greenbaum</surname><given-names>S.</given-names></name><name><surname>Fox</surname><given-names>J. W.</given-names></name><name><surname>Moore</surname><given-names>J. H.</given-names></name><etal/></person-group> (<year>1993</year>). <article-title>Decorin, versican, and biglycan gene expression by keloid and normal dermal fibroblasts: differential regulation by basic fibroblast growth factor</article-title>. <source>Exp. Cell Res.</source>
<volume>209</volume> (<issue>2</issue>), <fpage>200</fpage>&#x02013;<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1006/excr.1993.1302</pub-id>
<pub-id pub-id-type="pmid">8262136</pub-id></mixed-citation></ref><ref id="B207"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tasheva</surname><given-names>E. S.</given-names></name><name><surname>Koester</surname><given-names>A.</given-names></name><name><surname>Paulsen</surname><given-names>A. Q.</given-names></name><name><surname>Garrett</surname><given-names>A. S.</given-names></name><name><surname>Boyle</surname><given-names>D. L.</given-names></name><name><surname>Davidson</surname><given-names>H. J.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Mimecan/osteoglycin-deficient mice have collagen fibril abnormalities</article-title>. <source>Mol. Vis.</source>
<volume>8</volume>, <fpage>407</fpage>&#x02013;<lpage>415</lpage>.<pub-id pub-id-type="pmid">12432342</pub-id></mixed-citation></ref><ref id="B208"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tillgren</surname><given-names>V.</given-names></name><name><surname>Onnerfjord</surname><given-names>P.</given-names></name><name><surname>Haglund</surname><given-names>L.</given-names></name><name><surname>Heinegard</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>The tyrosine sulfate-rich domains of the LRR proteins fibromodulin and osteoadherin bind motifs of basic clusters in a variety of heparin-binding proteins, including bioactive factors</article-title>. <source>J. Biol. Chem.</source>
<volume>284</volume> (<issue>42</issue>), <fpage>28543</fpage>&#x02013;<lpage>28553</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.047076</pub-id>
<pub-id pub-id-type="pmid">19700767</pub-id></mixed-citation></ref><ref id="B209"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tracy</surname><given-names>L. E.</given-names></name><name><surname>Minasian</surname><given-names>R. A.</given-names></name><name><surname>Caterson</surname><given-names>E. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Extracellular matrix and dermal fibroblast function in the healing wound</article-title>. <source>Adv. In Wound Care</source>
<volume>5</volume> (<issue>3</issue>), <fpage>119</fpage>&#x02013;<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1089/wound.2014.0561</pub-id>
</mixed-citation></ref><ref id="B210"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tran</surname><given-names>K. T.</given-names></name><name><surname>Griffith</surname><given-names>L.</given-names></name><name><surname>Wells</surname><given-names>A.</given-names></name></person-group> (<year>2004</year>). <article-title>Extracellular matrix signaling through growth factor receptors during wound healing</article-title>. <source>Wound Repair Regener.</source>
<volume>12</volume> (<issue>3</issue>), <fpage>262</fpage>&#x02013;<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1111/j.1067-1927.2004.012302.x</pub-id>
</mixed-citation></ref><ref id="B211"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tziotzios</surname><given-names>C.</given-names></name><name><surname>Profyris</surname><given-names>C.</given-names></name><name><surname>Sterling</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Cutaneous scarring: pathophysiology, molecular mechanisms, and scar reduction therapeutics part II. Strategies to reduce scar formation after dermatologic procedures</article-title>. <source>J. Am. Acad. Dermatol.</source>
<volume>66</volume> (<issue>1</issue>), <fpage>13</fpage>&#x02013;<lpage>24</lpage>; quiz 25-16. <pub-id pub-id-type="doi">10.1016/j.jaad.2011.08.035</pub-id>
<pub-id pub-id-type="pmid">22177632</pub-id></mixed-citation></ref><ref id="B212"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Velasco</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>DiPietro</surname><given-names>L.</given-names></name><name><surname>Stepp</surname><given-names>M. A.</given-names></name><name><surname>Sandy</surname><given-names>J. D.</given-names></name><name><surname>Plaas</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Adamts5 deletion blocks murine dermal repair through CD44-mediated aggrecan accumulation and modulation of transforming growth factor beta1 (TGFbeta1) signaling</article-title>. <source>J. Biol. Chem.</source>
<volume>286</volume> (<issue>29</issue>), <fpage>26016</fpage>&#x02013;<lpage>26027</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.208694</pub-id>
<pub-id pub-id-type="pmid">21566131</pub-id></mixed-citation></ref><ref id="B213"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Velez-Delvalle</surname><given-names>C.</given-names></name><name><surname>Marsch-Moreno</surname><given-names>M.</given-names></name><name><surname>Castro-Munozledo</surname><given-names>F.</given-names></name><name><surname>Bolivar-Flores</surname><given-names>Y. J.</given-names></name><name><surname>Kuri-Harcuch</surname><given-names>W.</given-names></name></person-group> (<year>2008</year>). <article-title>Fibromodulin gene is expressed in human epidermal keratinocytes in culture and in human epidermis <italic>in vivo</italic>
</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<volume>371</volume> (<issue>3</issue>), <fpage>420</fpage>&#x02013;<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2008.04.095</pub-id>
<pub-id pub-id-type="pmid">18448071</pub-id></mixed-citation></ref><ref id="B214"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vestweber</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>How leukocytes cross the vascular endothelium</article-title>. <source>Nat. Rev. Immunol.</source>
<volume>15</volume> (<issue>11</issue>), <fpage>692</fpage>. <pub-id pub-id-type="doi">10.1038/nri3908</pub-id>
<pub-id pub-id-type="pmid">26471775</pub-id></mixed-citation></ref><ref id="B215"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vial</surname><given-names>C.</given-names></name><name><surname>Gutierrez</surname><given-names>J.</given-names></name><name><surname>Santander</surname><given-names>C.</given-names></name><name><surname>Cabrera</surname><given-names>D.</given-names></name><name><surname>Brandan</surname><given-names>E.</given-names></name></person-group> (<year>2011</year>). <article-title>Decorin interacts with connective tissue growth factor (CTGF)/CCN2 by LRR12 inhibiting its biological activity</article-title>. <source>J. Biol. Chem.</source>
<volume>286</volume> (<issue>27</issue>), <fpage>24242</fpage>&#x02013;<lpage>24252</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.189365</pub-id>
<pub-id pub-id-type="pmid">21454550</pub-id></mixed-citation></ref><ref id="B216"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vij</surname><given-names>N.</given-names></name><name><surname>Roberts</surname><given-names>L.</given-names></name><name><surname>Joyce</surname><given-names>S.</given-names></name><name><surname>Chakravarti</surname><given-names>S.</given-names></name></person-group> (<year>2005</year>). <article-title>Lumican regulates corneal inflammatory responses by modulating Fas-Fas ligand signaling</article-title>. <source>Invest. Ophthalmol. Vis. Sci.</source>
<volume>46</volume> (<issue>1</issue>), <fpage>88</fpage>&#x02013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.04-0833</pub-id>
<pub-id pub-id-type="pmid">15623759</pub-id></mixed-citation></ref><ref id="B217"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vuillermoz</surname><given-names>B.</given-names></name><name><surname>Wegrowski</surname><given-names>Y.</given-names></name><name><surname>Contet-Audonneau</surname><given-names>J. L.</given-names></name><name><surname>Danoux</surname><given-names>L.</given-names></name><name><surname>Pauly</surname><given-names>G.</given-names></name><name><surname>Maquart</surname><given-names>F. X.</given-names></name></person-group> (<year>2005</year>). <article-title>Influence of aging on glycosaminoglycans and small leucine-rich proteoglycans production by skin fibroblasts</article-title>. <source>Mol. Cell Biochem.</source>
<volume>277</volume> (<issue>1-2</issue>), <fpage>63</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1007/s11010-005-5073-x</pub-id>
<pub-id pub-id-type="pmid">16132716</pub-id></mixed-citation></ref><ref id="B218"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vynios</surname><given-names>D. H.</given-names></name></person-group> (<year>2014</year>). <article-title>Metabolism of cartilage proteoglycans in health and disease</article-title>. <source>BioMed. Res. Int.</source>
<volume>2014</volume>, <fpage>9</fpage>. <pub-id pub-id-type="doi">10.1155/2014/452315</pub-id>
</mixed-citation></ref><ref id="B219"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Walraven</surname><given-names>M.</given-names></name><name><surname>Beelen</surname><given-names>R. H.</given-names></name><name><surname>Ulrich</surname><given-names>M. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Transforming growth factor-beta (TGF-beta) signaling in healthy human fetal skin: a descriptive study</article-title>. <source>J. Dermatol. Sci.</source>
<volume>78</volume> (<issue>2</issue>), <fpage>117</fpage>&#x02013;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1016/j.jdermsci.2015.02.012</pub-id>
<pub-id pub-id-type="pmid">25795202</pub-id></mixed-citation></ref><ref id="B220"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Dodd</surname><given-names>C.</given-names></name><name><surname>Shankowsky</surname><given-names>H. A.</given-names></name><name><surname>Scott</surname><given-names>P. G.</given-names></name><name><surname>Tredget</surname><given-names>E. E.</given-names></name><name><surname>Wound Healing Research</surname><given-names>G.</given-names></name></person-group> (<year>2008</year>). <article-title>Deep dermal fibroblasts contribute to hypertrophic scarring</article-title>. <source>Lab. Invest.</source>
<volume>88</volume> (<issue>12</issue>), <fpage>1278</fpage>&#x02013;<lpage>1290</lpage>. <pub-id pub-id-type="doi">10.1038/labinvest.2008.101</pub-id>
<pub-id pub-id-type="pmid">18955978</pub-id></mixed-citation></ref><ref id="B221"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Westergren-Thorsson</surname><given-names>G.</given-names></name><name><surname>Coster</surname><given-names>L.</given-names></name><name><surname>Akesson</surname><given-names>A.</given-names></name><name><surname>Wollheim</surname><given-names>F. A.</given-names></name></person-group> (<year>1996</year>). <article-title>Altered dermatan sulfate proteoglycan synthesis in fibroblast cultures established from skin of patients with systemic sclerosis</article-title>. <source>J. Rheumatol.</source>
<volume>23</volume> (<issue>8</issue>), <fpage>1398</fpage>&#x02013;<lpage>1406</lpage>.<pub-id pub-id-type="pmid">8856620</pub-id></mixed-citation></ref><ref id="B222"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wight</surname><given-names>T. N.</given-names></name><name><surname>Kinsella</surname><given-names>M. G.</given-names></name><name><surname>Qwarnstr&#x000f6;m</surname><given-names>E. E.</given-names></name></person-group> (<year>1992</year>). <article-title>The role of proteoglycans in cell adhesion, migration and proliferation</article-title>. <source>Curr. Opin. In Cell Biol.</source>
<volume>4</volume> (<issue>5</issue>), <fpage>793</fpage>&#x02013;<lpage>801</lpage>. <pub-id pub-id-type="doi">10.1016/0955-0674(92)90102-i</pub-id>
<pub-id pub-id-type="pmid">1419056</pub-id></mixed-citation></ref><ref id="B223"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Williams</surname><given-names>K. E.</given-names></name><name><surname>Fulford</surname><given-names>L. A.</given-names></name><name><surname>Albig</surname><given-names>A. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Lumican reduces tumor growth <italic>via</italic> induction of fas-mediated endothelial cell apoptosis</article-title>. <source>Cancer Microenviron.</source>
<volume>4</volume> (<issue>1</issue>), <fpage>115</fpage>&#x02013;<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1007/s12307-010-0056-1</pub-id>
</mixed-citation></ref><ref id="B224"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>F.</given-names></name><name><surname>Vij</surname><given-names>N.</given-names></name><name><surname>Roberts</surname><given-names>L.</given-names></name><name><surname>Lopez-Briones</surname><given-names>S.</given-names></name><name><surname>Joyce</surname><given-names>S.</given-names></name><name><surname>Chakravarti</surname><given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>A novel role of the lumican core protein in bacterial lipopolysaccharide-induced innate immune response</article-title>. <source>J. Biol. Chem.</source>
<volume>282</volume> (<issue>36</issue>), <fpage>26409</fpage>&#x02013;<lpage>26417</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M702402200</pub-id>
<pub-id pub-id-type="pmid">17616530</pub-id></mixed-citation></ref><ref id="B225"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xie</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>K. Q.</given-names></name><name><surname>Deubner</surname><given-names>H.</given-names></name><name><surname>Emerson</surname><given-names>D. A.</given-names></name><name><surname>Carrougher</surname><given-names>G. J.</given-names></name><name><surname>Gibran</surname><given-names>N. S.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>The microvasculature in cutaneous wound healing in the female red Duroc pig is similar to that in human hypertrophic scars and different from that in the female Yorkshire pig</article-title>. <source>J. Burn Care Res.</source>
<volume>28</volume> (<issue>3</issue>), <fpage>500</fpage>&#x02013;<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1097/bcr.0b013e318053dafe</pub-id>
<pub-id pub-id-type="pmid">17438498</pub-id></mixed-citation></ref><ref id="B226"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xing</surname><given-names>X.</given-names></name><name><surname>Gu</surname><given-names>X.</given-names></name><name><surname>Ma</surname><given-names>T.</given-names></name><name><surname>Ye</surname><given-names>H.</given-names></name></person-group> (<year>2015</year>). <article-title>Biglycan up-regulated vascular endothelial growth factor (VEGF) expression and promoted angiogenesis in colon cancer</article-title>. <source>Tumor Biol.</source>
<volume>36</volume> (<issue>3</issue>), <fpage>1773</fpage>&#x02013;<lpage>1780</lpage>. <pub-id pub-id-type="doi">10.1007/s13277-014-2779-y</pub-id>
</mixed-citation></ref><ref id="B227"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>K.</given-names></name><name><surname>Ohga</surname><given-names>N.</given-names></name><name><surname>Hida</surname><given-names>Y.</given-names></name><name><surname>Maishi</surname><given-names>N.</given-names></name><name><surname>Kawamoto</surname><given-names>T.</given-names></name><name><surname>Kitayama</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells</article-title>. <source>Br. J. Cancer</source>
<volume>106</volume> (<issue>6</issue>), <fpage>1214</fpage>&#x02013;<lpage>1223</lpage>. <pub-id pub-id-type="doi">10.1038/bjc.2012.59</pub-id>
<pub-id pub-id-type="pmid">22374465</pub-id></mixed-citation></ref><ref id="B228"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamanaka</surname><given-names>O.</given-names></name><name><surname>Yuan</surname><given-names>Y.</given-names></name><name><surname>Coulson-Thomas</surname><given-names>V. J.</given-names></name><name><surname>Gesteira</surname><given-names>T. F.</given-names></name><name><surname>Call</surname><given-names>M. K.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Lumican binds ALK5 to promote epithelium wound healing</article-title>. <source>PloS One</source>
<volume>8</volume> (<issue>12</issue>), <elocation-id>e82730</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0082730</pub-id>
<pub-id pub-id-type="pmid">24367547</pub-id></mixed-citation></ref><ref id="B229"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ye</surname><given-names>Z.</given-names></name><name><surname>Houssein</surname><given-names>H. S.</given-names></name><name><surname>Mahato</surname><given-names>R. I.</given-names></name></person-group> (<year>2007</year>). <article-title>Bioconjugation of oligonucleotides for treating liver fibrosis</article-title>. <source>Oligonucleotides</source>
<volume>17</volume> (<issue>4</issue>), <fpage>349</fpage>&#x02013;<lpage>404</lpage>. <pub-id pub-id-type="doi">10.1089/oli.2007.0097</pub-id>
<pub-id pub-id-type="pmid">18154454</pub-id></mixed-citation></ref><ref id="B230"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yeh</surname><given-names>J. T.</given-names></name><name><surname>Yeh</surname><given-names>L. K.</given-names></name><name><surname>Jung</surname><given-names>S. M.</given-names></name><name><surname>Chang</surname><given-names>T. J.</given-names></name><name><surname>Wu</surname><given-names>H. H.</given-names></name><name><surname>Shiu</surname><given-names>T. F.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Impaired skin wound healing in lumican-null mice</article-title>. <source>Br. J. Dermatol.</source>
<volume>163</volume> (<issue>6</issue>), <fpage>1174</fpage>&#x02013;<lpage>1180</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2133.2010.10008.x</pub-id>
<pub-id pub-id-type="pmid">20738297</pub-id></mixed-citation></ref><ref id="B231"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ying</surname><given-names>S.</given-names></name><name><surname>Shiraishi</surname><given-names>A.</given-names></name><name><surname>Kao</surname><given-names>C. W.</given-names></name><name><surname>Converse</surname><given-names>R. L.</given-names></name><name><surname>Funderburgh</surname><given-names>J. L.</given-names></name><name><surname>Swiergiel</surname><given-names>J.</given-names></name><etal/></person-group> (<year>1997</year>). <article-title>Characterization and expression of the mouse lumican gene</article-title>. <source>J. Biol. Chem.</source>
<volume>272</volume> (<issue>48</issue>), <fpage>30306</fpage>&#x02013;<lpage>30313</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.272.48.30306</pub-id>
<pub-id pub-id-type="pmid">9374517</pub-id></mixed-citation></ref><ref id="B232"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>X. J.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>Y. Y.</given-names></name><name><surname>Xu</surname><given-names>W. S.</given-names></name></person-group> (<year>2007</year>). <article-title>Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts</article-title>. <source>Burns</source>
<volume>33</volume> (<issue>5</issue>), <fpage>634</fpage>&#x02013;<lpage>641</lpage>. <pub-id pub-id-type="doi">10.1016/j.burns.2006.08.018</pub-id>
<pub-id pub-id-type="pmid">17374457</pub-id></mixed-citation></ref><ref id="B233"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Garron</surname><given-names>T. M.</given-names></name><name><surname>Li</surname><given-names>X. J.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>Y. Y.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Recombinant human decorin inhibits TGF-beta1-induced contraction of collagen lattice by hypertrophic scar fibroblasts</article-title>. <source>Burns</source>
<volume>35</volume> (<issue>4</issue>), <fpage>527</fpage>&#x02013;<lpage>537</lpage>. <pub-id pub-id-type="doi">10.1016/j.burns.2008.08.021</pub-id>
<pub-id pub-id-type="pmid">19167828</pub-id></mixed-citation></ref><ref id="B234"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H. J.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>H. F.</given-names></name><name><surname>Zhang</surname><given-names>X. N.</given-names></name><name><surname>Zhan</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>F. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Overexpression of mimecan in human aortic smooth muscle cells inhibits cell proliferation and enhances apoptosis and migration</article-title>. <source>Exp. Ther. Med.</source>
<volume>10</volume> (<issue>1</issue>), <fpage>187</fpage>&#x02013;<lpage>192</lpage>. <pub-id pub-id-type="doi">10.3892/etm.2015.2444</pub-id>
<pub-id pub-id-type="pmid">26170933</pub-id></mixed-citation></ref><ref id="B235"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>He</surname><given-names>Z.</given-names></name><name><surname>Cui</surname><given-names>L.</given-names></name><name><surname>Lv</surname><given-names>X.</given-names></name></person-group> (<year>2016</year>). <article-title>Lumican alleviates hypertrophic scarring by suppressing integrin-FAK signaling</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<volume>480</volume> (<issue>2</issue>), <fpage>153</fpage>&#x02013;<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2016.09.159</pub-id>
<pub-id pub-id-type="pmid">27693693</pub-id></mixed-citation></ref><ref id="B236"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Z.</given-names></name><name><surname>Nguyen</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Khorasani</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>J. Z.</given-names></name><name><surname>Zara</surname><given-names>J. N.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Delayed wound closure in fibromodulin-deficient mice is associated with increased TGF-&#x003b2;3 signaling</article-title>. <source>J. Invest. Dermatol.</source>
<volume>131</volume> (<issue>3</issue>), <fpage>769</fpage>&#x02013;<lpage>778</lpage>. <pub-id pub-id-type="doi">10.1038/jid.2010.381</pub-id>
<pub-id pub-id-type="pmid">21191417</pub-id></mixed-citation></ref><ref id="B237"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Z.</given-names></name><name><surname>Jian</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Zara</surname><given-names>J. N.</given-names></name><name><surname>Yin</surname><given-names>W.</given-names></name><name><surname>Chiang</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Reprogramming of human fibroblasts into multipotent cells with a single ECM proteoglycan, fibromodulin</article-title>. <source>Biomaterials</source>
<volume>33</volume> (<issue>24</issue>), <fpage>5821</fpage>&#x02013;<lpage>5831</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2012.04.049</pub-id>
<pub-id pub-id-type="pmid">22622142</pub-id></mixed-citation></ref><ref id="B238"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Z.</given-names></name><name><surname>Jian</surname><given-names>J.</given-names></name><name><surname>Velasco</surname><given-names>O.</given-names></name><name><surname>Hsu</surname><given-names>C. Y.</given-names></name><name><surname>Zhang</surname><given-names>K.</given-names></name><name><surname>Levin</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2014</year>a). <article-title>Fibromodulin enhances angiogenesis during cutaneous wound healing</article-title>. <source>Plast Reconstr. Surg. Glob. Open</source>
<volume>2</volume> (<issue>12</issue>), <fpage>e275</fpage>. <pub-id pub-id-type="doi">10.1097/gox.0000000000000243</pub-id>
<pub-id pub-id-type="pmid">25587509</pub-id></mixed-citation></ref><ref id="B239"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Z.</given-names></name><name><surname>Lee</surname><given-names>K. S.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Nguyen</surname><given-names>C.</given-names></name><name><surname>Hsu</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>J. Z.</given-names></name><etal/></person-group> (<year>2014</year>b). <article-title>Fibromodulin-deficiency alters temporospatial expression patterns of transforming growth factor-beta ligands and receptors during adult mouse skin wound healing</article-title>. <source>PloS One</source>
<volume>9</volume> (<issue>6</issue>), <elocation-id>e90817</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0090817</pub-id>
<pub-id pub-id-type="pmid">24603701</pub-id></mixed-citation></ref><ref id="B240"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Dang</surname><given-names>C.</given-names></name><name><surname>Beanes</surname><given-names>S.</given-names></name><name><surname>Chang</surname><given-names>G. X.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Fibromodulin Is Essential for Fetal-Type Scarless Cutaneous Wound Healing</article-title>. <source>Am. J. Pathol.</source>
<volume>186</volume> (<issue>11</issue>), <fpage>2824</fpage>&#x02013;<lpage>2832</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajpath.2016.07.023</pub-id>
<pub-id pub-id-type="pmid">27665369</pub-id></mixed-citation></ref><ref id="B241"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Z.</given-names></name><name><surname>James</surname><given-names>A. W.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Jiang</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>J. Z.</given-names></name><name><surname>Chang</surname><given-names>G. X.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Fibromodulin reduces scar formation in adult cutaneous wounds by eliciting a fetal-like phenotype</article-title>. <source>Signal Transduct. Target Ther.</source>
<volume>2</volume>, <fpage>1</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1038/sigtrans.2017.50</pub-id>
</mixed-citation></ref><ref id="B242"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Ha</surname><given-names>P.</given-names></name><name><surname>Chang</surname><given-names>G. X.</given-names></name><name><surname>Yang</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>CDKN2B upregulation prevents teratoma formation in multipotent fibromodulin-reprogrammed cells</article-title>. <source>J. Clin. Invest.</source>
<volume>129</volume> (<issue>8</issue>), <fpage>3236</fpage>&#x02013;<lpage>3251</lpage>. <pub-id pub-id-type="doi">10.1172/jci125015</pub-id>
<pub-id pub-id-type="pmid">31305260</pub-id></mixed-citation></ref><ref id="B243"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhu</surname><given-names>K. Q.</given-names></name><name><surname>Carrougher</surname><given-names>G. J.</given-names></name><name><surname>Gibran</surname><given-names>N. S.</given-names></name><name><surname>Isik</surname><given-names>F. F.</given-names></name><name><surname>Engrav</surname><given-names>L. H.</given-names></name></person-group> (<year>2007</year>). <article-title>Review of the female Duroc/Yorkshire pig model of human fibroproliferative scarring</article-title>. <source>Wound Repair Regen.</source>
<volume>15</volume>, <fpage>S32</fpage>&#x02013;<lpage>S39</lpage>. <pub-id pub-id-type="doi">10.1111/j.1524-475X.2007.00223.x</pub-id>
<pub-id pub-id-type="pmid">17727465</pub-id></mixed-citation></ref></ref-list></back></article>